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Abstract 
The World Health Organisation estimates that more than 40% of the world's 
population is at risk of malaria infection, and that between 250400 million people live 
in areas where malaria is endemic. Neither drug administration nor vector control has 
fulfilled early hopes that malaria eradication might be possible. Instead insecticide and 
drug resistance have become worse problems in malarious areas. A greater 
understanding of the genetics and molecular biology of the parasite is therefore 
needed in order to develop novel chemotherapeutic, and possibly vaccine based, 
control strategies. One aspect of the parasite's biology which is both poorly 
understood and represents a potential target for anti-parasite intervention is the 
regulation of the cell cycle during intracellular development. 
The research outlined in this thesis was primarily designed to study certain 
genes and their encoded proteins which regulate the development of the malaria 
parasite, Piasmodiumfalciparum, through its intra-erythrocytic life cycle. The work 
has involved molecular cloning and characterisation of a P. falciparum homologue of 
the ras-related nuclear GTP-binding protein, RanITC4. This protein has been shown 
to play a key role in control of the cell cycle in mammalian and yeast systems. in this 
work, the homologous P. falciparum gene, pfran, has been cloned and characterised. 
Its predicted protein product is 214 amino acids long and contains consensus motifs 
found in the Ras superfamily. The expression of a 1.5 kb pfran transcript has been 
found to change during the cell cycle, reaching a peak at the trophozoite and schizont 
stages. Western blotting and immunoprecipitation using a polyclonal antiserum raised 
against the expressed protein have shown that pfran encodes a protein 27 kDa in size. 
Immunofluorescence assays have shown that pfran is localised in both the nucleus and 
cytoplasm of the parasite. Some experiments were undertaken to express pfran in 
yeast which had only limited success. 
Ran/TC4 is proposed to function in conjunction with the chromatin-binding 
protein RCC1, (regulator of chromosome condensation), to couple completion of 
DNA synthesis with initiation of mitosis. In response to completion of DNA 
synthesis Ran-RCC1 complex activate the cyclin-p34 CDC2 complex which initiate 
entry into mitosis. To understand better the regulation of the cell cycle in malaria 
parasites, and the role of Ran in this process, the P. falciparum homologue of the 
RCC 1 has been cloned and partially sequenced. Expression of this gene and its 
possible association with pfran have been studied. 
The implications of these findings are discussed in the thesis. 
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Malaria is caused by a protozoan parasite of the genus Plasmodium. More 
than 100 Plasmodium species infecting a wide range of hosts, including reptiles, 
birds, rodents and primates, have been identified. Each parasite species exhibits a 
narrow host specificity. Four species; P. vivax, P. malariae, P. ovale and P. 
falciparum, cause disease in man. The disease is transmitted to the vertebrate host by 
the bite of the female Anopheline mosquito. 
1.1 The current global malaria situation 
Malaria is the most important tropical parasitic disease, causing great morbidity 
and mortality. Control is becoming increasingly difficult and the epidemiological 
situation is deteriorating at present. Some 300 million people are believed to be 
infected with malaria parasites every year, and around 90% of these people are living in 
tropical Africa (W.H.O. 1992). Of the four species that infect man, P. falciparum 
accounts for most of the infections in Africa and for over one third of infections in the 
rest of the world. More than 2 billion people, nearly 40% of the world's population, 
are at risk (W.H.O.1992). Although virtually no reliable statistics exist on malaria 
morbidity and mortality in Africa, extrapolations from epidemiological studies suggest 
that the disease is probably responsible for between 500,000 to 1.2 million deaths 
annually, mainly among African children below the age of 5 years (W.H.O.1992). 
World-wide, it is estimated that there are about 120 million clinical cases of malaria per 
year. This enormous total of lives and days of labour lost plus the costs of treatment 
and the negative impact of the disease on development make malaria a major social and 
economic burden. 
The clinical symptoms of malaria are caused by the development of the parasite 
in red blood cells. The main symptom is fever, which shows a clear cyclic pattern in 
all but P. falciparum infections. Falciparum malaria is the most dangerous form of the 
disease largely because it can have life-threatening complications such as anaemia and 
cerebral malaria. Many infected people are partially protected from complications by 
immunity acquired from previous recent infections. Severe complications are found 
mostly in the relatively non-immunes, notably children, expatriates and migratory 
workers, entering highly endemic areas, and in the inhabitants of areas with unstable 
endemicity. 
Control programmes which, by 1970, had been successful in eradicating 
malaria from some non-tropical malarious areas, have failed in the tropics (Bruce-
Chwatt, 1985). This has been due to many causes, e.g. the development and spread 
of drug resistant parasite strains and vector resistance to insecticides. In endemic 
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areas, population movements have brought infected individuals into relatively malaria-
free areas and as well as non-immune individuals into areas of higher malaria risk. 
Significantly, long term implementation of control programmes have also become 
beyond the administrative capacities of almost all poor countries. In the developed 
world, strategies of malaria control have been directed towards designing new anti-
malarial drugs and vaccines. These 'knowledge intensive' strategies require a greater 
understanding of the biochemistry and molecular cell biology of the parasite. 
Metabolic or developmental pathways in the parasite that differ from those of the host, 
or enzymes that differ structurally or functionally from the mammalian enzymes, could 
be exploited as drug targets. 
In this chapter I will attempt to review the current knowledge on the molecular 
biology of the parasite life cycle. Where appropriate, comparisons and contrasts will 
be drawn with other parasites and organisms to illustrate similarities, and to highlight 
any differences. 
1.2 The life cycle of malaria parasites 
All four human malaria species have essentially the same life-cycle (Fig. 1. 1), 
alternating between vertebrate and arthropod hosts. The part of the life-cycle which 
occurs in the human host is predominantly asexual, although gametocytes are formed 
in this host. The sexual cycle and sporogony take place in the female Anopheles 
mosquito. 
Infections in man are initiated through the bite of an infected anopheline 
mosquito. While taking the blood meal the mosquito injects saliva containing 
sporozoites into the host skin capillary bed. The motile sporozoites travel to the liver, 
where they enter parenchymal cells (hepatocytes). Inside a hepatocyte, the parasite 
undergoes a series of rapid mitotic divisions to produce thousands of merozoites, a 
process called pre- or exo-erythrocytic schizogony. After 6-10 days, depending on 
species, the hepatocytes burst, releasing the merozoites into the blood stream where 
they rapidly enter erythrocytes and begin erythrocytic schizogony. The merozoite 
develops into the "ring" stage, which then grows through the trophozoite to the mature 
schizont, which contains 8-32 daughter merozoites. After the red cell ruptures, these 
merozoites initiate subsequent intra-erythrocytic cycles of development. Intra-
erythrocytic development becomes synchronous, with a generation time of 48 hours 
for P. falciparum, P. vivax and P. ovale, or 72 hours for P. malariae. Since red 
blood cell rupture and the release of parasites into the blood stream causes fever, early 
stages of the infection are characterised by constant or fluctuating fevers, but as the 
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Figure 1.1 
Life-cycle of the malaria parasite Plasmodiumfalciparum. Reproduced, with 
permission, from Hadley, Koltz and Miller (1986), Annual Review of Microbiology, 
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development of the parasite in the red blood cells becomes synchronous, typical 
periodic fevers occur. 
After a period of asexual replication, a proportion of intra-erythrocytic 
merozoites differentiate into macrogametocytes (female) and microgametocytes (male), 
and these sexual forms, when taken up by the mosquito, continue the life cycle in this 
host. Only mature gametocytes survive digestion and undergo further development 
(gametogenesis). The microgametocyte undergoes a process of rapid DNA replication 
in the gut of the mosquito to produce eight flagellated cells, termed microgametes. The 
macrogametocyte, on shedding the red blood cell membrane, becomes the 
macrogamete. The microgametes exflagellate and one of them fertilises the 
macrogamete to form a diploid zygote. Maturation of the zygote results in the first 
meiotic division shortly after fertilisation, and it is assumed that a second meiotic 
division follows (Sinden and Hartley 1985). Over the next 12-18 hours the zygote 
develops into an ookinete which, on maturation, passes through the mid-gut 
epithelium to rest between the basement cell membrane and the basal lamina of the 
mid-gut wall. Here, it differentiates into an oocyst which enlarges and matures over 
the next 10-12 days. During sporogonic development, the nuclei undergo divisions 
and several thousand sporozoites are formed, each containing a single nucleus. 
Eventually the elongated, motile, sporozoites are released from the oocyst and move 
through the insect's haemocoel to penetrate the salivary glands, to await transmission 
to the vertebrate host. 
1.3 The genome of malaria parasites 
Sequences of malaria parasite genes are characteristically eukaryotic in nature 
with introns, capped and polyadenylated RNA and small nuclear ribonucleoproteins 
(Hyde et al., 1984; Francoeur et al., 1985). The DNA is enclosed within a nuclear 
envelope and bound to histones, and presumably packaged into nucleosomes 
(Wunderlich et al., 1980; Ponzi et al., 1985; Dore et al., 1986), although little is 
known about the detailed nuclear organisation of the parasite. 
1.3.1 Genome Size: The total amount of DNA of the haploid genome, 
expressed in picograms (pg) or in base pairs (bp), is a characteristic of each living 
species, and can be described as genome size, genome complexity or C-value. Table 
(1) shows estimates of genome sizes of different Plasmodiwn species. The estimates 
vary widely, even for a single species, and range from 1x10 7 to 3.0x107 bp. The 
genome size of 1-3 x 107  bp, established for P. falciparum has been confirmed in 
several laboratories by determination of the yield of isolated parasite DNA, and by the 
cloning of size-selected genomic DNA restriction enzyme fragments (Goman et al., 
1982; Pollack et al., 1982; Wellems et al., 1987). The best estimates result from 
recent genome mapping work and are in the range of 30 megabases of DNA (3x10 7 
bp) (Walker-Jonah et al., 1992). The malaria parasite genome is thus about 6 times 
the genome size of Escherichia coli, twice that of yeast, one third of Caenorhabiditis 
elegans and less than one hundredth of the human haploid genome. 
Table 1: Estimates of the genome size of different Plasniodium species. 
Plas,nodium Genome size in references 
species base pairs  
P. falciparum 1-2 x107 bp Goman et al. (1982) 
2 x107 bp Pollack et al.(1982) 
3 x107 bp Wellems et al. (1987) 
P. berghei 1.5 x 107 bp Dore etal.(1980) 
2.5 x 107 bp Cornelissen etal(1984) 
P. knowlesi 1.9 x 107  bp Guttendge etal. (1971) 
P. yoelii 1.5 x 107  bp Dore etal. (1980) 
Birago et al. (1982) 
Casaglia etal. (1985a) 
1.3.2 Base composition of DNA: The base composition of the nuclear 
DNA differs among the various mammalian malaria species. The guanine-cytosine 
(G+C) content of P. falciparum (Goman et al., 1982; Pollack et al., 1982; McCutchan 
et al., 1984), P. berghei, P. vinckei and P. chabaudi (McCutchan et al., 1984) has 
been reported to be around 18% which is considerably lower than the G+C content of 
host DNA (37%). The slightly higher values (23-24%) for P. berghei and P. vinckei 
found in earlier investigations (Guttendge etal., 1971; Dore etal., 1980) can probably 
be attributed to contamination with host DNA (McCutchan et al., 1984). In 
comparison to the these species, the primate parasites P. know!esi and P.fragi!e show 
a much higher G+C content: 30-38% (Gutteridge et al., 1971; McCutchan et al., 
1984) and 30% (McCutchan et al., 1984), respectively, while the DNAs of P. 
cynomo!gi and P. vivax consist of two components, one with a low (about 20%) and 
the other with a high (about 30%) G+C content (McCutchan etal., 1984). 
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1.3.3 Molecular karyotype Malaria parasite chromosomes do not condense in 
mitotic divisions during asexual multiplication and so cannot be visualised by light 
microscopy (Bahr and Mike!, 1972). However, using electron microscopy, 
condensed chromatin has been found during the final stages of microgamete formation 
in the rodent malaria parasite P. yoelii (Sinden et al., 1976). 
The development of pulsed field gradient electrophoresis (PFGE) made it 
possible to separate P. falciparum chromosomes on agarose gels ( Kemp et al., 1985, 
Van der Ploeg et al., 1985), showing the genome of P.falciparum to contain 14 
distinct chromosomes (Kemp et al., 1987b; Wellems et al., 1987). This figure is in 
agreement with the number of kinetochores, the attachment sites of chromosomes to 
spindle microtubules, in serial sections of mitotic spindles visualised by electron 
microscopy (Prensier and Slomianny 1986; Sinden and Strong, 1987). All species of 
Plasmodium studied to date appear to have 14 chromosomes (Langsley et al., 1987; 
Sharkey et al., 1988; Sheppard et al., 1989). Many genes have now been mapped to 
their chromosomes by blotting and hybridisation techniques (Kemp et al., 1990; 
Walker-Jonah et al., 1992). Currently the construction of yeast artificial 
chromosomes (YACs) containing large segments of Plasmodium chromosomes is 
proving to be an important technique for making a complete malaria genome map 
(Triglia and Kemp, 1991; Watanabe and Inselburg, 1994) 
The sizes of P. falciparum chromosomes range from 630 kilobases (kb) for 
the smallest (chromosome 1) to about 3.5 megabases for the larger chromosomes 
(Triglia et al., 1992). The sizes of homologous chromosomes vary widely among 
isolates; an individual chromosome may vary in size by several hundred kilobases, 
both in parasites recently isolated from patients, and in isolates maintained in culture 
over long periods of time (Corcoran et al., 1986). PFGE fractionation of 
chromosomes from the progeny of a genetic cross carried out by Walliker and 
colleagues (1987), revealed considerably more chromosomal size polymorphism than 
in the parent clones, suggesting that size polymorphism may be generated during 
meiosis. This has also been found in other malaria parasites such as P. chabaudi, P. 
vinckei and P. berghei (Sharkey et al., 1988; Janse et al., 1986b). During asexual 
division which is only mitotic, DNA rearrangements can occur in the subtelomeric 
regions of the chromosomes (Janse et al., 1992). Such size variations in the 
chromosomes of P. berghei appear to be mainly due to variation in the copy number 
of 2.3 kb. repeats, generated by either deletion or expansion of this repeat unit (Pace 
etal., 1991). 
The fluidity of the genome of P. falciparum is in accordance with observations 
on other protozoa. In Trypanosoma brucei, genes for the variant surface 
glycoproteins (VSGs) of the surface coat of the parasite undergo re-arrangements that 
regulate their expression (Van der Ploeg et al., 1984). This involves the transposition 
of large segments of DNA from one chromosome to another to produce marked 
chromosome size polymorphisms (Van der Ploeg and Cornelissen, 1984). 
Chromosome size polymorphisms in P. falciparum do not appear to involve inter-
chromosomal exchange of large segments of DNA (Corcoran et al., 1986), and it is 
possible that these polymorphisms can be attributed to changes in the abundance of 
repetitive DNA present in the genome in the absence of strong selective pressure. 
Recombination events within these blocks of repeats, particularly in the sub-telomenc 
repeats, have been shown to account largely for chromosome size polymorphisms 
(Oquendo et al., 1986). Thus, in contrast to T. brucei , intra-chromosomal deletions 
and duplications rather than inter-chromosomal translocation appears to be the 
predominant mechanism responsible for length polymorphism. Analysis of molecular 
karyotypes of Leishmania species and strains by PFGE has also revealed chromosome 
size polymorphisms similar to those in P. falciparum (Spithill and Samaras, 1987). 
1.3.4 Repetitive DNA: Repetitive DNA sequences (repDNA) have been 
reported for several malaria species. About 10% of the DNA of P. falciparum 
consists of repetitive sequences (Hough-Evans & Howard, 1982). In P. berghei and 
P. yoelii , repDNA fractions were found to be 5-11% and 9-17%, respectively (Dore 
et al., 1980; Birago etal., 1982; Casaglia etal., 1985b). 
Restriction enzyme analyses of total DNA of P. falciparum has shown 
significant differences in the arrangement of repetitive sequences between isolates 
from different geographical origins and between clones from a single isolate (Goman 
et al., 1982; Bhasin et al., 1985; Oquendo etal., 1986). Even within a cloned line the 
arrangement of repDNA sequences changed after a six month culture period (Bhasin et 
al., 1985), further confirming the relative plasticity of the genome. Cloned repetitive 
sequences from P. falciparum did not cross-hybridise with DNA of other malaria 
species (Guntaka et al., 1985; Aslund et al., 1985; Bhasin et al., 1985; Cornelissen et 
al., 1985; Oquendo et al., 1986). 
A repetitive DNA sequence, termed rep20, has been reported by several 
groups (Aslund et al., 1985; Oquendo et al., 1986; Rao et al., 1986 and ZoIg et al., 
1987). This 21-bp tandemly repeated sequence is very AT rich and has many of the 
properties of eukaryotic satellite DNA. The 21-bp repeat is not transcribed in the 
erythrocytic stages, is specific for P. falciparum, and comprises about 1% of the 
genome (Aslund et al., 1985; Oquendo et al., 1986). Rep20 was mapped to sub-
telomeric regions of the chromosomes (Oquendo et al., 1986). This sequence is 
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present in all resolved parasite chromosomes and displays significant restriction 
fragment length polymorphism between different isolates of P. falciparum (Oquendo 
et al., 1986). 
1.3.5 Extra-nuclear DNA: There is evidence from electron microscopy 
that the intra-erythrocytic forms of malaria parasites have at least one mitochondrion 
per cell whereas the gametocyte forms appear to possess more (Sinden, 1983; 
Prensier and Slomianny 1986). However, biochemical studies on these organelles 
have been hindered by technical difficulties in isolating pure mitochondnal fractions. 
Malaria parasites have two types of extrachromosomal DNA; a multi-copy 6-
kb linear molecule and a lower copy number 35-kb circle (Wilson et al., 1991). 
Subcellular fractionation suggests that the 6-kb element is mitochondrial in origin, 
unlike the 35-kb molecule which has yet to be assigned to a specific organelle. 
Crosses between two different clones of P. falciparum showed that inheritance of 
allelic forms of the mitochondrial gene cytochrome b found on the 6-kb element was 
uniparental (Creasey et al., 1993), thus providing further support for the hypothesis 
that its origin is mitochondrial. 
1.3.6 Chromatin structure: Little is known about the structural 
organisation of the DNA of malaria parasites. Electron micrographs of chromatin 
prepared from erythrocytes infected with schizonts of Plasmodium knowlesi show a 
beaded fibre structure suggesting the presence of nucleosome filaments similar to that 
of higher eukaryotes (Wunderlich et al., 1980). The same nucleosomal pattern has 
been observed in the ring and mid-trophozoite stages of P. knowlesi. However, these 
data are not entirely conclusive, since structures that appear similar to nucleosomes in 
electron micrographs can be detected even in the absence of histones (Sinha et al., 
1982). A histone H2A gene has been identified in P. falciparum (Creedon et al., 
1992) and recently Cary and collegues, (1994) have been able to show that 
micrococcal nuclease digestion of chromatin in isolated P. falciparum nuclei yields a 
ladder of DNA fragments characteristic of nucleosomal organisation. In addition, they 
isolated a set of major proteins from P. falciparum nuclei that are similar in size and 
charge to histones of other eukaryotes. 
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1.4 Genetics: 
The asexual forms of the malaria parasite are haploid. Proof comes from the 
fact that despite considerable variation in protein and DNA sequences between 
different strains of a species, cloned parasites always exhibit only one of these 
variable traits (Walliker, 1983). Furthermore, although chromosomes vary in size 
between different strains, it has been shown that only one form of each chromosome 
is found within a single clone (Walliker, 1987). In addition, crossing experiments 
between clones of the rodent malaria parasites P. bergheiand P. chabaudi (Walliker et 
al., 1973; Walliker et al.,, 1975) and the human parasite P. falciparum (Walliker et 
al., 1987) have been carried out which have demonstrated that blood forms of the 
parasites are haploid. Recombination between alleles of different genes occurs, by re-
assortment of genes on different chromosomes (Fenton and Walliker, 1990; Walker-
Jonah et al., 1992), and by crossing-over between linked genes (Sinnis & Wellems, 
1988) during meiosis in mosquitoes. Recent work has also proved that intra-genic 
recombination within the msp-1 gene has occurred in some of the progeny of the 
laboratory crosses referred to above (Kerr et al. 1994). 
1.5 DNA replication and cytogenetic events during the malaria parasite 
life cycle 
Studies on the organisation of the malarial genome, its replication and 
division, have been hampered by the complexity of the parasite's life cycle and the 
small size of the parasite and its nuclei. However, studies on DNA replication in 
malaria parasites have progressed rapidly in the last decade. Considerable progress 
has been made in understanding the patterns of DNA replication in malaria parasites 
and in isolating genes encoding proteins responsible for DNA synthesis. 
1.5.1 DNA synthesis: Malaria parasites are incapable of de novo 
synthesis of the purines necessary for the synthesis of nucleic acids and other 
metabolic functions, and therefore must operate purine salvage pathways (Homewood 
and Neame, 1980). De novo synthesis of pynmidines does occur and involves the 
vitamin para-amino-benzoic acid (PABA) and folate co-factors. Antimalarial drugs 
such as the biguanides, proguanil and pyrimethamine act on the parasite's 
dihydrofolate reductase with little effect on the corresponding host enzyme (Ferone et 
al,1969). Thus the main effect of these drugs on the parasite is probably to disrupt 
thymidine synthesis and hence DNA synthesis. Sulfonamides and sulfones compete 
with PABA for the active site on the enzyme dihydropteroate synthase, and thus also 
starve the parasite of a vital source of DNA synthesis substrates (Ferone et al, 1969; 
Peters, 1987). 
DNA synthesis in the malaria parasite takes place at five points in the life cycle: 
two of these are in the vertebrate host, the first one during exo-erythrocytic 
schizogony in the hepatocytes and the second during erythrocytic schizogony. DNA 
synthesis also occurs in the mosquito during microgamete formation, after fertilisation 
and before meiosis and finally during the oocyst stage to produce thousands of 
sporozoites. 
DNA synthesis during asexual reproduction starts approximately mid-way 
through the 48 hours erythrocytic cycle (late trophozoite stage), and continues during 
schizogony almost to erythrocyte rupture, as demonstrated by the incorporation of 
radiolabelled precursors into the DNA of synchronised erythrocytic forms of the 
parasite (Inselburg and Banyal, 1984; Gritzmacher and Reese, 1984; and Waki et al., 
1985). Each round of DNA replication is accompanied immediately by mitotic 
division (Janse et al., 1986a). DNA synthesis in this phase can be inhibited by 
aphidicolin (Inselburg and Banyal, 1984), an inhibitor of polymerase ö and a 
(Ikegami et al., 1978), the enzymes primarily responsible for DNA chain elongation in 
eukaryotes (Scovassi et al., 1980). Recently the genes encoding polymerase a and ö 
in P. falciparum have been cloned and sequenced ( Ridley et al., 1991; White et al., 
1993). 
DNA synthesis during sexual reproduction has never been demonstrated 
directly. Early studies using mitomycin C as an inhibitor of DNA synthesis indicated 
that DNA replication takes place during the early stages of maturation of gametocytes 
(Sinden and Smalley 1979; Toye et al., 1977), although later studies have suggested 
that the use of mitomycin C may be unreliable as a test for DNA synthesis in 
Plasmodium (Janse et al., 1986a). 
The DNA content of mature P.berghei macrogametocytes and 
microgametocytes has been assessed by microfluorometry. It appears that the DNA 
content of both macrogametocyte and microgametocyte is intermediate between 
haploid and diploid levels (Janse et al., 1986b, 1989), and it has been suggested that 
this increase, mainly in microgametocytes, is due to selective gene amplification, for 
example of those genes encoding ribosomal RNA (Janse et al., 1986b; 1988). 
However, no amplification of these genes was detected during gametocytogenesis 
(Cornelissen et al., 1985), and no changes in the size of the chromosomes containing 
these genes were found (Van der Ploeg et al., 1985). After gametocytes have been 
taken up by the mosquito the microgametocyte is converted into eight flagellated 
microgametes, over a period of only 20 minutes, during which three very rapid 
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rounds of DNA replication occur. This DNA is then distributed into each 
microgamete, which each contains the haploid amount of DNA (Janse et al., 1986c). 
Each macrogametocyte, in contrast, is thought to give rise to a single macrogamete 
which does not involve DNA synthesis. Fertilisation of haploid gametes produces a 
diploid zygote. A round of DNA replication follows fertilisation, that can be inhibited 
by the drug aphidicolin (Janse et al., 1986c). The DNA content of sporozoites has 
also been determined by microfluorometry which indicates that sporozoites also 
contain the haploid content of DNA (Cornelissen et al., 1984; Janse et al., 1986b). 
Liver forms of the parasites are probably also haploid, as shown from the observation 
that where two clones of P. falciparum differed in the structure of a merozoite surface 
protein, the liver form in progeny derived from a cross between these clones always 
expressed a single allelic variant and never both (Szarfman etal., 1988). 
1.5.2 Mitosis: Mitosis occurs in different phases of the life-cycle of malaria 
parasites, in the exo-erythrocytic and erythrocytic schizonts, during microgamete 
formation and in the oocysts. Mitosis in malaria parasites is different from that found 
in higher eukaryotes: chromosomes do not condense, the nuclear membrane remains 
intact during mitosis and the spindle fibres are formed inside this membrane (Aikawa 
and Seed, 1980; Sinden, 1991). Moreover, activated microgametocytes, exo-
erythrocytic schizonts and oocysts have large polyploid nuclei, containing numerous 
spindles. Nuclear fission in these stages appears to occur only just prior to so-called 
budding-off of microgametes, merozoites and sporozoites, respectively. During 
erythrocytic schizogony a normal mitotic sequence of genome segregation and nuclear 
fission is assumed to occur. 
1.5.3 Meiosis: Malaria parasites are haploid during the greater part of their 
life cycle, and meiosis is assumed to be post-zygotic, although without direct evidence 
(Sinden, 1978; Walliker, 1983; Kemp et al., 1985 and Casaglia 1985a). However, 
the exact time of the first division of meiosis has been determined in P. berghei, 
which is within 2.5 hour of fertilization (Sinden & Hartley, 1985) resulting in the 
synthesis of approximately 4 times the haploid DNA quantity (Janse et al., 1986). 
These observations are consistent with duplication of the diploid chromosome set at 
the first stage of meiosis. Electron microscopy has shown synaptonemal complexes, 
structures associated with chromosome pairing during the first division of meiosis, in 
the early ookinete stage (Sinden & Hartley, 1985). The second meiotic division, 
reducing the chromosome number to in, has no tbeen discovered yet. Figure 
(1.2) is schematic illustration of the cytogenetic events during the parasite life cycle. 
11 
Figure 1.2: 
Schematic illustration of cytogenetic changes in the life-cycle of Plasmodium. 
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1.6 The eukaryotic cell cycle and its relationship to the cell cycle of P. 
falciparum 
1.6.1 The phases of the cell cycle: The 'standard' eukaryotic cell-cycle 
is the complete process of DNA replication, mitosis, and cytokinesis that leads to the 
production of two daughter cells from a single mother cell. This cycle is traditionally 
divided into four phases: G1(gapl), S (DNA synthesis), G2 (gap2) and M (mitosis) 
(Howard and Peic, 1953) and currently two major regulatory transitions at 01/S and 
G2/M are recognised (Murray and Hunt, 1993). The replication of DNA and 
synthesis of histone proteins occurs only in the synthetic (S) phase of the interphase. 
In this period, each double-helical DNA molecule is replicated into two identical 
daughter DNA molecules, and histone and other chromosomal proteins bind quickly 
to newly replicated DNA. The S-phase is preceded and followed by two gap periods 
of interphase (G1 and G2 respectively) in which there is no net synthesis of DNA, 
although repair of damaged DNA can occur. During the mitotic (M) period, identical 
copies of the cellular DNA are distributed to each of the daughter cells. 
All cell types undergo some version of the basic cycle described above, 
although details of its regulation and the size of the gap phases differ. Generally, 
DNA synthesis in eukaryotes is periodic and does not occupy all the cell cycle. The 
exception may be in the very rapidly dividing cells of early amphibian embryos 
(Newport and Kirschner, 1984). In most mammalian cells, the following pattern has 
been observed; Gi of 8-10 hours, S of 6-7 hours and G2 of 3-5 hours. The total cycle 
time is 18-20 hours, and mitosis takes about an hour. However this is not the 
universal pattern even with one cell line. The majority of S phases last for 6-8 hours, 
but there are cases where DNA synthesis takes longer (Murray and Hunt 1993). 02 
is less variable and there are a few cases where it is less than 2 hours or greater than 6 
hours. Gi is the most variable of the phases. It can be entirely absent, as in the 
Chinese hamster lung cells (Robbins and Scharff, 1967), or as long as 16 hours. It 
has been assumed that cells which grow fast generally have short 01 periods. Exactly 
why gap periods are required at all is not fully understood. 
In mammalian tissues and cell cultures, there is a tendency for the S period 
to last 6-8 hours and also for the G2 period to be relatively constant. As a result, the 
main difference between fast and slow growing cells is in the length of 01 period, 
which can vary from zero to many hours. Although data on lower eukaryotes is 
scanty, it has been observed that cycles without Gi are quite common in for example, 
Amoeba, Physarwn, Schizosaccharomyces and in the micronuclei of Tetrahymena and 
Paramecium (Mitchison, 1971). It is obvious that the asexual forms of P.falciparum 
have schizogony rather than a yeast or mammalian type G1/S/G2/M cycle. This might 
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approximate to a G1--S/M/S/M/S/M/S/M--lysis--invasion, Gi type cycle, although 
this is highly speculative; the truth is that little is known about the cell cycle of the 
malaria parasite. 
1.6.2 Study of cell cycle control using yeast as a model system: 
Our understanding of how progression through the cell cycle is regulated has 
advanced enormously during the last two decades. Data from genetic, biochemical 
and molecular investigations of diverse organisms, especially the cloning of some key 
cell cycle control genes, has given new insights into the control mechanisms of the cell 
cycle and realisation that certain aspects are universal in all eukaryotes (Nurse, 1990; 
Forsburg and Nurse, 1991; Norbury and Nurse, 1992). 
Because of the possibility that all eukaryotes could have similar cell cycle 
controls, many scientists have sensibly started to explore the cell cycle in simple 
experimental systems. Two of the most successfully used are Saccharomyces 
cerevisiae (budding yeast) and Schizosaccharomyces pombe (fission yeast). Their 
small nuclear genome and well characterised genetics, in addition to their suitability 
for gene manipulation, has made them model organisms for cell cycle studies. Since 
yeasts are unicellular, can be haploid and have a cell cycle that can be as short as 2 
hours, they can be readily grown as large populations for both biochemical analysis of 
cell cycle gene products and for analysis of the effects of cell division cycle (cdc) 
mutants. A powerful way of interfering with the cell cycle has been the use of such 
cdc mutants. It has become possible to isolate conditional mutants that make altered 
proteins which are functional under one condition but non-functional under another. 
This conditional type of mutant has been widely used, with increased temperature as 
the restrictive condition. 
1.6.3 Evolutionarily conserved elements involved in control of 
the cell cycle: Isolation of temperature sensitive (ts) mutants in yeasts has resulted 
in a collection of mutants that can be arrested at different stages of the cell cycle. 
Among the the key genes identified are CDC28 of S. cerevisiae and cdc2 of S. pombe 
(Reed 1980; Nurse and Thuriaux, 1980). Cloning and sequencing of cdc2 and 
CDC28 genes has revealed that they both encode proteins of 34kDa that both are 
protein kinases sharing 60% amino acid sequence homology (Lee and Nurse, 1987). 
In addition, it has been shown that CDC28 of the budding yeast can complement a 
cdc2 mutant in S. pombe and vice versa (Beach et al, 1982; Booher and Beach 1986). 
The similarity between the products of cdc2 and CDC28 genes in the distantly related 
yeasts S. pombe and S. cerevisiae indicated the possibility that such a conserved gene 
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product might also exist in other eukaryotic organisms. A human cdc2 gene, cdc2Hs, 
was successfully cloned by complementation of a temperature sensitive mutation of 
cdc2 gene in fission yeast with a human cDNA (Lee and Nurse, 1987). At the same 
time, Draetta and colleagues also identified a 34 kDa protein kinase in human HeLa 
cells using a monoclonal antibody against fission yeast p34' 2 protein (Draetta etal., 
1987; ). This was confirmed later as the human homologue of the fission yeast cdc2 
gene product. To date, homologues of the cdc2 gene or gene product have been 
isolated from a variety of eukaryotes including starfish (Anon etal., 1988), sea urchin 
(Meijer etal., 1989), clam (Draetta et al., 1989), Drosophila (Lehner and O'Farrell, 
1990), maize (Colasanti et al., 1991), soybean (Miao et al., 1993), Leishmania 
(Mottram etal., 1993) and recently P.falciparum (Ross-McDonald etal., 1994). The 
key cell regulating protein p34CdC2  is present in all eukaryotes and the fundamental 
mechanism that controls mitotic initiation in all eukaryotes is probably universal. 
At about the same time as CDC28 and cdc2 were discovered, cytological and 
biochemical analysis of Xenopus oocytes identified an activity described as 
maturation-promoting factor (MPF) which was present in metaphase cytoplasm of 
maturing oocytes and unfertilised eggs, and which could cause immature oocytes to 
mature (Masui and Marker, 1971; Doree, 1990). Highly purified MPF was later 
found to consist of a complex of a 34 kDa serine/threonine protein kinase, identified 
as a Xenopus homologue of the cdc2 gene product, p34CdC2,  and a 45 kDa substrate, 
identified as a Xenopus B-cyclin. When the PSTAIR antibody, antibody against the 
sequence EGVPSTAIREIELLKE that is highly conserved in cdc2 proteins from 
yeasts to human, (Lee and Nurse, 1987) was used on a Western blot of the purified 
MPF preparations, it revealed that the 34 kDa component of MPF co-migrated with 
authentic human p34cdc2  (Gautier etal., 1988). Identification of p34CdC2  as the kinase 
component of MPF, which is today recognised as the regulator of G2IM transition, 
further confirmed the universality of these components of cell cycle control in diverse 
organisms. 
1.7 Signal transduction in the eukaryotic cell cycle: 
All biological systems have the ability to process and respond to enormous 
amounts of stimuli. Much of this information is provided to individual cells in the 
form of changes in concentration of hormones, growth factors, neuromodulators, or 
other molecules. These ligands interact with specific receptors, and such binding 
events are transduced into intra-cellular signals. Several families of cell surface 
receptors have been characterised that are coupled to different mechanisms of signal 
transduction. A family of guanine nucleotide-binding regulatory proteins (G-proteins) 
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is known to be involved in a variety of receptor-mediated signal transduction systems 
in mammalian cells (Gilman, 1984). The general significance of G-proteins in cell 
biology was recognised by the award of the Nobel Prize for medicine to Alfred 
Gilman of Texas University (USA) this year for his research in 0-proteins. 
1.7.1 G-proteins as signal transducers: The 'classical' guanine-
nucleotide-binding proteins (0-proteins) comprise a family of homologous, 
membrane associated (although not transmembrane), proteins which form part of a 
heterotrimenc complex of molecules. They function to allow communication between 
cell surface receptors for hormones, growth factors and neurotransmitters and the 
effector systems which convert this primary message within the cell into a signal 
which will generate a physiological response (Gilman, 1987; Milligan, 1989). The 
heterotrimer consists of distinct a-(39-46 kDa), -(35-36 kDa) and y-(8 kDa) subunits 
(Valencia et al., 1991). The a-subunits of the various 0-proteins are assumed to 
define the specificity and selectivity of both receptor/G-protein and G-proteinleffector 
interactions (Bourne, et al., 1990; Simon et al.,1991). Very strong evidence for a 
positive signalling role of the f3 and y subunits has been provided by the genetic 
analysis of 0-proteins involved in the mating pheromone response in the budding 
yeast Saccharomyces cerevisiae (Marsh et al., 1991). In addition, a considerable 
family of small (19-27 kDa) GTP-binding proteins has recently been identified, 
including members of the Ras, Ral, Rho, Rab, Ran, and ARF families of gene 
products. While there is no evidence to indicate that these polypeptides can interact 
with 3/y subunits of 0-proteins, and may serve different functions, the potential role 
of at least some of these proteins as proto-oncogenes has stimulated considerable 
interest in the concept that they may function as transducer elements analogous to the 
'classical' G-proteins (Milligan et al., 1988). Members of the small monomeric GTP-
binding proteins such as Rho and Ran may also be involved in signal transduction 
through the indirect activation of serine/threomne kinase. 
1.7.2 Signal transduction and the P. falciparum life-cycle: 
Recently, it has been observed that recognition and invasion of hepatocytes by malaria 
sporozoites may involve multiple binding events which might be mediated by binding 
of the circumsporozoite protein to sulfated glyco-conjugates (Cerami et al., 1992). 
This defined receptor/ligand interaction highlights the importance of intra-cellular and 
inter-celluar signalling systems and pathways in malaria parasites, although very little 
is yet known about them. As discussed above, key components of signalling 
pathways in higher eukaryotes are 0-proteins and there are quite strong resemblances 
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between certain well understood receptor/ligand activated signal transduction 
pathways in yeast and some developmental processes in P. falciparum. 
In both the budding yeast S. cerevisiae and P. falciparum single haploid cells 
can differentiate into gametes of both sexes. In S. cerevisiae cell to cell signalling 
leads to differentiation in preparation for mating, manifested by transcriptional 
induction of many genes, morphological changes and the arrest of the cell cycle at 01 
phase (Marsh et al., 1991). In P. falciparum cultures, at high parasitaemia, a high 
proportion of P. falciparum merozoites differentiate sexually into 01 arrested 
gametocytes, but when the culture is diluted with fresh medium and red blood cells, a 
marked reduction has been noticed in the proportion of parasites which develop into 
sexual forms (Bruce et al., 1990). Malaria merozoites which invade red blood cells 
and become gametocytic sexual forms differentiate into elongated forms over a period 
of 8-10 days and some sexual stage specific proteins are known to be produced 
(Alano and Carter, 1990). However, neither the induction nor the signal transduction 
processes are understood in this parasite, at least partly because of the intractability of 
its genetics and life cycle and the problems associated with a difficult and fragile 
culture system (Comelissen, 1988). However, it is clear that many aspects of signal 
transduction for sexual differentiation in yeast are evolutionarily conserved and 
although very little is known about the mechanisms of signal transduction in malaria 
parasites, it is tempting to speculate that elements of evolutionary conservation could 
exist between signal transduction in Plasmodium and yeast 
1.8 The Ras superfamily of GTPases: 
In 1980, two ras genes were discovered: the first, now known as v-H-ras, is 
the transforming gene of Harvey, BALB and Rasheed sarcoma viruses, and the 
second, v-K-ras, is the transforming gene of Kirsten sarcoma virus (Barbacid, 1987). 
Now more than 50 distinct Ras-like proteins controlling many different aspects of cell 
growth and behaviour have been identified in mammals as well as in many other 
eukaryotes. The primary sequence structure of Ras-related proteins may be 
subdivided into several main parts (Fig. 1.3). The N-and C-terminal parts of the 
sequence form two subdomains of the structure. The N-terminal end is of variable 
length, ranging from 5 to more than 30 amino acids. The N-terminal subdomain 
contains phosphate-magnesium binding sites. The C-terminal subdomain has guanine 
binding sites which are highly conserved between the various Ras-related proteins. 
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Figure 1.3: 
Diagrammatic structure of the main sequence elements and highly conserved residues of ras-like proteins. GNB= 
guanine nucleotide binding domain, PMn= phosphate magnesium binding regions, Gn= guanine base binding regions, 
Caax: a=aliphatic, X= any residue. GxxxGKs: s=Serine or Threonine. Reproduced with modification from Valencia et 
al., (1991), Biochemistry 30, 4637-3648. 
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The C-terminus extension is highly variable, even among closely related proteins of 
the Ras superfamily. The last 4-5 residues always include a cysteine-containing motif 
that appears to be required for in vivo covalent modification (Valencia etal., 1991). 
The Ras proteins are members of an extended family of GTPases (Bourne et 
al., 1990, 1991) which includes proteins involved in protein synthesis (the elongation 
and initiation factors) and signal transduction (the a subunit of heterotrimeric G 
proteins). The GTPases of the Ras superfamily regulate many aspects of cell growth, 
differentiation and action. Their functions depend on their ability to alternate between 
inactive and active forms, and on their cellular localisation. Figure (1.4) shows a 
simplified representation of these proteins' switching cycle (Bourne et al., 1990; 
Boguski and McCormick, 1993). The GTP-bound form is slowly converted to the 
GDP-bound form by the protein's intrinsic capacity to hydrolyse GTP, a process 
accelerated by GTPase-activating proteins (GAPs). 
Numerous proteins affecting GTPase activity, nucleotide exchange rates and 
membrane localisation of Ras superfamily members have now been identified. Many 
of these proteins are larger and more complex than their targets, containing multiple 
domains capable of interacting with an intricate network of cellular enzymes and 
structures (Bourne et al., 1990; Boguski and McCormick, 1993). Proteins that 
activate Ras proteins by exchanging bound GDP for free GTP, known as guanine-
nucleotide exchange factors (GEF5), are being discovered at a rapid rate. In 
Saccharomyces cerevisiae, Schizosaccharomyces pombe, Drosophila melanogaster 
and Caenorhabditis elegans, genetic loss of GEF function has similar effects to those 
induced by loss of the Ras-like proteins themselves, showing that GEFs are essential 
for Ras action (Boguski and McCormick, 1993). 
1.8.1 The Ras-related proteins (the small GTPases): A large 
superfamily (more than 50 members) of monomeric GTP-binding proteins 
homologous to Ras has been described in the last few years (Bourne et al., 1991). 
The Ras protein family consists of small proteins (20-35 KDa) with sequence 
similarities, especially in their guanine nucleotide-binding domains, to the products of 
Ras proto-oncogenes. Many of these proteins were discovered because they bind 
GTP or because their cDNAs hybridise with nucleotide sequences derived from ras 
genes. Not much is understood about the cellular function of individual small 
GTPases and therefore these proteins are classified according to similarities of primary 
structure. Based on sequence homology the Ras superfamily can be divided into four 
subfamilies: Ras and Ras-like, Rho, Rab and Ran (Downward, 1992; Hall, 1990). 
19 
Figure 1.4 
Simplified diagram showing regulation of Ras-like GTPase by guanine-
nucleotide-exchange-factors (GEF), guanine-nucleotide-dissociation-inhibitors (GDI) 
and GTPase-activating proteins (GAP). 
GEFs catalyse exchange of the GDP for GTP; GAPs catalyse conversion of GTP-
bound forms back to their inactive GDP states. GDJ proteins for small GlPases, 




The Ras-related proteins have been implicated in many cellular processes from 
signal transduction to vesicular transport (Bourne et al., 1991), and function as 
oncogenes following mutational activation. These proteins transmit signals from 
tyrosine kinases at the plasma membrane to a cascade of serine/threonine kinases, 
which delivers signals to the cell nucleus (Bourne et al., 1991). The Rho/Rac protein 
subfamily is involved in organisation of the cytoskeleton (Boguski and McCormick, 
1993). Rac proteins are essential components of the NADPH oxidase system that 
generates superoxide in phagocytes (Segal and Abo, 1993), and may also be involved 
in signal transduction through the direct activation of senne/threonine kinases (Manser 
et al., 1994). The Rab protein subgroup is involved in regulation of membrane 
trafficking, that is, the transport of vesicles between different intracellular 
compartments (Pryer et al., 1992). Recently a number of Rab homologues have been 
identified in Plasinodiumfalciparum (G.Langsley, personal communication). 
1.8.2 RanITC4: Ran/TC4 is the prototype of a fourth major subfamily of 
ras-related genes, first identified in human cDNA libraries (Drivas et al., 1990, 
1991). Homologues have since been identified in other mammals (dog, mouse), 
Drosophila, Caenorhabditis, Dictyostelium, and in yeasts (S. cerevisiae and S. 
pombe). The Ran subfamily is highly conserved; the predicted sequences of all 
known Ran-like proteins are at least 70% identical. However, the subfamily shows 
only limited resemblance to other Ras proteins. Outside the four stretches of sequence 
that specify the Ras guanine nucleotide binding site, there are no obvious homologies 
between Ran sequences and those of other Ras family members. One striking 
difference is that, while other Ras-related proteins share a carboxyterminal cysteine-
rich motif that mediates isoprenylation and membrane association, Ran proteins have a 
stretch of acidic amino acid residues at this position (Bischoff and Ponstingl, 1991a, 
Ren et al., 1993). 
Ran-GTPases appear to be involved in cell cycle control. In the eukaryotic 
cell cycle, nuclear replication (S phase) and mitosis (M phase) are linked such that 
replication must be complete before mitosis can begin. To prevent cell division 
beginning prematurely, eukaryotic cells have systems for detection of unreplicated 
DNA which transmit signals that inhibit the activation of mitotic factors (Hartwell and 
Weinert, 1989; Nishimoto, et al., 1992). Both genetic and biochemical approaches 
have been taken to elucidate the pathway through which unreplicated DNA sends 
inhibitory signals, and a number of proteins required for signal transmission have 
been identified (Enoch and Nurse, 1990; Enoch et al., 1992; Roberge, 1992). 
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1.9 The regulator of chromosome condensation (RCC1): 
Ran/TC4 has been hypothesised to function mainly in the nucleus in 
conjuction with a guanine nucleotide exchange factor to couple completion of DNA 
synthesis with initiation of mitosis through the activation of a cyclinp34ic 2 complex 
(Ren et al., 1993). However, only one gene product, the regulator of chromosome 
condensation (RCC1), has been found to be a chromatin-associated protein (Ohtsubo, 
et al., 1989), making it the most likely candidate for a protein which interacts with 
DNA directly to monitor the completion of replication. 
An RCC1 mutant was first isolated in a temperature-sensitive cell line (tsBN2 
cells) derived from BHK21/13 hamster cells (Nishimoto et al., 1978). Genes 
homologous to RCC1 have been isolated from organisms including humans (Bischoff 
and Ponstingl, 1991a), Xenopus (Nishitani et al., 1991), S. cerevisiae (Clark and 
Sprague, 1989; Aebi et al., 1990), S. pombe (Matsumoto and Beach, 1991) and 
Drosophila (Frasch, 1991). The predicted amino acid sequences of RCC1 proteins 
are well conserved across vertebrate species. The RCC1 protein has a domain 
consisting of seven homologous and very conserved repeats of about 60 amino acids 
(Ohtsubo et al., 1989; Ohtsubo et al., 1991). RCC1 has been shown to be a nuclear-
localised DNA binding protein (Ohtsubo et al., 1989; Frasch, 1991). It is present at 
about one million copies per nucleus, equivalent to one copy per nucleosome (Seino et 
al., 1992). 
A mutation of the RCC1 gene in the tsBN2 cell line has been found to confer 
a pleiotropic phenotype, including Gi arrest and premature induction of mitosis in 
cells synchronised at the GuS boundary (Ohtsubo et al., 1989). Similarly, mutations 
of the SRM1/PRP20 gene, the S. cerevisiae homologue of RCC1, are pleiotropic: the 
srml mutant shows Gi arrest and a suppression of mating defect in a mutant lacking 
pheromone receptors, and the prp20 mutant shows an alteration in mRNA metabolism 
(Clark and Sprague 1989). 
1.10 The role of Ran/TC4 and RCC1 in regulation of the cell cycle: 
Genetic and biochemical evidence collectively suggest that Ran/TC4 and 
RCC1 are key components of a control system that monitors the progress of DNA 
replication and regulates mitosis. 
A key component of eukaryotic cell cycle control is mitosis promoting factor 
(MPF). MPF is a complex of two proteins, cyclin B and a cyclin-dependent senne-
threonine protein kinase denoted p34lC2  (Freeman and Donoghue 1991; Norbury and 
Nurse 1992). Its regulation involves interactions among tyrosine and senne-threonine 
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protein kinases, protein phosphatases, a cyclin protease, and other activators and 
inhibitors. It is formed late in Gi or in S phase depending on the cell type, by the 
association of newly synthesised cyclin B with p34CdC2,  and is inactivated by 
phosphorylation of specific threonine and tyrosine residues. 
Premature entry into mitosis occurs upon loss of RCC1 (see section 1.8.3) 
requires MPF activation and the presence of cdc25 the phosphatase that activates 
preMPF (Nishitani et al., 1991; Seino el al., 1992; Seki et al., 1992). A fission yeast 
temperature-sensitive mutant, defective in coupling mitosis to the completion of DNA 
replication, contain a mutation in the RCC 1-homologous gene called premature 
initiation of mitosis-1 (Pimi) (Matsumoto and Beach, 1991). pimi mutants are 
rescued by overexpression of a wild-type allele of suppressor of piml £SPI 1), the 
fission yeast homologue of RanITC4 (Matsumoto and Beach, 1991, 1993). It has 
been shown that human RCC1 protein can be purified from HeLa cells in the form of 
a complex with Ran'TC4 (Bischoff and Ponstingl, 1991a). RCC1 protein specifically 
catalyses exchange of guanine nucleotides on the Ran/TC4 protein (Bischoff and 
Ponstingl, 1991b). 
Models have been proposed, in which the cell cycle is coupled to a Ran-
GTPase cycle (Bischoff and Ponstingl, 1991a, 1991b; Roberge, 1992; Ren et al., 
1993). Ran can switch between an active GTP-bound form and an inactive GDP-
bound form, and this switch may regulate the MPF-driven cell cycle (Fig. 1.5). In this 
figure, START, the commitment of the cell to DNA replication, stimulates the guanine 
nucleotide exchange function of RCC1, and this in turn converts RanITC4 to its active 
GTP-bound form. The Ran-GTP complex (active) transduces a signal that inhibits the 
conversion of preMPF to MPF. FINISH, the completion of DNA replication, is 
associated with the inactivation of RCC1 and the activation of Ran-specific GAP, 
restoring Ran to its inactive GDP-bound form. 
The model predicts that unreplicated DNA present between START and 
FINISH alters the level of Ran/TC4-GTP. This may be an essential step of a pathway 
that leads to MPF inactivation, although there may be multiple intermediate steps. For 
example, Ran/TC4-GTP could stimulate, either directly or through regulatory kinases 
and phosphatases, activation of the kinase that phosphorylates p34cdc2  on tyrosine to 
inactivate MPF (Smythe and Newport, 1992). Ran/TC4-GTP could also inhibit, 
directly or indirectly, the tyrosine phosphatase that dephosphorylates p34CdC2 , and 
that is required for MPF activation (Millar and Russell, 1992). 
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Figure 1.5: A model for RanIGTPase cycle. 
A model coupling the cell cycle and a GTPase cycle via nuclear proteins Ran 
and RCC1. The inner circle represents the Ran-GTPase, the second circle represents 
the MPF (maturation-promoting factor) cycle, and the outer circle represents the cell 
cycle. 
START is the point of commitment to DNA synthesis, as distinguished from 
the point at which DNA replication actually begins. FINISH is the end of DNA 
replication. For detailed description see section 1.10, Chapter 1. The figure is 
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1.11 The cell cycle of malaria parasites 
Research on the molecular mechanisms that control the cell cycle in yeast and 
higher eukaryotes, has led to a detailed model of how the eukaryotic cell cycle is 
regulated. The control of the cell cycle is important not only for the normal growth of 
the cells but also in developmental processes, most notably where the cycle is 
interrupted in differentiated lineages. 
There have been rather few studies on the biochemistry and molecular biology 
of the cell cycle of P. falciparum (Sherman 1979; Homewood and Neane, 1980; 
Kemp et al., 1986; Janse et al., 1986 a, b, c) and the genetic and molecular processes 
underlying and directing the extensive cyclic differentiation are poorly understood. 
Obviously studies of malaria cell cycle lack cell cycle mutants and it is difficult to 
perform experiments that seek to vary growth rates and measure cell size in the rather 
fragile in vitro culture model. However, several genes implicated in DNA replication 
and other cell cycle events in P. falciparum have recently been isolated. Genes 
encoding protein homologues of DNA polymerase a and ö, known to play an 
essential role in DNA replication in eukaryotes, have been cloned in P. falciparum. A 
group of DNA polymerases has also been identified in the rodent malaria, P. berg/wi, 
(Ridley etal., 1991; De Vries etal., 1991; White et al., 1993). The gene encoding 
the malarial homologue of the proliferating cell nuclear antigen (PCNA), an auxiliary 
factor for extended DNA replication by DNA polymerase ö, has been isolated and 
characterised in P.falciparum (Kilbey et al., 1993). Recently, a malarial homologue 
of the type II DNA topoisomerase gene homologue has been identified in this species 
(Cheesman et al., 1994), together with several members of the kinase family, such as 
the cdc-2 like protein kinase and pfcrk-like kinase (Ross-MacDonald et al., 1994; C. 
Doerig, personal communication). 
1.12 The aim and outline of the research presented in this thesis 
The research outlined in this thesis has been primarily designed to study the 
signal transduction pathways involved in the regulation of the cell cycle of the malaria 
parasite Plasmodiumfalciparwn. The specific aim of my research project, and indeed 
this thesis, has been to clone, sequence and characterise, from P. falciparum, gene 
members of the GTPase superfamily protein that have been implicated in regulation of 
cell cycle in other organisms. The work can be divided into three complementary 
parts, all aimed at trying to see if P. falciparum homologues of certain key genes 
involved in signal transduction for cell cycle regulation exist and, if so, whether they 
can be analysed in studies aimed at clarifying cell cycle events in this protozoan 
parasite. 
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The first part (chapter 3) is devoted to molecular cloning and sequencing of the 
P. falciparum homologue of the Ran/TC4 gene. Using a PCR-based approach, a 
fragment which displays a high degree of homology to RanITC4 was obtained from 
the genome of P. falciparum (Sultan et al., 1994), and this fragment was used to 
screen genomic and cDNA libraries to obtain the full coding length of the gene. At the 
same time the copy number, chromosomal location and level of RNA expression of 
the P.falciparum homologue were determined (Sultan et al., 1994). 
The second part of the work (chapter 4) was mainly aimed at characterising the 
pfran gene product. Polyclonal antibodies against a specific segment of the predicted 
protein sequence were raised . The anti-pfRan serum recognises, in total protein 
prepared from the parasite, a band of 27 kDa which corresponds to the predicted 
molecular weight of the pfRan protein. In addition, the serum was used to determine 
the localisation of the protein in infected red blood cells prepared from parasite culture. 
To gain further insight into intra-nuclear processes occurring during the cell 
cycle regulation in the malaria parasite, and the role of Ran in this process, the P. 
falciparum homologue of RCC1 was cloned and almost completely sequenced 
(chapter 5). This protein known to interact with Ran-GTP and to regulate the 
functional state of the GTPase-switch that monitors the progression of DNA 




MATERIALS AND METHODS 
2.1 MATERIALS 
2.1.1 Chemicals and equipments 
Standard laboratory chemicals and solvents were obtained from British Drug 
House (BDH) plc., Fisons Scientific Apparatus or Sigma Chemical Co. Ltd., UK. and 
were of analytical grade. Radioactive nucleotides were supplied by Amersham 
International plc. The sources of other materials are given in the text. 
Centrifugation was either carried out in a bench top centrifuge MSE,(Fisons) or 
IMV- 13 microfuge (IBI). Higher speed centnfugations were performed in either 
Sorval 1 -RC-5B - refrigerated centrifuge or ODT-65 ultracentrifuge (DuPont 
Instruments). 
2.1.2 Parasite source 
The parasites used in this work were clones 3137A, 106/1, 10511, 102/1, ClO, 
1776, Dd2, 708, T9/94 and T9/96. These P. falciparum clones are kept in the WHO 
Registry of Standard Strains of Malaria Parasites in the Centre for Parasite Biology, 
ICAPB, University of Edinburgh. 
2.1.3 Erythrocytes 
Fresh whole blood, group 0 Rh +, used for parasite culturing was obtained 
from Edinburgh and South-East Scotland Blood Transfusion Service. The blood was 
washed and centrifuged at 1500g three times in incomplete RPMI medium to remove 
citrate. The 'buffy coat' of white blood cells was removed from the red cell pellet, 
which was resuspended in complete medium to give a haematocrit of 50%. The 
washed red blood cells (RBCs) were kept at 4°C for up to one week. 
2.1.4 Genomic and cDNA libraries 
Four Plasmodium falciparum cDNA and genomic libraries were screened 
during the course of this work. These were: asexual cDNA library made from rings 
and late trophozoites in plasmid pJEF14 (a gift from Dr. A. Craig, Oxford university), 
Xgtll, gametocyte cDNA library from clone 3D7 ( Alano, et al., 1991), XNM 1149, 
Hindlil digested genomic DNA from isolate Ki and Xgtl 1 (Goman, et al., 1982), 
partial Dral digested genomic DNA from isolate K! (a gift from Dr. B. Kilbey). 
2.1.5 Bacterial strains 
The following bacterial strains were used in the course of this study: INVctF' 
(Hanahan, 1983b), TO-i strain and Y 108 (Young and Davies, 1983). 
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2.1.6 Oligonucleotide primers used in this study: 
Oligonucleotide primers used in this study were synthesised by the Oswel DNA 
Service, Department of Chemistry, University of Edinburgh, and HPLC purified if 
necessary. The sequence of the primers are given below (+: sense; - anti-sense): 
M13 (40), + 	 5'- GTT TTC CCA GTC ACG AC-3' 
M13, - 	 5'- CAG GAA ACA GCT ATG AC-3' 
?. gtll,+ 5'-GGTGGCGACGACTCCTGGAGC CCG-3' 
gtll, - 	 5'- TTGACACCAGACCAAC7GGTAATG-3' 
pJFE-14, + 5'- TCT AGA GAT CCC TCG ACC TC-3' 
pJFE-14, - 	 5'- CGC GGA COT CCA GCG CCG GC-3' 
Ran Primers: 
A482,+ (Ran- 1) 5'- GGA(AT) GAT GG(AT) GG(AT) AC(AT) GG(AT) AA-3' 
A483,+ (Ran-2) 	5'- GG(AT) GAA TT(AC) GGA AA(AG) AA(AG) TA- 3' 
A484,- (Ran3) 5'- GG(CT) TT(TC) TC(TG) AA(AG) TT(AG) TA(AG) TT-3' 
(Ran/iv) 	5'- TAT TTC TCC TU TCA TTA CO -3' 
(Ran/iv) 5'- CAA TAC GAT CTA TCT GC -3' 
02037,- (RanS) 	5'- ITT TCA ATA TCT TOT TCA TC -3' 
G1701,+ (Antb/F) 51 - CCC GGA TCC GOT TAG CTA GGA GAT TG -3' 
G1702,- (Antb/R) 5'- GGG GAA TTC ATT TTC AAT ATC TTC ITC-3' 
G5793,+ (yes/F) 	5'- CGCCATATGGATTCACAAGAATATATTCC-3' 
G5794,- (yes/R) 5'- CGCGGATCOTTAATTFTCAATATC1TTCITTC-3' 
RCC-1/Pim-1 Primers 
05058, - 5'- GTA TC(AT) CO (AT) CC(AT) A(AG)(AT) GC(AT) CC-3' 
05146,- 	5'- CG(AT)A(AG)(CT)TG(AG)(AT)(AT)(CT)TG(CT)TG(AT) 
CC(AG)TT(AT)CCC CA -3' 
G6037,+ 5'- G(AC)(AT) G(CT)(AT) GG(AT) GG(AT) ATG CA-3' 
G8119,+ 5'- COG TTG ATA ATA ATG GTG-3' 
G8695,+ 5'- GAA YT'C TilT ATG TAT GTG CAG 0-3' 
08913,- 5'- CCA AAA TAA GTA TAT TCA iTT TG-3' 
G8914,+ 5'- AliT TCT AAA TTTA CCT AAG C-3' 
G8118,+ 5'- 000 OCT CGA GAA ATG OAT TCA CAA GAA TAT-3' 
G9075,-- 5'- AAG 11TA TAA TAA GCC CC-3' 
09161,- (iv) 5'- CAC CAC CTG TGC AGA TAG CC-3' 
09191,- (antb) 5'- TGC ACA TAC ATA AAG AAT TC-3' 
G9192,+(antb) 5'- CCC GGA TCC TGC ACA CAT TGG CTA TCT GC-3' 
H0472,+ 5'- GAA GGA TGT ACA TTT TG-3' 
H1041,+ 5'- GIG TAT TTI' TAT TAG AAA GC-3' 
H1790,+ 5'- GAA CCT GTT CAT GIG AAG-3' 
H4252, 5'- AAT ITT GTA AAT GAC ACC-3' 
H4253, 5'- GGA AGT TGT AGT GAT ATG G-3' 
H4254, 5'- AAA CAT GAC TGG ITT ACT CC-3' 
2.1.7 General stock solutions and media 
All aqueous solutions were prepared in de-ionised glass distilled water. pH 
values of solutions were measured with a pH meter model PW 9410 (Philips). 
TAE 	50x stock solution 
242g Iris base, 37.2g Na2 EDTA, 21-120 57. 1 m glacial acetic acid, 
dH20 to 1 litre. This solution was diluted x50 to give lx working solution 
(40mM tris acetate, 2mM EDTA). 
TBE 	lOx stock solution 
108g Iris base, 55g boric acid, 40m1 0.5M EDTA pH 8.0, dH2O to 1 litre 
This solution was diluted xlO to give lx working solution (89mM Iris 
base, 89mM boric acid, 2mM EDTA). 
MOPS 	lOx stock solution 
0.2M 3-[N-Morpholino]- propane-suiphonic acid, 0.5M Na acetate pH7.0, 
0.01M Na2 EDTA, H20 to 1 litre. lx working solution is (0.02M 
morpholino-sulphonic acid, 0.05M Na acetate, 0.001M EDTA) 
SSC 	20x stock solution 
175g NaCl, 88g Na3 citrate.2H20, adjusted to pH 7.0 and made up to 1 
litre with dH20. 2x working solution is (0.3 M NaCL, 0.03M Na3 
citrate.2H20). 
SDS 	10% stock solution 
bOg was dissolved in 900ml H20, heated to 68°C and the pH was adjusted 
to 7.2 by HC1, and made up to 1 litre with dH20. 
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PBS 	lOx stock solution 
80 g NaCl, 2g KCL, 11.5g Na2 HPO4.7H20, 2g KI-12PO4 , dHO to 1 
litre, working solution, pH-7.3 was 137 mM NaCl, 2.7mM KC1, 4.3mM 
Na2HPO4.7H20 1.4mM KH2PO4. 
TE buffer (lx) 	 10mM Tris-HC1 pH 8.0 
1mMEDTA pH 8.0 
SOC medium 	 2% Bacto-tryptone 
0.5% bacto-yeast extract 
10mM NaCl, 2.5mM KC1 
10mM M92Cl, 10mM M92SO4 
20mM glucose 
SM medium (per litre) 	 5.8 g NaCl 
2 g MgSO4.7H20 
50ml 1M Tris.Cl (pH 7.5) 
5m1 of 2% gelatin 
Transformation Buffer I 	 30mM potassium acetate (30 ml of a 1M 
TFB 1 (amounts/litre) stock pH7.5) 
100mM RbC1 (12g) 
50mM MnC1 2.2H20 (9.99) 
10mM CaC1 2.2H20 (1.5g) 
15% (w/v) glycerol (150g) 
pH adjusted to 5.8 with 0.2M 
acetic acid, 
Solution sterilised by filtration. 
Transformation Buffer II 	 10mM MOPS (20m1 of a 0.5M stock 
TBF II (amounts/litre) pH 6.8) 
10mM RbCl (1.2g) 
75mM CaC12.2H20 (11 g) 
15% (w/v) glycerol (150g) 
pH of the solution was adjusted with 
KOH to 6.8 and sterilised by filtration. 
We 
Luria-Bertani 	 1% Bacto-tryptone 
medium (LB) 0.5% Bacto-yeast extract 
1%NaC1 
adjusted to pH 7.2 with NaOH 
LB agar 	 LB medium with 1.5% agar 
LB-amp. 	 LB supplemented with 
ampicillin to 50.tg/ml 
EMM (per litre) 	 20g Glucose, 5g NH4 Cl, 3g K phathlate 
1.8g Na2HPO4 ig MgCl2.6H20 
100mg Na2SO4, 15mg CaC1 2 .71-120 
imI Vitamins solution ( Stock solution 
consists of 5g Inositol, 5g Nicotinic 
acids, 0.5g Pantothenoic acid and 5g of 
Biotin) 
0. imi Trace elements ( stock solution is 
ig boric acid, 1.04g MnSO4.4H20, 0.8g 
ZnSo4.7H20, 0.4g FeC13.6H20, 80mg 
CuSO4.5H20, 2g Citric acid and 20mg 
1(1 dissolved in 200m1 dH20. 
20g of Bacto-agar for plates 
X-Gal 	 Fresh dry LB-amp. plates, spread with 
25.tl X-Gal (40mglml stock solution 
in dimethyl-formamide) 
IPTG 	 Stock solution (0. 1M) was made up by 
dissolving 0.238g in lOmi dH20, filter 
sterilised, and stored in lml aliquots at 
-20°C. 
Gel Loading Buffer (GLB) 	 50 mM Na2 EDTA, 
0.25% bromophenol blue 
0.25% xylene cyanol 
40% (wlv) sucrose in H20 
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made in 20m1 and stored as small aliquots 
at 4°C. 
Protein Sample Buffer 
(2X concentrated) 
RPMI (incomplete) medium 
Complete RPMT medium 
Protease inhibitors 
125mM Tris-HC1, 10% SDS, 20% glyc-
erol, 0.002% bromophenol blue, pH 6.8. 
(reducing) contains: 
10% 2mercaptoethanol. 
10.4g of RPMI 1640,5.94 g of HEPES, 
dissolved in 960 ml of distilled 2H20. 
Filtered through 0.22mM Nalgene filter 
and stored at 40C for up to four weeks. 
Was prepared by addition of 42 ml of 
Sodium bicarbonate, SOmg/ml 
gentamycin, and 40 ml heat inactivated 
human serum to 600m1 of incomplete 
RPMI medium. 
Leupeptin SOmg/ml (in dH20) 
Chymostatin 10mg/mi (in acetic acid) 
Pepstatin lOmg/ml in methanol. 
PMSF 200mM in Propanol. 
Idoactamide 20mg/mi in dH20. 
EDTA 500 mM, EGTA 500mM. 
Percoil gradient: 
Solution for gradient layers of 52.5%, 45% and 30% Percoll were made up in 
incomplete RPMI medium as follows: volume of lOx conc. RPMI medium was added 
to 9 volumes of stock Percoll (Sigma) to make an isotonic 90% Percoll solution. Then:- 
to 2 volumes of 90% Percoll, 1 volume of 1xRPMI was added to make 60% Percoll. 
to 1 volume of 60% Percoil, 1 volume of 1xRPMI was added to make 30% Percoli. 
to 1 volume of 60% Percoli, 1 volume of the 30% Percoii was added to make 45% 
Percoll gradient. 




2.2.1 In vitro culture of P. falciparum. 
2.2.1.1 Asexual parasite cultures 
Freshly thawed parasites were resuspended in 5mls of complete medium 
containing washed RBC, to initiate a new culture at 5% haematocrit in 25ml culture 
flasks (Trager and Jensen, 1976; Zolg et al., 1982). The flasks were gassed with a 
mixture of 1% 02,3% CO2 and 96% N2, and maintained at 37°C. The medium was 
replaced with fresh pre-warmed medium daily. Small quantities of blood were 
removed in a Pasteur pipette, smeared on a slide, stained with Giemsa's stain at pH 7.2 
(Sorensen's buffer), and examined microscopically to measure the parasitaemia and 
health of the culture. The cultures were diluted every 2-3 days with fresh RBCs in 
order to maitain the parasites in a healthy state. 
2.2.1.2 Culture synchronisation 
In order to obtain synchrony of different parasite stages, cultures with low 
parasitaemia (about 1%), and a high proportion of ring-forms were used as starting 
material. Treatment with sorbitol destroys large parasites (trophozoites and schizonts) 
in erythrocytes (Lambros and Vandenberg, 1979), resulting in a synchronously 
growing population, starting from the remaining ring-forms. 
Cultures were centrifuged at 1000g for 5 minutes, and the supernatant was 
discarded. The cells were then resuspended in 5% sorbitol solution in dH20 
(10%[v/v]), and allowed to stand at room temperature for 5 minutes. The mixture was 
then centrifuged as above and the cells resuspended in complete RPMI medium. The 
centrifugation was repeated once more, to remove any residual sorbitol, and the cells 
were finally resuspended in RPMI medium at 5% hematocnt (method 2.2.1.1). After 
24 hours of culture, a blood smear was prepared and examined under the microscope. 
At this stage the culture should not contain ring-forms, but mainly trophozoites and 
maturing schizonts. Six hours later, another blood smear was examined and if a new 
generation of small rings was seen, a second sorbitol treatment was carried out as 
above to remove remaining trophozoites/schizonts. The culture was then monitored 
over 48 hours to ensure that it was synchronous. If not, more sorbitol treatments were 
carried out at times when the only ring-forms present were small. When cultures were 
fully synchronous, they were harvested for the desired experiments. 
2.2.1.3 Density gradient separation of different stages of the parasite 
Parasitised cells are less dense than intact red cells, mainly due to loss of 
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haemoglobin and lipid formed by the parasites (Heidrich, 1988). They can thus be 
purified on density gradients using materials such as Plasmagel, Physiogel, Ficoll, 
Gelatin and Percoll, (Jensen, 1978; Stanley et al., 1982; Dulzewski et al., 1984). Such 
methods are also quite effective in separating red cells infected with large parasites, i.e; 
trophozoites and schizonts, from those with ring-forms. 
Gelatin or plasmagel (Sigma) can be used to float the mature stages 
(trophozoites and schizonts). These stages are less dense than red blood cells or ring-
forms parasites; and so remain at the top of a gelatin solution. Cultured erythrocytes 
(parasitaemia 10-15%) were collected in sterile screw-capped tubes. One volume of 2x 
gelatin solution in RPMI medium was added to the erythrocyte suspension and placed 
in water-bath at 37°C for 30 minutes until the suspension was separated into two 
portions. The upper portion (which contained mainly the mature stages) was removed 
carefully into a sterile tube and centrifuged at 2000rpm for 10 minutes. After washing 
with 1xPBS, the pellet was ready for further analysis. 
2.2.1.4 Gametocyte culture 
15ml cultures were set up at 6% haematocrit in 75ml flasks (Ifediba and 
Vanderberg, 1981). Parasitised RBCs from asexual stock cultures at parasitaemias 
above 4% were chosen to ensure a high rate of commitment to sexual development. 
These were used to give a starting parasitaemia in the cultures of 0.5 to 0.7%. Cultures 
were gassed as for asexual parasites (method 2.2.1.1), and maintained at 37°C. The 
medium was replaced daily with pre-warmed medium at 37°C. 4 to 5 days after the 
start of each culture, when a high parasitaemia had been reached, samples of the 
parasites were examined microscopically for changes in the morphology associated 
with gametocyte development, such as, ring forms and early trophozoites becoming 
somewhat triangular in shape. When such features were observed, the haematocnt was 
reduced to 3.6% by the addition of 25m1 of complete RPMI medium instead of lSml. 
The gametocyte cultures were then maintained at 25mls until the desired stage of 
maturity was reached according to the Hawking et al., (1971) classification. Young 
gametocytes or mature gametocytes were usually harvested 8 to 10 days or 14 to 17 
days respectively after the start of these cultures. 
2.2.1.5 Purification of gametocytes 
By using a high gametocyte producing line, such as 3137A, grown manually in 
75cm2-base culture flask, a yield of 2-5x10 7 stage IV or V gametocytes can be 
obtained. Mature gametocytes are activated to undergo gametogenesis at temperatures 
below 36°C, although they also require another environmental change such as the pH 
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being raised above 8.0 in the presence of bicarbonate ions (Alano et al., 1993). In 
order to minimise the risk of inducing gametogenesis, efforts were taken to keep the 
gametocytes at 37 0C prior to resuspending in bicarbonate-free medium (incomplete 
RPMI medium). 
Gametocyte cultures were pooled together and centrifuged at 2000g for 5 
minutes in a bench centrifuge pre-warmed to 37 0C. The cells were resuspended to a 
final haematocrit of about 20% in incomplete RPMI medium and divided into 4m1 
amounts in 15m1 Corex tubes. Using a lOmi syringe and a 6 inch 16 gauge needle, 3ml 
of 30% Percoll solution, (for preparation of Percoll gradients see material) was inserted 
beneath the cell suspension; and the process was repeated with 3ml of 45% Percoll 
solution, and then with 3m1 of a 52.5% Percoll solution, layering each Percoll solution 
underneath the previous one. The gradient was then centrifuged at 10,000rpm for 10 
minutes at room temperature. After centrifugation the tubes were placed onto a vertical 
test tube rack and, using a syringe and 6 inch 16 gauge needle, the material at the 
gradient interfaces was removed in the following order first the interface between the 
upper supernatant and the 30% Percoll layer was removed; this contained large 
amounts of acellular parasite debris, malaria pigment, and RBC ghosts; second, the 
interface between the 30% and 45% Percoll layers; this contained largely gametocytes 
whose degree of purity with respect to other cells varied from at least 90% to 60% and 
third, the interface between the 45% and 52.5% layers; this contained fewer 
gametocytes, many RBCs and some asexual parasites. The material in each layer was 
checked by viewing a sample under a cover-slip using phase contrast optics. The 
gametocyte preparation was either used immediately to prepare RNA or isolate nuclei, 
or it was frozen at -70°C until it was needed for use. 
2.2.2. DNA isolation and purification 
Unless otherwise stated in the text the methods used were based on those described in 
Sambrook et al. (1989). 
2.2.2.1 Preparation of P. falciparuin DNA P. falciparum parasites 
were cultured in vitro as described above. DNA was prepared from 5 ml of cultured 
parasites (4-10% parasitaemia) as follows. The parasitised erythrocyte pellet was 
collected by centrifugation, using a bench top centrifuge, at 4,000rpm for 10 minutes. 
After centrifugation, the pellet was resuspended in 1 ml of 0.1% saponin in phosphate-
buffered saline (PBS), then incubated at room temperature for 5 minutes. The lysed 
erythrocyte suspension was then transferred to a microfuge tube and spun in a 
microfuge for 10 minutes (8,000rpm). The supernatant containing haemoglobin and 
red cell ghosts was removed and the parasite pellet resuspended in 1 ml of ice-cold 
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PBS and the centrifugation step repeated. After removing the supernatant and the 
residual ghosts, the parasite pellet was lysed by addition of 600tl of 10mM Tris-HC1 
pH 7.6, 50mM EDTA pH 8.0, 0.1% SDS, 1mg/mi proteinase K. The resulting 
viscous lysate was then homogenised by 30 passages through a 25 gauge needle and 
incubated overnight at 50 0C. The lysate was extracted twice with phenol/chloroform 
then once with chloroform. DNA was then precipitated from the supernatant by the 
addition of 0.1 volumes 5M sodium Acetate and 1 volume isopropanol, and left to 
stand at room temperature for 15 minutes. DNA was then pelleted by centrifugation, 
washed in 70% ethanol, dried and resuspended in lOOmI of TE buffer (10mM Tns-
HC1/ 1mM EDTA, pH 7.6). 
2.2.2.2 Mini-prep plasmid DNA isolation: The Magic Minipreps DNA 
Purification SystemTM (Promega Corp.) was used, when necessary, for mini-prep of 
plasmid DNA preparation. 
Single colonies were picked into 5m1 of LB broth containing 50ig/ml ampicillin 
and grown overnight at 370C with shaking. The bacteria from 1-3ml of the overnight 
culture were pelleted by microcentrifugation for 2 minutes and resuspended in 200il of 
cell resuspension solution (10mM EDTA, 50mM Tns-cl pH 8.0, lOOj.tg/mi RNase A). 
The cells were then lysed by the addition of 200tl of cell lysis solution (0.2N NaOH, 
1% SDS) and mixed by inversion of the tube several times. This was followed by 
addition of 200il of neutralisation solution (2.55M potassium acetate pH 4.8), mixing 
and inversion. In order to pellet precipitated bacterial proteins, the solution was 
microcentnfuged for 5 minutes and the supernatant transferred to a fresh Eppendorf 
tube. Then imi of the Magic Minipreps DNA Purification Resin was added to the 
supernatant and mixed by inversion of the tube several times. The resin/DNA mix was 
pipetted into a syringe barrel, and the syringe plunger was applied to push the slurry 
into a MinicolumnTM. The resin in the Minicolumn was then washed with 2ml of wash 
solution (200mM NaCl, 20mM Tns-HC1; pH7.5, 5mM EDTA, 50% ethanol). After 
that, the Minicoiumn was spun for 30 seconds to dry the resin. Then 50tl of TE buffer 
was added to the Minicolumn and left at room temperature for 2-5 minutes, and the 
piasmid DNA eluted by centrifugation of the Minicolumn for 30 seconds in 
microcentrifuge. The plasmid DNA was collected in Eppendorf tube, and stored at 4°C 
or -2€PC. 
2.2.2.3 Maxi-prep of plasmid DNA: Large scale preparations of 
piasmid DNA were prepared using, QIAGENTM commerial kit, following the 
manufacturer's instructions. 
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A single colony was picked into 250m1 of LB-amp and grown overnight at 
370C with vigorous shaking. The bacteria were pelleted by centrifugation at 3000rpm 
for 10 minutes at 40C and the pellet resuspended in 4m1 of buffer P1 (100ig/ml RNase 
A, 50mM Tris-HCL, 10mM EDTA, pH 8.0). The cells were lysed by the addition of 
4m1 of buffer P2 (200mM NaOH, 1% SDS). The suspension was mixed and 
incubated at room temperature for 5 minutes. After the addition of 4m1 of buffer P3 
(2.55M potassium acetate pH 4.8) and mixing, the solution was centrifuged at 
11,500rpm (SS-34 Sorvall rotor) for 30 minutes at 4 0C to pellet the bacterial debris. 
The supernatant was then centrifuged again for 10 minutes to ensure removal of all 
debris. Meanwhile, a QIAGEN Tip 100 column was equilibrated with 3m1 of a low 
salt buffer QBT (750mM NaCl, 5OmMMOPS, 15% ethanol pH 7.0, 0.15% Triton X-
100). The supernatant was applied to the column and allowed to enter by gravity flow. 
The column was washed with lOml of a medium salt buffer QC (1.OM NaCl, 50mM 
MOPS, 15% ethanol pH 7.0) and the DNA eluted with 5ml of a high salt buffer QF 
(1.25M NaCl, 50mM MOPS, 15% ethanol pH 8.2). DNA was precipitated at room 
temperature with 0.7 volume of isopropanol for 10 minutes and pelleted by 
centrifugation at 12,000rpm (SS-34 rotor, sorvall) for 30 minutes at room temperature. 
The DNA was washed with lml of 70% ethanol, air dried and dissolved in 200tl of 
TE buffer. 
2.2.3 Purification of DNA fragments 
DNA fragments obtained after PCR amplification, restriction digestion and 
ligation were purified by one of the following methods: 
2.2.3.1 Phenol/chloroform extraction: After one of the above reactions 
was completed, an equal volume of phenol/chloroform was added to the reaction 
product in Eppendorf tube, and the mixture vortexed for a few seconds. The mixture 
was microcentnfuged for 5 minutes and the aqueous upper phase, containing the DNA 
removed. Then the residual phenol was removed by one chloroform extraction. The 
DNA was precipitated by addition of 0.2 volumes of 3M sodium acetate and 2 volumes 
of absolute ethanol, and dissolved in an appropriate volume of TE buffer. 
2.2.3.2 Magic PCR PrepsTM  DNA purification system: D N A 
contained in agarose gel slices was also purified using Magic PCR PrepsTM purification 
Kit ( Promega) according to the manufacturers protocol. The gel slice was dissolved in 
a 1.5ml Eppendorf tube at 7 0C until the agarose had completely melted. lml of the 
Magic PCR PrepsTM resin was added to the melted agarose and vortexed briefly. The 
mix was pipetted into a syringe barrel, then the syringe plunger was applied slowly into 
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a mini-column. The mini-column was washed with 2m1 of wash solution (80% 
isopropanol). The syringe was removed and the mini-column centrifuged for 20 
seconds at 13,000rpm in a microfuge to dry the resin. The mini-column was then 
transferred to a new Eppendorf tube. The DNA was eluted by application of 50il of TE 
buffer to the column. After 1 minute the Eppendorf tube containing the mini-column 
was centrifuged for 1 minute at 13,000rpm. The mini-column was removed and 
discarded. Purified DNA was stored either at 4°C or -20°C until required. 
2.2.4 Spectrophotometry 
The concentration of DNA in solution was estimated by measuring its 
absorbence at 260nm in spectrophotometer. It was assumed that an 0D 260 of 1.0 is 
equivalent to a concentration of 50ig/ml for double stranded DNA and 35mg/ml for 
oligonucleotides. 
2.2.5 Restriction endonuclease digestion of DNA 
Restriction endonuclease enzymes were obtained from Boehringer Mannheim 
Chemical Company and New England Biolabs. Restriction enzyme digestions were 
performed in the appropriate buffer supplied by the manufacturer. The reactions were 
carried out at 37°C for 1-2 hours (unless otherwise indicated) and 4-12 units of 
restriction endonuclease were used per ig of DNA. Reactions were terminated by 
addition of 1/10 volume of 50mM Na2 EDTA, 40% w/v sucrose, containing 0.25% 
bromophenol blue, 0.25% xylene cyanol. 
2.2.6 Agarose gel electrophoresis 
Agarose gels were used to check the integrity of DNA, to analyse PCR 
products and restriction enzyme digests. 1% - 2% agarose (IBI) was dissolved in 
appropriate volume of 1xTAE buffer at 90°C. After the solution had cooled to around 
45°C, ethidium bromide (EtBr) was added at concentration of 0.5ig/ml, mixed and the 
gel was poured onto a pre-levelled electrophoresis gel plate (IBI) and left to polymerise 
at room temperature. The appropriate amount of DNA was mixed with 0.1 volumes of 
gel loading buffer (40% w/v sucrose , 50mM EDTA pH 8.0, 0.25% bromophenol 
blue, 0.25% xylene cyanol) and loaded into the submerged gel. Electrophoresis was 
carried out in 1xTAE at 100 volts for the appropriate time depending on the size of the 
fragment being separated. Fluorescence from DNA bound-ethidium bromide was 
visualised by short wave-length UV light and photographed. 
In order to estimate the size of DNA fragments 2tg of DNA markers were 
loaded adjacent to the DNA samples on agarose gels. The standards, pBR328 
BglI+Hinf I digest (Boehringer Mannheim) consisted of the following sized fragments 
2176, 1766, 1230, 1033, 653, 517, 453, 394, 298, 234, 220, and 154 base pairs(bp), 
and Hind III digest of bacteriophage X c1 857 (Boehringer Mannheim) consisted of the 
following sized fragments (bp): 23130, 9416, 6562, 4368, 2322, 2027, 564 and 125. 
2.2.7 Pulsed field gradient gel electrophoresis (PFGE) 
Physical mapping of P. falciparum has been transformed in recent years by the 
introduction of pulsed field gradient electrophoresis (PFGE) (Schwartz and Cantor, 
1984). Southern blots of PFGE separations readily serve to assign genetic markers to 
chromosomes. Pulsed field gel electrophoresis of the parasite was performed 
essentially as described by Kemp and colleagues (1987). On a practical level, 
important features of PFGE methods include embedding cells in agarose blocks and 
removing protein and lipid so that the DNA remains intact but free within the gel 
matrix, and movement of the large chromosomal DNA molecules through the gel by 
switching direction of the applied electric field at fixed time intervals. 
2.2.7.1 Preparation of parasite DNA in agarose blocks For 
preparation of chromosomal DNA in agarose blocks, parasites were first grown in 5m1 
asynchronous culture at 5% haematocrit and 10% parasitaemia (method 2.2.1.1). 
Parasitised red blood cells were pelleted by centrifugation at 4000rpm for 5 minutes at 
4°C. Parasites were released from the red blood cell pellet by lysis with an equal 
volume of 0.15% saponin in 1xPBS (made up fresh). After incubation at room 
temperature for 10 minutes the parasites were pelleted by centrifugation as above. The 
supernatant was removed and the pellet was washed twice in excess of 1xPBS. The 
pellet was resuspended in 2 volumes of 1xPBS at room temperature, and the 
suspension was fixed by addition of an equal volume of 2% low-melting point agarose 
(IBI) made up in 1xPBS at 42°C, mixed gently and pipetted into a pre-warmed mould 
(Bio-Rad), quickly before the agarose had set. The mould was then placed at 4°C for 
20 minutes to allow the gel to set. The agarose blocks were transferred from the mould 
into lysis solution (1% sarkosyl, 0.5M EDTA pH 9.0, 0.01M Tris pH 9.0, containing 
0.25mg/ml proteinase K), approximately 0.5ml per block, and incubated for 48 hours 
at 50°C with one change of the lysis solution. The blocks were stored in the lysis 
solution, without proteinase K, at 4°C until they were used. Blocks can last for several 
years if properly made and stored. 
2.2.7.2 Electrophoresis conditions: Chromosome separations were 
performed in 0.8% PFGE-grade agarose in 0.5xTBE buffer. Molten agarose was 
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cooled to about 60°C poured into the casting stand, and a comb inserted. The gel was 
allowed to set at room temperature for about 30 minutes. After that the comb was 
removed and the blocks containing parasite DNA were inserted into the wells. The 
blocks were sealed into the wells with low-melting agarose in 1xPBS, avoiding trapped 
air bubbles in the wells. The temperature of the buffer was maintained at 14°C by 
circulating it through a cooling manifold. Table 2.1 shows the conditions used for 
separating DNA of various sizes using Bio-Rad CHEF DRII system. 
Table(2. 1) Electrophoresis Conditions for Separation of P. falciparum DNA 
Fragments by Bio-Rad CHEF DRII PFGE systems: 
Fragment size Voltage Switching interval Run time 
2-200 kb 120 V 2-10 sec 24 h 
50-400 kb 140 V 10-20 sec 48 h 
100-500 kb 180 V 20-40 sec 48 h 
>500 kb 180 V 20-40 sec 72-96 h 
2.2.8 Photography 
After electrophoresis the agarose gels were stained with ethidium bromide and 
photographed under UV transilluminator (IBI) using short wave-length. A 
photograph of the gel was obtained by exposing it to Polaroid 667 or 665 professional 
film or using a gel video documentation system (Video Copy Processor, Mitsubishi TM) 
2.2.9 Southern blotting 
The blotting of DNA fragments from agarose gels was performed by the 
method of Southern (1975). The agarose gel containing fractionated DNA was 
soaked in 0.25M HC1 for 15-30 minutes in order partially to depunnate the DNA. The 
gel was then rinsed in dH20 for 5 minutes before being soaked in 0.4M NaOH twice 
for 15 minutes. The gel was then placed onto blotting paper pads, submerged into a 
reservoir containing 0.4M NaOH, overlaid with a Hybond N+  membrane. On top of 
this were placed 3 pieces of 3M paper cut to the size of the gel and pre-wetted in 0.4M 
NaOH, then another 3 sheets of dry blotting paper, a stack of towels, a glass plate and 
a weight. Exposed areas of the blotting paper pads were covered with Saran wrapTM in 
order to minimise evaporation and to ensure that flow of 0.4M NaOH was only 
through the blot. After overnight transfer the membrane was removed and neutralised 
in 0.5M Tris-HC1 for 5 minutes, air dried, and wrapped in Saran wrap, (Dow 
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Chemical Company), until it was required for the hybridisation reaction (method 
2.2.12). 
For transfer of DNA from mini-gels onto HybondN+ membrane (Amersham) 
prior to probing the following method was used: The agarose gel was first soaked in 
denaturation solution (0.5M NaOH, 1.5M NaCl) for 15 minutes and then transferred 
into neutralisation solution (1.5M NaCl, 0.5M Tris pH 7.5) for another 15 minutes. 
The gel was then placed on a glass plate and overlaid with a piece of Hybond N+ 
membrane and 3 sheets of blotting paper all pre-wetted in neutralisation solution. Onto 
this were placed 3 sheets of dry blotting paper, a stack of paper towels, a glass plate 
and a weight. After transfer for 4-6 hours, the membrane was removed, rinsed in 
2xSSC and air-dried. The membrane was then ready for prehybndisation and probing. 
2.2.10 Dot blotting 
Cut plasmid DNA or P.falciparum genomic DNA was appropriately diluted in 
TE, denatured by heating to 95°C for 5 minutes and left on ice for at least 2 minutes. 
Then 1 volume of 20xSSC was added to the sample. A commercial dot blotting 
apparatus (HybaidTM) was used to spot the samples on HybondN+ membrane in equal 
aliquots. The membrane was then placed, DNA side up, on a filter paper wad soaked 
in denaturing solution (1.5M NaCl, 0.5M NaOH) for 5 minutes. Then the membrane 
was transferred to a filter wad soaked in neutralisation solution (1.5M NaCl, 0.5M 
Tris-HC1 pH 7.2) and left for 1 minute. The DNA was then fixed by placing the 
membrane for 20 minutes, DNA side up, on a pad of absorbant filter paper soaked in 
0.4M NaOH. After that, the membrane was rinsed in 5x SSC with gentle agitation for 
1 minute. The membranes were either used immediately or wrapped in SaranWrap and 
stored at 4°C until needed. 
2.2.11 Probe synthesis 
The selection of an appropriate combination of label and labelling method for a 
particular experiment depends mainly on the level of sensitivity and resolution required. 
For most filter hybridisation applications, sensitivity is considered to be of greater 
importance. Accordingly, for maximum sensitivity in filter hybridisation, phosphorus-
32 (32P)  is the most widely used radiolabel as it is available at high specific activity and 
can be detected with high degree of efficiency. Several methods are available for 
making probes. End-labelling with polynucleotide kinase is employed with short 
oligonucleotides, whereas longer DNA fragments are generally labelled by random 
priming methods. 
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2.2.11.1 Random priming method: In this work, random primer 
labelling method was used which was first described by Feinberg and Vogeistein 
(1983). The approach utilises Klenow enzyme, the large fragment of E. coli DNA 
polymerase I, which has 5'-3polymerase activity. This enzyme is used because it 
lacks the 5'-3' exonuclease activity which would otherwise degrade the primers. The 
absence of the 5'-3' exonuclease also ensures that incorporated nucleotides are not 
subsequently removed as monophosphates. A mixture of random DNA 
hexanucleotides is used to prime the DNA and the complementary strand synthesised 
from the 3'-OH termini of the primers with the incorporation of radiolabelled dNTP. 
The length of the DNA fragments to be labelled influences the reaction. Linear single-
stranded or denatured double-stranded DNA molecules are usually used as substrates. 
Covalently-closed circular DNA can also be used, but slightly lower incorporations are 
obtained. 
In this work, the Random Primed DNA Labelling Kit (Boehnnger Mannheim), 
was used to synthesised radioactive probes for hybridisation reactions. The DNA 
template (25-50ng in TE buffer) was first denatured by boiling for 5-10 minutes and 
chilled on ice to prevent reannealing. A mixture of 2pi hexanucleotide mixture in lOx 
reaction buffer [900mM HEPES, adjusted to pH 6.6 with 4N NaOH, 100mM M9 021, 
1.tl [0.5mM] each of dCTP, dGTP, dTTP, 5i.tl  [50pC, 1.85MBq] of [a-32P] dATP 
(Amersham International. Plc.), and 1i.l (2 units) of Klenow enzyme were then added 
to the denatured DNA template and incubated at 37°C for 30-60 minutes. The reaction 
was stopped by addition of 0.5mM EDTA and the unincorporated nucleotides separated 
from the labelled DNA by chromatography column as described in the next section. 
This procedure can routinely be used to obtain specific activity as high as 1.8x10 9 
dpm/ gig. 
2.2.11.2 Removal of unincorporated nucleotides and proteins: In 
general, the denatured labelled DNA can be used directly as a hybridisation probe 
without stopping the reaction or removing unincorporated label. Sometimes, if small 
amounts of target RNA or DNA molecules are present on the hybridisation membrane, 
further purification of labelled probe is necessary in order to get rid of any possible 
interference either from unincorporated nucleotides or from protein debris. 
Removal of unincorporated nucleotides was performed by passing the labelling 
reaction over a Sephadex 0-50 column. The column was made by packing a 
glasswool-plugged disposable plastic syringe with Sephadex G-50 prepared in TE 
buffer (10mM Tris-HC1 pH 8.0, 1mM EDTA pH 8.0). The column was washed 
several times with TE buffer. After the radiolabelling reaction was completed, 5#il  of 
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gel loading buffer was added to the DNA sample. The DNA sample was applied in a 
volume of 100t1 to the column and the column was washed with approximately lOOm! 
of TE buffer. The column was connected to a reservoir of TE buffer so that the flow 
rate was about 0.5ml/min. 15-20 fractions, approximately 0.5m1, of the material were 
collected in Eppendorf tubes (usually the sample was collected up to the xylene cyanol 
band, which usually contains all incorporated material). The radioactivity in each tube 
was measured by a hand-held Geiger counter, and the radioactive fractions in the 
leading peak pooled and stored at -2(PC until needed. The probe was boiled for 10 
minutes before it was added to hybridisation solution. 
2.2.12 Hybridisation 
All hybridisations were performed in a Hybridisation oven (Hybaid'). In the 
course of this study all Southern blots, Northern blots and filters were probed for 
homologous DNA sequences and therefore hybridisation was carried out under 
stringent conditions throughout. In general, to maximise the rate of annealing of the 
probe with its target, hybridisations were usually carried out in the presence of 10% 
dextran sulphate in a solution of high ionic strength at a temperature that was 20-25°C 
below the melting temperature (T m) (Sambrook et al., 1989). 
Prehybridisation was carried out in 10-20m1 aqueous hybridisation buffer 
which was made by addition of lOg of dextran sulphate [MW-500,000], lOml of 10% 
SDS and 5.8g NaCl, to 85 ml of dH20 and heated at 65°C for 30 minutes. This buffer 
usually prepared in bulk and stored at -20°C. Just before prehybndization was carried 
out, the buffer was diluted and 100tg/ml denatured, sonicated salmon or herring sperm 
DNA was added. Prehybridization was performed at 65°C for 1-2 hours. The boiled, 
denatured probe was then added and hybridisation continued overnight at 65°C. Non-
specifically bound nucleotides were removed by washing the membrane twice with 
excess 2xSSC at room temperature for 10 minutes. Then the membrane was washed 
stringently in 0.5xSSC, 0.1% SDS at 65°C (4x15 minutes). Filters were then placed 
between two layers of Saran Wrap and autoradiographed (method 2.2.14). 
2.2.13 Stripping probes from DNA blots 
Blots were stripped before were used in different hybridisation reaction. For 
efficient removal of probes, the membranes were not allowed to dry during the 
hybridisation and detection procedure. DNA filters were incubated at 45°C for 30 
minutes in 0.4N NaOH and then in neutralisation solution (0.1xSSC, 0.1% SDS, 
0.2M Tris-CI pH 7.5) for 30 minutes. The filters were then exposed to X-ray films 
and autordiographed to check for removal of the probe. 
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2.2.14 Autoradiography 
This was performed using X-ray film (Kodak XAR-5 or AGFA Curix) for 32P 
probed filters, in a cassette containing intensifying screens. The cassette containing 
32P probed filters were stored at -70°C while those containing 35S  labelled gels were 
stored at room temperature. After the appropriate length of time the film was developed 
using a X-O'GRAPH Xl automatic X-ray film processor. 
2.2.15 Recombinant DNA techniques 
2.2.15.1 Ligation of DNA: In order to prevent the religation of the 
compatible ends of digested plasmid, lineansed DNA was treated with calf intestine 
alkaline phosphatase (CIP) which removes the 5'-phosphatase residues from DNA. 
After digestion of the plasmid with the appropriate restriction endo-nuclease, 1 unit of 
CIP (New England BioLabs.) was added and the preparation incubated at 37°C for 1 
hour. To inactivate the enzyme, 0.1 volume of 250mM EDTA pH 8.0 was added and 
the solution incubated at 75°C for 10 minutes. 
Vector DNA (SOng) and insert DNA were cut with suitable restriction enzyme 
endonucleases (method 2.2.5), and if necessary treated with phosphatase as above and 
purified (method 2.2.3). Ligation of the insert to vector was performed at a ratio of 
approximately 3 molecules of insert to 1 molecule of vector. To the mixture of vector 
and insert DNA, in TE, was added l.tl of lOx ligase buffer (500mM Tris-HC1 pH 7.5, 
100mM MgC12, 100mM DTT, 100mM ATP), 1 unit of T4 DNA ligase (New England 
BioLabs.) and the total reaction volume made up to 10p1 with dH20. The reaction was 
incubated at 16°C overnight and then diluted 5-fold with dH20 prior to E. coli 
transformation ( method 2.2.15.4). 
2.2.15.2 Subcloning of PCR products into pCRII plasmid vector: 
The TA Cloningmt System, Fig.2.1, from Invitrogen Corp. was used routinely during 
this study to provide a quick one-step cloning strategy for direct insertion of PCR 
product into a plasmid vector (Mead et al., 1991). The procedure eliminates any 
enzymatic modifications of the PCR product such as Kienow or 14 polymerase 
treatment to create blunt ends, and it does not require the use of specifically designed 
primers containing restriction sites. The system takes advantage of the non-template 
dependent activity of the thermostable polymerases used in PCR that add single 
deoxynucleotides to the 3' end of all duplex molecules. These A-overhangs are used to 
insert the PCR product into specifically designed vectors providing single 3'T-
overhangs ready for the insertion site. 
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Figure 2.1 
Schematic diagram showing the pCRII plasmid vector map. The sequence 
above the diagram represents the pCRII vector sequence with a PCR product cloning 
site indicated. 
M13 Reverse Primer 	
Sp6 Promoter 
CAG GA. ACA T ATG A C ATG A ACG CCA A fAT  TTA r GAC ACT ATA 4 
CIC CIT TCT CGA TAC T G TAC TAA T GT TCG TA AAT CXA CIG TGA TAT CIT 
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CM TCA CAC CAC CIT AAG _• 
TT CCC CIT MG ACG TCT ATA 
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The ligation and transformation were carried out following the manufacturer's 
instructions. Briefly, after the final PCR amplification cycle was completed, the 
appropriate amount of PCR sample was removed from underneath the mineral oil 
overlay and transferred to a new tube. The ligations with the pCRTM vector (3.9kb) 
were set up as 1:1 to 1:3 molar ratio of vector: PCR insert. For each ligation reaction; 
2.tl (SOng) of vector, 1tl (12.5ng) of PCR product, 1ti lOx ligation buffer (0.5M Tris 
pH 7.4, 0- IM MgCl 2 , 0. IM dithiothreitol, 10mM spermidine, 10mM ATP, 1mg/mi 
BSA), 11d of T4 DNA ligase and 6tl of dH20. The ligation mix was incubated 
overnight at 14-16°C. 
2.2.15.3 Preparation of competent Cells: The method used was 
modified after Hanahan (1983). Cells of the appropriate E. coli strain were plated on 
LB agar overnight at 37°C. 2-3 colonies were picked and grown in lOmI LB broth 
overnight at 37°C with shaking. The following morning the culture was diluted 50-
fold in LB broth and incubation continued for approximately 2 hours until the cell 
density was 4-7 x 10 viable cells/ml, which corresponds to O.D.550 of 0.3-0.6. The 
culture was chilled on ice for 15 minutes. The bacterial pellet was then collected by 
centrifugation at 5,000rpm for 5 minutes at 4°C, and resuspended in ice-cold 
transformation buffer I (TBI) (material 2.1.7) at 1/3rd the original culture volume. The 
cells were then incubated on ice for 5 minutes, collected again by centrifugation as 
above. The pellet was then resuspended in 1/12.5 of the original culture volume ice-
cold transformation buffer II (TBII) (material 2.1.7), and incubated on ice for 30 
minutes. The cells could then be stored at -70°C in small aliquots (100-200!1l) after the 
addition of glycerol to 15% v/v, or could be used the same day. 
2.2.15.4 Transformation of E. Coil Competent cells (50-100itl) were 
mixed with either 25 ml of a 5-fold diluted ligation reaction or 20ng of uncut plasmid 
DNA. The cells were then incubated on ice for 30 minutes, heat-shocked at 42°C for 
60 seconds and incubated on ice for 2 minutes. To each transformation, 400-450ii of 
pre-warmed LB or SOC medium was added and the mixture was incubated at 370C, 
with gentle shaking, for 1 hour. 25-100tl of from each transformation were plated out 
on appropriate selective LB agarose plates and incubated overnight at 37°C. 
2.2.15.5 Colony screening: The procedure used was that described by 
Hanahan and Meselson (1983) and Buluwela et al., (1989) in which colony lysis, 
DNA denaturation and DNA fixation to the membrane is carried out in a single step. 
Using sterile, blunt-ended forceps (Millipore) a sterile Hybond-N filter was 
laid on a surface of a day-old LB agar plate containing ampicillin. When the filter was 
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thoroughly wet, the bacterial suspension was directly plated from the transformation 
mixture onto the surface of filter. The plates were left at room temperature for 10-15 
minutes to allow the inoculum to evaporate. After that the plates were inverted and 
incubated overnight at 37°C for about 8-10 hours. The next morning, the filters were 
peeled off the overnight plate and laid, colony side up, on a dampened pad of sterile 
3MM paper. A fresh, sterile HybondN+ filter was laid on the master filter. Care were 
taken to prevent air bubbles from becoming trapped between the two filters. The two 
filters were pressed firmly together with a heavy glass plate (with a 3MM paper 
between the glass and the filters). The two filters were then oriented by making a 
series of holes in them with an 18-gauge needle and before being peeled apart. The 
replica filter was laid on a fresh LB-amp. agar plates and incubated at 37°C until the 
colonies appeared (4-8 hours). The master filter was replaced on a fresh LB-amp. agar 
plate and incubated for 1-2 hours, and kept at 4°C until needed. 
The replica filters were removed and placed for 3 minutes, colony side up, onto 
filter paper pre-wetted with 10% SDS solution. This treatment, which is optional, 
seems to result in a sharper hybridisation signal. It probably works by limiting the 
diffusion of plasmid DNA during denaturation and neutralisation. The filters were 
then placed for 5 minutes onto a second sheet of 3MM paper that had been saturated 
with denaturing solution (0.5M NaOH, 1.5M NaC1). After that, filters were placed 
for 5 minutes onto a third sheet of 3MM paper that had been saturated with neutralising 
solution (1.5M NaCl, 0.5M Tris.Cl pH 8.0). Finally, the filters were rinsed briefly 
into 2xSSC solution and allowed to dry at room temperature for 30-60 minutes. The 
filters were either used immediately in hybridisation reactions or wrapped loosely in 
aluminium foil and stored under vacuum at room temperature. Positive signals were 
then identified and the appropriate colony on the master plate picked for further 
analysis. 
2.2.16 Polymerase Chain Reaction (PCR) 
The polymerase chain reaction (PCR), is a powerful in vitro method for 
enzymatic synthesis of specific DNA sequences (Saiki et al., 1988). The double 
stranded DNA is first denatured, then specific primers corresponding to each end of the 
target sequence annealed, and the sequence extended. This cycle is repeated as much 
as 40 times and has the potential of amplifying the target sequence as much as 10 9 
times. Due to the high temperature required for the denaturation step, a thermostable 
DNA polymerase called Taq polymerase is needed which was originally isolated from 
The rmus aquaticus. 
PCR was performed in 0.5m1 Eppendorf tubes. Each reaction contained 1tl of 
each primer at 10mM, dNTP solution ( a mixture of 10mM dGTP, dATP, dTTP, 
dCTP) at 40mM, 10il of lOxTaq polymerase buffer (500mM KC1, 100mM Tris-HC1 
pH 8.3, 20 mM MgC12, 0.02% gelatin), dH20 to a total reaction volume of 99il and 
1i1 (0.25 units) of Taq polymerase (Cetus Corp.). The reaction mixture was overlaid 
with 100d of mineral oil and PCR was performed using HybaidOmnigene thermal 
reactor. The products of the PCR reactions were analysed by agarose gel 
electrophoresis and ethidium bromide staining. The gels were then observed under the 
UV light and, if necessary, a photograph was taken. 
2.2.17 Inverse Polymerase Chain Reaction (IPCR) 
This method is used for rapid in vitro amplification of DNA sequences that 
flank a region of known sequence. The method uses the PCR, but it has the primers 
oriented in the reverse direction of the usual orientation. The template for the reverse 
primers is a restriction fragment that has been ligated upon itself to form a circle (Triglia 
et al., 1988). 
1 tg of P. falciparum genomic DNA was digested in 20tl to completion with 
the enzyme of choice. The reaction was heat inactivated if possible, but otherwise it 
was phenol/chloroform extracted and alcohol precipitated. Then the DNA was 
resuspended in an appropriate volume of TE buffer. The product of the digestion was 
ligated and inverse PCR was carried out in 50tl PCR reaction using 2tl of the ligation 
mix as template DNA. 
2.2.18 DNA sequencing 
DNA sequence determination was performed by the chain termination method 
of Sanger et al., (1977), using the Sequenase version 2.0 Kit based on T7 DNA 
polymerase from United States Biochemical Corporation (USB), following a 
modification of protocol of Winship (1989). In this protocol, the use of culture grade 
DMSO at 10% in the sequencing reactions is recommended to enhance the intensity of 
the signal and to reduce background and prevent formation of secondary structure 
when sequencing double-stranded DNA fragments. 
For sequencing plasmid and double-stranded DNA templates the alkaline-
denaturation method was used. Approximately 5tg of double stranded DNA in 20jil 
of TE buffer was incubated with Sd of 0.4 NaOH, 20pi 1mM EDTA and 55p1 dH20 
for 30 minutes at 37°C. After incubation, 20il of Na acetate and 250t1 of absolute 
ethanol were added and incubated at -70 °C for 30 minutes. The DNA was collected by 
centrifugation at 10,000rpm for 10 minutes. The pellet was washed with 70% ethanol 
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and resuspended in 6il of TE buffer. An aliquot (6tl) of denatured template was used 
for the subsequent sequencing reaction. It was added to 2p1 of reaction buffer (200mM 
Tris-HC1 pH 7.5, 100mM MgC12, 250mM NaC1), mixed with 11ii of primer (1ng/tl) 
and 1tl of 10% DMSO. The annealing reaction was performed at 37oC for 15-30 
minutes. To this was added 1tl of 0.1M DTT, lp.d of 1:5 diluted labelling mix (1.5M 
each of dCTP, dGTP, dTTP), 1tl of [a-35-S]dATP,1000ci mM, 10iCi 1 , 
(Amersham),and 1 t (2 units) Sequenase (diluted in enzyme dilution buffer of 10mM 
Tns-CI pH 7.5, 5mM DTT and 0.5mg/mi BSA). The solution was mixed thoroughly 
and incubated at room temperature for 5 minutes. Then 3.5tl of the solution was 
aliquoted into appropriate pre-warmed (37 °C) termination mix (80tM dNTP [dGTP, 
dATP, dCTP, dTTP]; 8ptM ddNTP [ddGTP, ddATP, ddCTP, ddTTP, respectively]; 
50mM NaC1 and 10% DMSO). The termination was stopped after 5 minutes 
incubation at 37°C by adding 4p1 of stop solution (95% formamide, 20mM EDTA, 
0.05% bromophenol blue and 0.05% xylene cyanol FF). The samples were boiled for 
3 minutes prior to loading, (3i1 per well) into a 6% denaturing polyacrylamide gel. 
2.2.19 Polyacrylamide gel electrophoresis 
Sequence reactions were separated on a 380mm x 0.3mm, 6% polyacrylamide 
gel (8 M Urea, 6% acrylamide, 0.16% bis-acrylamide, 0.08% ammonium persulphate 
in 1xTBE pH 8.8-8.9. 30 xl of TEMED ( N,N,N'N'- tetramethylethylenediamine) 
were added before pouring the gel between cleaned glass plates. Just before loading, 
samples were heated to 85°C for 3 minutes, and then loaded onto a pre-run (15-30 
minutes) polyacrylamide gel. Electrophoresis was then carried at 40W constant power. 
Following electrophoresis, the gel was fixed in 7% acetic acid and 7% methanol for 30 
minutes. Gel were dried under vacuum on a gel dryer (Model 583 Gel Dryer, BlO-
RAD) for 1-2 hours at 80°C, and exposed to X-ray film (Kodak XAR-5 or AGFA 
CURIX) in a cassette for about 16-24 hours. Films were developed in an automatic X-
ray film processor (X-ograph XI). 
Sequences were analysed using the University of Edinburgh Computing 
facilities. Compiling of data, analysis and manipulation was performed using the 
University of Wisconsin Genetics Computer Group, (GCG), Sequence Analysis 
Software Package Version 7.1 (Devereux et al., 1984). 
2.2.20 RNA methods 
2.2.20.1 Preparation of total RNA from parasite cultures 
Total RNA was prepared from synchronous P. falciparum using the RNA 
Extraction Kit from Pharmacia (Pharmacia LKB Biotechnology). The primary problem 
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facing any RNA extraction procedure is to protect RNA from degradation by 
ribonucleases, which are widely prevalent both in tissues and in the laboratory 
environment. The inclusion of the chaotropic salt guamdium thiocyanate (GTC) in the 
extraction buffer provides a high degree of protection from RNase activity, (Chirgwin 
et al., 1979). The caesium chloride used for equilibrium centrifugation is replaced in 
this kit by caesium trifluoroacetate, (CsTFA), which is more effective in inhibiting 
RNase activity and deproteinising nucleic acids. 
Cultures were centrifuged at 4,000rpm for 5 minutes to collect the parasites. 
Then the parasites were released from the RBCs by lysis in 0.1% saponin in 1xPBS 
(described in section 2.2.2.1) and centrifuged. The pellet was then homogenised in 
Extraction Buffer (guanidinium thiocynate, N-Iauryl sarcosine, and EDTA), the cellular 
debris was removed by centrifugation at 7,000rpm in a Beckman JA-14 rotor for 20 
minutes at 15°C, and the supernatant passed through an 18 gauge syringe needle to 
shear chromosomal DNA. The extract was then loaded onto a "cushion" of CsTFA 
solution and was ultracentrifuged for 20 hours at 33,000rpm. After centrifugation, the 
bulk of the liquid was aspirated off, stopping just before the DNA band (or about 1 cm 
from the bottom if the DNA band was not visible), and then the remaining liquid was 
decanted, taking care not to disturb the RNA pellet. The tube was then inverted and 
allowed to drain on a paper towel for 5 minutes. The RNA pellet was dissolved in 100-
200p,l TE buffer, heated at 65°C for 10 minutes and vortexed. Sometimes 
precipatation with ethanol was carried out to concentrate the RNA or to remove traces 
of CsTFA. In such cases 0.1 volume of 2M potassium acetate and 2.5 volumes of 
ethanol were added to the dissolved pellet. The mix was then chilled at -20°C for 2 
hours and the RNA was collected by centrifugation at 5000g for 20 minutes. The 
supernatant was decanted and the RNA pellet was dissolved in 200d of TE buffer. 
The total RNA was used either used immediately or stored frozen at -70°C until used. 
2.2.20.2 Formaldehyde gel electrophoresis 
RNA was fractionated in 1.2% w/v agarose gel prepared and run in 1xMOPS 
buffer (20mM MOPS, 5mM NaAc pH 7.0, 1mM EDTA, pH 7.0) containing 3% 
formaldehyde. The RNA in solution was mixed with an equal volume of formamide 
sample buffer (2xMOPS buffer, 50% formamide, 10% formaldehyde) and heated to 
65°C for 10 minutes then immediately cooled on ice. After addition of 0.25 volumes 
of normal sample buffer (0.25% bromophenol blue, 0.25% xylene cyanol, 30% 
glycerol) the sample and an aliquot of RNA molecular weight marker (Boehnnger 
Mannheim RNA marker II consisted of the following bands (kb) 7.4, 5.3, 1.9, 1.6, 
1.0, 0.6, 0.4, and 0.3) were loaded. The gel was run at 70V for 1-2 hours. After the 
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electrophoresis was complete the gel was stained in EtBr. at 0.5igIml and 
photographed. 
2.2.20.3 Northern blotting 
The RNA gels were first rinsed in 1xSSC for 10 minutes to remove 
formaldehyde from gels. Large RNA molecules were slightly denatured by soaking the 
gels for 10 minutes in 1xSSC, 50mM NaOH solution. The gels were blotted overnight 
onto HybondN+ membrane using 1OxSSC. After overnight transfer the membrane 
was removed and rinsed in 2xSCC. The blot was then ready for hybridisation. 
2.2.20.4 Pre-hybridisation and hybridisation 
Membranes were pre-hybridised at 60°C for 16 hours in 0.25M sodium 
phosphate buffer pH 7.2 and 7% SDS. The buffer was changed once after 8 hours. 
The probe was random-primer labelled. Hybridisation was carried out at 60°C 
overnight using the same solution overnight. Filters were washed in 2xSSC, 0.1% 
SDS, then in 0.1xSSC, 0.1% SDS for 30 minutes twice before exposed to X-ray 
films. 
2.2.20.5 Stripping of Northern blots 
When necessary Northern blots were first stripped prior to probing. A solution 
of boiling 0.1% (wlv) SDS poured over the blot and allowed to cool to room 
temperature. The filter was then autoradiographed to check complete removal of the 
probe. 
2.2.21 Nuclear run-on analysis 
Nuclear run-on is an in vitro assay that can be used to study transcriptional 
activity of specific gene(s). The purpose is to prepare a cell-free extract which is active 
in RNA synthesis. The RNA synthesised should reflect both qualitatively and 
quantitatively the RNA synthesised in the intact cell. In particular, only the correct 
DNA strand should be transcribed, and initiation, termination and processing should 
occur at the same sites in vivo as in vitro. In addition, only these genes which are 
expressed in vivo should be expressed in vitro (Marzluff and Huang, 1989). 
To obtain nuclei active in faithful RNA synthesis , it is necessary to preserve 
RNA polymerase activity and structure during the isolation of nuclei and to exclude 
degradative activities (nucleases, proteases, tnphophatases) from the preparation. 
All steps were carried out on ice. lOml cultures of P. falciparum (clone 3137) 
were set up in 25m1 flasks and the cultures were allowed to reach a parasitaemia of 8 
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% before the contents of the flasks (10 flask per preparation) were collected by 
centrifugation and washed in 1xPBS. The red blood cells were lysed by addition of 
equal volume of 0.15% saponin, followed by three washes in E buffer (250 mM 
sucrose, 20mM PIPES pH 6.3, 0.5mM Cad 2 , 1mM PMSF, 2tgIml apotinin, 
2pg/leupeptin, 1.tg/m1 pepstatin A, 2tg/ml antipain, 0. 1mM benzamidine, and 0.1mM 
metabisulfite). The pellet free of RBCs was then resuspended in 3m1 of E buffer and 
transferred to a dounce homogeniser. 200m1 of 10% NP-40 solution was added and 
about 10-15 strokes with a B-pestle were applied. Nuclei were collected by 
centrifugation at 10000rpm for 10 minutes in a pre-chilled Sorvall SM24 rotor, and 
washed three times /in E buffer before being transcribed (7x10 8 nuclei) at 37°C for 10 
minutes in 600i.tl of solution B (50mM HEPES pH 7.9, 50mM NaCl, 10mM Md2, 
1.2mM DTT, 10mM creatine phosphate, 1mM GTP, 1mM CTP, 4mM ATP, 25% 
glycerol, 125U/ml rRNasin (Promega), 0.2mg/mi creatine kinase and 0.51M [a- 32P] 
UTP 3000 Ci/mmol). Radiolabelled RNA was isolated by the Chomcyski and Sacchi, 
(1987) method and then purified by using chroma- 100 spin column (Clontech Trs4). 
The single stranded DNA fragments (0.2pmol) from pfran, pfrccl, mspl, CS, 
pfg27125 and pfs230 genes, were immobilised on Hybond-N+ membrane by the dot 
blotting method 2.2.10. Prehybndisation, hybridisation and washing were carried out 
as described in method 2.2.12. The membranes were dried and exposed at -70°C with 
an intensifying screen for up to a week. 
2.2.22 Protein methods 
2.2.22.1 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
Protein extracts prepared from bacteria and parasites were fractionated by SDS-
PAGE (Laemmli,1970) with a discontinuous buffer system. Both large (160mm x 
180mm x 1mm) and mini-gels (80mm x70mm x 0.75mm) (Hoefer), were used in the 
course of this study and gel mixtures were prepared according the recipes given in 
Table 2.2. Large gels were prepared with a 160mm resolving gel and a 20mm stacking 
gel, while mini-gels were cast with a 50mm resolving gel and 10mm stacking gel. 
The resolving gel was poured and overlaid with a small volume of water-
saturated butanol. After gel polymerisation the overlay was removed and the gel 
surface rinsed with dH20. The stacking gel was then poured and the appropriate comb 
inserted. Once the gel had polymerised, the comb was removed and the wells rinsed 
with dH20. The gel was then ready for loading. 
Protein samples were prepared by the addition of an equal volume of 2x 
sample loading buffer (material 2.1.7) and then boiled for 5 minutes prior to loading. 
Gels were run in an electrode buffer (25mM Tris, 190mM glycine, 1%SDS), either at 
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65V overnight for large gels or at 150V for an hour for mini-gels. Separated proteins 
were then either stained with Coomassie blue stain (method 2.2.22.3) or 
electrophoretically transferred onto a nitrocellulose membrane (method 2.2.22.6). 




(0. 125M Tris) 
Monomer Concentration 10% 12% 4% 
Acrylamide/bis-acrylamide (30: 0.8) lOmI 12ml 2.6ml 
dH20 12.5m1 10.5m1 6.1ml 
1.5M Tris-HC1, pH 8.8 7.5ml 7.5m1 - 
0.5M Tns-HC1, PH 6.8 - 
- 5.Oml 
10% SIDS oOOjLl 600.tl 200tl 
10% ammonium persuiphate 300i! 300R1 100tl 
TEMED 50pJ 50tl 20!1l 
Total volume 30m1 60ml 20m1 
2.2.22.2 Protein molecular weight markers 
Colored (rainbow) marker (Amersham) contained Myosin (200,000 blue), 
Phosphorylase b (92,500 brown), BSA (69,000 red), Ovalbumin (46,000 yellow), 
Carbonic anhydrase (30,000 orange), Trypsin inhibitor (21,000 green) and Lysozyme 
(14,000 magenta) was used routinely in this study. The marker was prepared in 2x 
loading buffer and boiled for 5 minutes before being loaded. For mini-gels 2pg of 
each marker protein was loaded per well, and for large gels 10ig per lane was loaded. 
2.2.22.3 Coomassie blue staining of protein gels 
Protein gels were stained with 0.25% Coomassie brilliant blue R-250, in order 
to visualise fractionated protein. The stain was prepared in water: methanol: glacial 
acetic acid 5:5:1 for 2 hour at room temperature with gentle agitation. Excess stain was 
removed by destaining the gel in water: methanol: glacial acetic acid 5:5:1 until the 
background was clear. Coomassie staining can detect approximately 0.5-1pg of 
protein per band. 
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2.2.22.4 Raising antisera to recombinant glutathione S-transferase 
(GST) fusion proteins 
2.2.22.4.1 Expression of GST fusion proteins: pGEX vectors were 
used to express polypeptides in E. coli as fusions with glutathioneS-transferase (GST). 
The basic protocol used for expressing, purifying and cleaving fusion proteins was that 
described by Smith and Corcoran (1990). 
The chosen P.falciparum DNA fragments were subcloned into the appropriate 
pGEX vector (pGEX-3 in this study). TG-1 cells were used for transformation and 
the cells were grown on LB-amp agar plates overnight at 37°C. 
Single colonies were picked and put into into LB-amp, 5m1 for a small scale 
preparation or lOOml LB-amp. for a large scale preparation, and grown overnight at 
37°C with shaking. The following day the culture was diluted 1:10 in LB-amp and 
grown at 37°C with shaking. After one hour, lml of culture was removed as a control 
before induction, and to the remaining culture 100mM IPTG was added to a final 
concentration of 0.1mM in order to induce fusion protein expression. Cells were then 
grown for a further 3 hours. These were determined as the optimum growth conditions 
to give consistently high yields of fusion protein. Cells were collected by 
centrifugation, at 5,500 rpm (Sorvall) for 10 minutes at 4°C. They were then 
resuspended in ice-cold PBS, 1:100 dilution of the original culture. In order to check 
expression of the fusion protein 100tl of culture was spun down, resuspended in lOml 
of loading buffer and checked by SDS-PAGE and Coomassie staining. 
2.2.22.4.2 Purification of GST fusion proteins: Bacterial cells, 
containing the expressed fusion protein, were lysed using a sonicator with a 5mm 
diameter probe, with lysis generally occurring after 30 seconds sonication. 10% 
Triton X-100 was added to the lysed cell suspension to a final concentration of 1%, in 
order to minimise any association of fusion proteins with bacterial proteins. An aliquot 
of the lysed bacterial extract was then spun and a sample of both the supernatant and 
pellet analysed by SDS-PAGE and Coomassie staining. If the fusion protein was 
soluble the protein was further purified by the following method: 
If the GST fusion protein was soluble, the lysed cells were microcentrifuged 
for 10 minutes in 1 ml aliquots and the supernatant, containing the soluble fusion, 
transferred into a clean microfuge tube. To each aliquot of supernatant was added a 
50% slurry in PBS of pre-swelled S-linkage glutathione-agarose beads (Pharmacia) 
and this mixed was gently for 1 hour at room temperature. The beads were collected 
by microcentrifugation for 5 seconds and pooled. The supernatant was then treated 
with a second aliquot of beads. Each batch of pooled beads were then washed in 50 
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volumes of ice-cold PBS and collected by centrifugation at 1000rpm for 1 minute at 
4°C. The wash was repeated 2 times. The beads were then resuspended in loading 
buffer and an aliquot analysed by SDS-PAGE and Coomassie staining in order to 
estimate the concentration of bound protein. 
For large scale purification, a colony of pGEX transformants was inoculated 
into lOOml LB-amp medium and grown overnight at 37°C in a shaking incubator. 
This culture was then diluted 1:10 into 500m1 fresh LB-amp. medium and grown at 
37°C. After 1 hour the culture was induced by addition of 100mM IPTG to a final 
concentration of 0.1mM. The incubation was then continued for an additional 3 
hours. The culture was centrifuged for 10 minutes in a Beckman rotor at 5000rpm 
and the supernatant discarded. The pellet was resuspended in lOmi ice-cold PBS and 
the cells were lysed by sonication. After sonication, 10% Triton X-100 was added to 
give a final concentration of 1%. This was mixed and centrifuged for 5 minutes at 
10000rpm at 4°C. The supernatant was collected and lml of glutathione agarose 
beads was added and mixed for 5 minutes at room temperature. The beads were 
washed three times with 1xPBS. The pellet was resuspended in lml of ice-cold PBS 
and then transferred to an Eppendorf tube. The fusion protein was eluted by addition 
of lml of 50mM Tris-Ci (pH 8.0)/5mM reduced glutathione. An aliquot of induced 
proteins were run in parallel to non-induced ones on SDS-PAGE. 
2.2.22.4.3 Immunisation regime : New Zealand 5 month old male 
rabbits were used to raise antibodies against the GST fusion protein. Approximately 
0.5mg of protein was used per immunisation emulsified in lml of adjuvant. A rabbit 
was also used to raise antibodies against the GST moiety. Prior to the first 
immunisation a lml ear bleed was taken from each rabbit as a sample of 'pre-immune' 
sera. Protein for the first immunisation was prepared in lml Freund's adjuvant and 
0.25m1 injected subcutansously (s.c.) into four different part of the rabbit. Three 
weeks later the animals were boosted with protein prepared in incomplete Freund's 
adjuvant. Again 0.25ml was injected s.c.into four different parts of the skin. Rabbits 
were boosted again 3 weeks later following an identical procedure. Two weeks after 
each boost a 20ml ear bleed was taken. 
To separate the serum from whole blood the blood sample was left for 1 hour at 
37°C, incubated at 4°C overnight and the serum decanted into a fresh tube. In order to 
remove any remaining traces of blood clot the serum was centrifuged for 10 minutes at 
2000rpm. The clarified serum was then removed, aliquoted into Eppendorfs and 
stored at -20°C. The sera were tested by western blotting, IFA and 
immunoprecipitation. 
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2.2.22.5 Preparation of total proteins from P. falciparum 
Parasites were released from infected RBCs by saponin lysis and washed in 
1xPBS as described in section 2.2.2.2. The parasites were pelleted by centrifugation at 
4,000 rpm for 10 minutes, washed in PBS and resuspended in SDS-PAGE loading 
buffer (method 2.2.4.1), 100tl per ml of original infected blood. Samples were boiled 
for 5 minutes prior to loading, 10-15.t1 per lane. 
2.2.22.6 Western transfer 
Proteins separated by SDS-PAGE were transferred onto nitrocellulose 
(Schleicher & Schuell, BA85) or Hybond-C (Amersham) by the method of Towbin et 
al., (1979). 
The following gel 'sandwich' was assembled in a blotting cassette and 
submerged in transfer buffer (48mM Tris-base, 39mM glycine, 0.037% SDS, 20% 
methanol): a sponge pad, a sheet of blotting paper cut to gel size, the gel, a 
nitrocellulose filter cut to size, another sheet of blotting paper and another sponge pad. 
The cassette containing the gel sandwich was placed, with nitrocellulose towards the 
anode, into the transfer chamber (Hoeffer Scientific). Transfer was conducted, in 
transfer buffer, at 60V for 4 hours or overnight at 30V. Filters were then ready to be 
probed for bound antigen. 
After the Western transfer was completed the following method was used to 
detect antigens bound to nitrocellulose filters. The filters were first incubated in 
blocking solution (5% fat free dried milk in 1xPBS, 0.025% Tween 20) for 1 hour. 
The filters were then incubated in an antiserum in blocking solution with gentle shaking 
for 2 hours. The polyclonal rabbit serum was used at dilution 11500. The filters were 
washed three times, 5-10 minutes per wash in 1xPBS, 0.025% Tween 20 and washed 
once more in TBS solution (0. 12g Tris-base, 0.9g NaCl in lOOml of dH20). The 
filters were then incubated for 2 hours in Horse Radish Peroxidase conjugated anti-IgG 
second antibody (DAKO, Denmark) diluted 1/1000 in blocking solution. The filters 
were washed as before and the bound second antibody detected using 4-chloro-1-
naphthol (Sigma). For 50 ml of detection solution, 40m1 of TBS solution, lOml of 
methanol and 30.tl of Hydrogen Peroxide were added to 30mg of 4-chloro-1-naphol 
and the solution used immediately. Colour development was continued until the 
desired intensity was achieved. Filters were then rinsed in dH20 and dried. All 
incubations and washing was performed at room temperature with shaking. 
W. 
2.2.22.7 Immunoprecipitation of radiolabelled parasite proteins 
The method is based on the iodination of tyrosine groups in the parasite surface 
proteins (Howard et al., 1982). It is therefore essential that the cells be resuspended in 
protein-free solution. Appropriate precautions were taken for handling 125iodine, 
which was used in the form of sodium 125iodine and therefore contains volatile 
125iodine. All operations involving unbound 12 iodine were conducted in a fume hood 
with the air-evacuation fan on, or in closed containers when brought into open 
laboratory as for centrifugation. 
20ml of parasite culture was pelleted by centrifugation at 2,500rpm for 5 
minutes. The pellet was resuspended in 100tl of NETT (50mM Tns-HC1, 0.15M 
NaCL, 5mM EDTA, 0.5% Triton X-100, 0.01% sodium azide, pH 7.4) and a cocktail 
of protease inhibitors (Sigma), (material 2.1.7). The solution was vortexed briefly 
and spun for 5 minutes at 10,000rpm. The supernatant was transferred to a 
microcentnfuge tube which had been treated with IODOGEN (1,3,4,6-tetrachloro-
3a,6u-diphenyl glycocolunl). The tube was placed in a fume hood and 500tCi of 
sodium 125iodide (5t1 of the stock solution of sodium 125iodide at lOOmCi/ml in 
NaOH, pH 7-11), was added to the solution and agitated intermittently for 5 minutes. 
50t1 of the antibody was added to the tube and incubated for 1 hour at room 
temperature. After that, 40tl of a 25% suspension of protein A Sepharose beads in 
NETT were added to the tube and agitated gently on a rocker for 2 hours at room 
temperature. The beads were centrifuged and the supernatant was discarded. The 
beads were then washed once with NETT and once with NETTS (this was necessary to 
remove unbound antigen). 50tl of non-reducing lx sample buffer (material 2.1.7) 
was added to the beads and the solution was heated at 100°C for 5 minutes. The 
sample was spun briefly to return condensation to the bottom 01 tne tune anu was 
loaded on an SDS-PAGE gel (for detailed description of the SDS-PAGE, see method 
2.2.22.1). 
2.2.22.8 Indirect Immunofluorescence Assay (IFA) 
2.2.22.8.1 Preparation of slides : In order to prepare slides from 
different developmental stages of P. falciparum, cultures were first synchronised 
according to the method (2.2.1.2), and examined regularly by thin blood film, until 
parasitaemias of 5%-10% was obtained. Then the cultures were centrifuged at 
2,000rpm for 5 minutes, and the cells were washed three times in incomplete RPMI 
medium. The pellet was then resuspended at 10% in complete RPMI medium. Then on 
a clean multispot slide (Hendly, Essex, UK), 20pi was aliquoted onto each well and 
allowed to dry at room temperature. Sometimes thin smears from synchronised cultures 
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were spread on slides. The slides were either used immediately or stored with 
desiccant (silica gel) at -20°C. 
2.2.22.8.2 Staining of slides: Slides were fixed in acetone for 5 minutes, 
allowed to air dry and then gnded into 12 squares using nail varnish. On each square 
was placed 20.tl of appropriately diluted antibody, in PBS with 1% BSA and 0.05% 
sodium azide. Slides were incubated in a moist chamber for 30 minutes, the antibodies 
were then aspirated off, and washed twice in PBS and once in dH20, allowing 5 
minutes per wash. Slides were then air dried and incubated with 20iil of the 
manufacturer's recommended dilution of the second conjugated antibody per square. 
This was either a fluorescein isothiocyanate conjugate of immunoadsorbant-purified 
polyvalent anti-mouse immunoglobulin (FITC-anti IgG, Sigma) or a rhodamine 
isothiocynate conjugate of immuoadsobant-purified anti-rabbit immunoglobulin (RITC-
IgG Sigma). In addition, parasite nuclei were counter-stained with DAPI (4;6 
diamidino-2-phenyl-indole, Sigma). In order to do this DAPI was included in the 
second antibody solution at 1:40 dilution in PBS/azide (final concentration of 5tg/ml). 
Slides were then incubated and washed as before, and mounted in mounting solution 
(50% glycerol in PBS, DABCO-25g/1) to prevent fading. The slides were then 
examined by fluorescence microscopy (Leitz, Germany). 
2.2.23 Yeast expression methods 
2.2.23.1 Expression of pfran into yeast vector pREP!: The pfran cDNA 
was engineered with appropriate restriction sites for cloning into the S. pombe 
expression vector pREP! (Kindly provided by Dr. P.Fantes) by PCR. 
Oligonucleotides G5793,+ 5' CGC CAT ATG GATTCA CAA GAA TAT AU 
CC (29 bases, nucleotides 680-703 plus 6 additional bases at the 5' end which 
provided a BarnHI recognition site) and G5794,- 5' CGC GGA TCC TTA ATT TTC 
AAT ATC TTC TTC (30 bases, nucleotides 1305-1325 plus additional 9 bases at the 
5' end providing an NdeI recognition site) were used as primers. This construct 
contains the AUG start codon and the termination codon TAA of the pfran gene. These 
primers were used for amplification of the pfran construct as described in method 
2.2.16. The PCR product was treated with proteinase K prior to endonuclease 
digestion to improve the cloning efficiency by getting rid of Taq polymerase which 
remained bound to the DNA (Crowe et al., 1991). The PCR generated fragment was 
introduced by ligation into the restriction sites of the expression vector. 
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2.2.23.2 Transformation into pimi mutant The Pimi mutant (Matsumoto and 
Beach, 1991) was obtained from Dr. D.Beach (Howard Medical Centre, Cold Spring 
Harbor, USA). First the mutant was grown on Edinburgh Minimal Medium (EMM) 
plates (material 2.1.7) at 26°C overnight. A single colony was picked and grown at 
26°C into lOml EMM broth containing leucine. imi from the overnight culture was 
subcultured into lOOm! of EMM containing leucine. The growth was monitored until 
the cell density was 1x107/ml. The cells were collected by centrifugation for 5 minutes 
at 2000rpm at 4°C. The cell pellet was washed three times in ice-cold 1.2M sorbitol 
and resuspended finally into lml of ice-cold 1.2M sorbitol. The construct was then 
transformed into the Pimi mutant cells by electroporation. 
2.2.23.3 Electroporation 
lOOjil of the electrocompetent cells were placed in a pre-cooled 2mm cuvette on 
ice. The DNA was added and incubated on ice for 1 minute. Appropriate voltage 
(25kV/cm with time pulse of approximately 5 seconds) was applied using a 
FlowgenTM pulser. The cells in the cuvette were then resuspended with lml of 1.2M 
sorbitol, and an aliquot of this was plated onto selective media. 
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CHAPTER 3 
CLONING AND CHARACTERISATION OF 
THE P. falciparum Ran/TC4 HOMOLOGUE. 
3.1 Summary 
Degenerate oligonucleotides based on conserved amino acid sequences in the 
RanITC4 of other organisms, were used to amplify Plasmodiumfalciparum genomic 
DNA, to obtain a DNA fragment encoding the P.fakiparum RanITC4 homologue. The 
fragment was used to screen a cDNA library to obtain full-length clones. pfran (P. 
falciparum ras-like nuclear protein), encodes a protein of 214 amino acids with 70% 
amino acid sequence identity with other eukaryotic Ran/TC4 proteins. The GTP -
binding sites, characteristic of the GTPase superfamily were highly conserved in the 
P. falciparum gene. Like other P. falciparum mRNAs, pfran mRNA contains an 
exceptionally long 5' untranslated region (679bp). Southern blotting experiments have 
shown that pfran is a single copy gene on chromosome 11. RNA hybridisation 
experiments have shown that pfran mRNA is abundant in late trophozoite and schizont 
stages, but present only at very low levels in gametocytes and ring stages. 
3.2 Introduction 
'Knowledge based' strategies for vaccine development and chemotherapy of 
malaria require a better understanding of the basic molecular biology of the parasite. 
One large gap in what we know about malaria parasites concerns the mechanisms 
controlling intra-erythrocytic proliferation. The control of the cell-cycle in eukaryotes 
employs a regulatory network of proteins (Norbury and Nurse, 1992; Draetta, 1990; 
Peter and Herskowitz, 1994), many of which are highly conserved across a wide range 
of species. Key features include protein complexes such as serine/threonine kinases, 
cyclins and cyclin inhibitory factors, heterotrimeric G proteins and the small GTP-
binding proteins of the GTPase superfamily. This latter group of proteins has been 
found to play several roles in cell cycle, notably those involving signal transduction. 
Ran/TC4, (s-related nuclear GTP-binding protein), is a component of a 
GTPase switch that is postulated to regulate the progression of the cell-cycle (Dnvas et 
al., 1990; Bischoff & Ponstingl, 1991b; Dasso, 1993; Ren et al., 1993). In contrast to 
other GTPases of the Ras superfamily which play a wide variety of roles in the 
cytoplasm including regulation of growth and differentiation, actin polymensation and 
vesicular traffic, Ran/TC4 has been considered to function mainly in the nucleus 
(Bischoff and Ponstingl, 1991b; Boguski and McCormick, 1993), where it interacts 
with the guanine nucleotide exchange factor RCC 1 (regulator of chromosome 
condensation) that appears to be involved in chromosome condensation and the onset 
of mitosis (Bischoff and Ponstingl, 1991b; Ren et al., 1993). The Ran/TC4-RCC1 
complex may couple completion of DNA synthesis with initiation of mitosis through 
the activation of a cyclinp34cdc2 complex (Ren et al., 1993). It is therefore possible 
that the RanITC4-RCC1 complex functions as signal transducer to regulate the cell 
cycle in eukaryotes. 
RanJTC4 is an abundant small GTPase which has been found to constitute 
about 0.36% of total HeLa cell protein (Moore and Blobel, 1993). Recently, it has 
been shown that RanJTC4 is also an essential component in the transport of proteins 
into the nucleus (Moore and Blobel, 1993; Goldfarb, 1994; Moore and Blobel, 1994). 
In addition, the RanITC4-RCC1 complex has been implicated in the regulation of RNA 
processing and transport in Saccharomyces cerevisiae (Kadowaki et al., 1993). 
The gene was first identified in a human teratocarcinoma cDNA library (Drivas 
et al., 1990), and since then, homologues have been reported from S. pombe 
(Matsumoto and Beach, 1991), Onchocerca volvulus and Brugia malayi (Dissanayake 
et al., 1992), S. cerevisiae (Belhumeur et al., 1993) and Dicytostelium discodium 
(Bush and Cardelli, 1993). 
This Chapter describes the cloning and characterisation of the Ran/TC4 
homologue of the malaria parasite P. falciparum. Cloning the gene encoding P. 
falciparum homologue of the Ran/TC4 is the first step towards understanding its 
structure and function. Apart from sequence comparison with other Ran/TC4 genes, it 
also allows identification of key features such as GTP-binding domains or the 
characteristic carboxy terminal sequences which are believed to be responsible for its 
nuclear localisation (Bischoff and Ponstingl, 1991a; Ren et al., 1993). It will also 
provide the opportunity to produce specific antibodies which could be used to study its 
possible role in cell cycle control in P. falciparum. 
3.3. Strategies and methods used to isolate the P. falciparum Ran/TC4 
homologue 
A PCR based approach was used to isolate the RanITC4 gene homologue. This 
type of approach has been shown to be useful in identifying the Rab and Rho genes 
members of the GTPase superfamily proteins from the mouse genome (Chavier et al., 
1992). 
Three degenerate oligonucleotides were synthesised based on the conserved 
blocks of amino acids in previously identified Ran/TC4 sequences from human, S. 
pombe and S. cerevisiae (Matsumoto and Beach, 1991). Two of these 
oligonucleotides, A482,+ and A484,-, (Chapter 2, section 2.1.6) were based on the 
conserved amino acid sequences of the first and fifth domains which are known to 
participate in the formation of the GTP-binding site of all ras-related proteins (Valencia 
et al.,1991), see Fig. 1.3 (Chapter 1). The third oligonucleotide (A483,+) was 
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designed in order to a recognise a region outside the GTP-binding sites; this sequence 
is found only in the Ran/TC4 gene subfamily. To reduce the degeneracy of the 
oligomers, advantage was taken of the codon bias of the malaria parasites towards A+T 
rich codons (Weber, 1987; Saul and Battistutta 1988). 
Amplification was performed with the 3 oligomers in all possible combinations. 
Several different PCR conditions were tried, before the following programme gave an 
optimal result; denaturation at 94°C for 30 seconds, annealing at 50°C for 60 seconds 
and extension at 72°C for 90 seconds. The template was genomic DNA isolated from 
asexual cultures of P. falciparum clone 3137A. 
The PCR amplified fragment was cloned into the pCRII vector (see Chapter 2, 
section 2.2.15.2). After the amplification was completed, the PCR product was ligated 
to the vector, and transformed into E. coli INVaF' cells. Positive colonies were 
identified by hybridisation to the PCR insert (method 2.2.12). DNA was prepared 
from the positive clones and sequenced, on both strands as described in method 
2.2.18. 
In order to identify the full coding sequence of the Ran/TC4 gene homologue of 
P. falciparum, a cDNA library was screened, as described in method 2.2.15.5, using 
the PCR fragment as a radioactive probe. The library (a gift from Dr. A. Craig, Oxford 
University) was made in the plasmid vector pJFE14 (Fig.3. 1), from asexual stage 
mRNA (late rings/early trophozoites) of the P. falciparum clone 1T04. 
3.4 Results 
3.4.1 Isolation of the P. falciparum Ran/TC4 homologue 
A 552bp DNA fragment was obtained by amplifying P. falciparum genomic 
DNA using two degenerate primers based on conserved regions of the Ran'TC4 protein 
from other organisms (Fig. 3.2). Sequencing of the PCR product confirmed that the 
amplified fragment represented part of a gene encoding an open reading frame (ORF) 
with homology to published RanITC4 sequences. The ORF of the 552bp fragment is 
interrupted by an intron (165 bp long) between nucleotides 796 and 797 (Fig. 3.413). 
The intron is 90% A+T which compares with 67% A+T for the coding sequence and 
85% A+T for the non-coding regions. The sequences at the ends of the intron (Fig. 
3.5) have the universally conserved GT and AG dinucleotides marking the intron-exon 
boundaries, and the 3' AG splice acceptor site is preceded by a stretch of 17 thymidine 
residues, an exaggeration of the pyrimidine nucleotide motif at the 3' intron boundary 
of all eukaryotic genes (Weber, 1987). The sequence at the 5' intron boundary 
(GTAAGTGAA) is also fairly well conserved among Plasmodium introns and quite 
similar to the consensus eukaryotic intron boundary sequence. 
62 
Figure 3.1: 
Schematic diagram represents the map of the pJFE14 plasmid vector (Elliot et 
al., 1990) which has been used to engineer the P. falciparum asexual cDNA library 
used during the course of this study. The asexual RNA was prepared from ring and 
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Sequence of the Polylinker from pJFE14 plasmid vector: 
5' TCrAGAGATCCCTCGACCrCGAGATCCAUGTGcTGGC'.. ..3óObp'stuffer 
GCCAGCACAATGGATC1CGAGGGATCTTCCATACCrACCAGUCT 
GCGCCTGCAGGTCGCGGCCGC000AGGCCGAATTC 3' 
c g c g g ac g t cc a g c g cc g g  
Figure 3.2: 
A. 
Amplification of P. falciparum genomic DNA of clone 3D7 and HB3 and 
isolate Ki, using the Ran primers. Three degenerate primers (Ran 1 = primer A482+, 
Ran2 = primer A483+, Ran3 = primer A485-) were tried in different combinations to 
obtain the fragment encoding the P. falciparum RanITC4 homologues. 5d of 
amplified product was run on a 1.5% IBI agarose gel in 1xTAE buffer. 
Lane 1. DNA from isolate Ki with primer Ran 2+ Ran 3. 
Lane 2. No DNA (control) with Ran 2+Ran 3. 
Lane 3. DNA from clone HB3 with Ran 2+ Ran 3. 
Lane 4. DNA from clone HB3 with Ran 1+ Ran 3. 
Lane 5. DNA from clone 3D7 with Ran 2+ Ran 3. 
Lane 6. DNA from clone 3137 with Ran 1+ Ran 3. 
M. 	DNA molecular weight marker VI (pBR 328 DNA cut with Bgl 1+ Hinf I). 
RP 
Amplification product of genomic DNA from clone 3137. The Ran 2 and Ran 3 
primers were used on the template with different annealing temperatures to optimise 
the PCR conditions. 
Lane 1. annealing temperature used was 37 0C. 
Lane 2. annealing temperature used was '40°C. 
Lane 3 . annealing temperature used was 45°C. 
Lane 4. annealing temperature used was 50°C. 
Lane 5 . annealing temperature used was 52°C. 
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Figure 3.3 
An autoradiograph showing the result of secondary screening of the three 
positive clones isolated from the asexual cDNA library, probed with the PCR product 
(552 bp) produced by the amplification of genomic DNA from clone 3D7 with Ran2 + 
Ran 3 primers. 
The PCR fragment was radiolabelied by random priming and used as a 
hybridisation probe to screen these clones. DNA from the positive clones was 
transferred to Hybond N+ filters, and the filters were prehybridised for 1 h at 65°C in 
5xSCC/ 5xDenhardt's solution! 0.1% SDS! 50mM sodium phosphate buffer pH 7.0! 
100mg/mi denatured salmon sperm DNA. Hybridisation was carried out, with the 
radiolabelled PCR fragment, in the same buffer, with 10% dextran sulphate added, at 
65°C overnight. Filters were extensively washed in 2xSCC at room temperature and 
then washed in 0.5x SSC/0. 1 SDS at 65°C for lh. The filters were exposed to X-ray 
film for 24 h before developing. 
Five clones (numbered) were picked and sequenced on both strands by the dideoxy 
chain termination method. Clone No. 4 was found later to encode the whole P. 
falciparum Ran/TC4 homologue. 
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The PCR fragment was used as a hybridisation probe to screen the cDNA 
library. 50,000 colonies were screened, (method 2.2.15.5), which yielded 3 positive 
clones. A second round of screening was carried out on these clones, using the PCR 
fragment as a probe, in order to confirm the result of the primary screening and to 
obtain single isolated colonies (Fig. 3.3). Finally, one clone with a 1.4 kb insert, C 
4.1, was selected for analysis. The clone was sequenced on both strands using the 
dideoxynucleotide chain termination method of Sanger et al., 1977, (method 2.2.18). 
The sequence of the cDNA clone C4.1 is shown in Figure (3.4A). The insert 
contained a single open reading frame (ORF) extending from nucleotide 677 to a stop 
codon 77 bases upstream from the 3' terminus. The deduced amino acid sequence had 
a methionine codon at nucleotide 680 which permitted a homologous alignment of the 
sequence with available sequences of other Ran /TC4 proteins. The C4.1 cDNA 
contained a long (679 bp) 5' untranslated region (UTR), and 77 bp of non-coding 
sequences at the 3' end. Sequences of genomic DNA adjacent to the original 552 bp 
PCR product were obtained by utilising the inverse PCR procedure (Triglia et al., 
1988) as described in method 2.2.17. The coding sequence, the intron-exon 
boundaries, and three hundred base pairs of 5' UTR sequence proximal to the start 
codon were confirmed as identical in both the genomic DNA and the cDNA clone (Fig. 
3.5). 
3.4.2 Sequence comparison and data-base searches 
Comparison of the amino acid sequence deduced from clone C4.1 with the 
sequences contained in the Gene-bank data-bases was performed by a BLAST search 
of the Swissprot 22 data-base (Devereaux et al., 1984). The search was done for 
predicted amino acid sequences and scored for both identity and similarity. The search 
showed that clone C 4.1 (hereafter known as pfran gene) was clearly related to proteins 
of the small GTPase superfamily (Fig. 3.6). The highest similarity scores were with 
the members of the RanITC4 subgroup of this family, 72% and 70% with S. cerevisiae 
Gspl and 2 respectively (Belhumeur et al., 1993), 69% with S. pombe 
Spil(Matsumoto and Beach, 1991), 68% with the filarial worms Ran/TC4 proteins 
(Dissanayake et al., 1992), 67% with the human Ran/TC4 (Drivas et al., 1990; 
Bischoff and Ponstingi, 1991a), and 66% with Dictyostelium Dd.TC4 (Bush and 
Cardelli, 1993). 
W. 
Figure 3.4 : Nucleotide sequences of pfran gene. 
The complete sequence of eDNA clone 4.1 containing the large 5' untranslated region and complete coding 
sequence of the pfran gene of P. falciparum. The predicted amino acid sequence for the coding region is shown below the 
nucleotide sequence, in single letter code. The site of the intron, detected in the genomic sequence, is indicated by an 
asterisk. The underlined sequences are the nucleotides used to designed the primers (P1, P2, and P3) used for 
amplification of DNA from the clone C4.1 clone 3137 genomic DNA, to check for the presence of other introns (for the 
result see Fig. 3.5). 
N.B. The nucleotide sequence data in this figure is deposited in the EMBL, Genbank and DDBJ data-bases under the 
accession number X73954. 
Nucleotide sequence of the intron in the P. falciparum pfran gene obtained from genomic DNA. Intron 








Primer P1 -----> 	 * 
ATGGATTCACAAGAATATATTCCACAATATAAATTAATCTTAGTCGGTGATGGTGGTGTTGGCAAAACAACCTTTGTGAAAAGACACTTGACTGGAGAATTCGAAAAAAAATATATAGCT 799 
MD S Q E YIP Q Y K L 	L 	G 	G G V G K T T F V 	R 	L T GE FE K KY IA 
Primer P3 ---> 
ACTCTTGGTGTGGAAGTTCACCCCTTAAAATTTCAAACAAACTTTGGAAAAACTCAATTTAACGTATGGGATACTGCAGGACAAGAAAAGTTTGGTGGTTTAAGAGATGGATATTATATA 919 
T L G V E V HP L 	F Q TN F G K T Q F N V W P TAG Q E K F G G L 	D G Y Y I 
AAAAGTGATTGTGCTATAATTATGTTTGATGTATCTTCTCGTATTACTTACAAGAACGTTCCAAATTGGTATAGAGATATTACAAGAGTGTGTGAAACAATTCCTATGGTTTTAGTTGGA 1039 
K S DC A I I M F DV S SR IT Y K NV P N WY RD IT R V CE TI PM V L 	G 
AACAAAGTTGATGTTAAAGACAGACAAGTAAAATCAAGGCAAATTCAATTTCACAGAAAAAGGAATTTACAATACTACGATCTATCTGCAAGATCAAACTACAATTTCGAAAAACCTTTC 1159 
N K V D V K DR QV K SR Q I Q F HR K RN L 	Y Y DL S AR S NY N FE K P F 
TTATGGTTAGCTAGGAGATTGTCCAACCAACCAAATCTTGTTTTCGTAGGAGAACATGCTAAAGCACCAGAGTTCCAAATTGATCTAAATATTGTAAGAGAAGCTGGAAAAGAATTAGAG 1279 
L W L A R R L S 	Q P N L 	F 	GE H AK APE F Q ID L 	I 	RE AG K E LE 
Primer P2 <----
CAAGCAGCAGCTGTAGCTATTGATGAAGAAGATATTGAAAATTAAATAAATAGAAAAAAAAAAAAAAAAAAAAAAAGGGAAACAGCCAAAATGGAAGTAAAAAAAAAAAAAAAAAGAAA 1398 




E K KY I 
797 
tatatttattttttatatttttgtatttatttattttattataatttttttttttttttttag GCTACTCTTGGTGTG 
AT L 	V 
Figure 3.5 : Exon/intron boundaries of pfran. 
Autoradiograph showing a sequence comparison of border of exon 1/intron 1 
(Track A) and intron 1/exon 2 (Track C) of genomic pfran 3D7 DNA with the pfran 
cDNA from clone C4.1 (Track B), showing that intron 1 has been removed. 
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Figure 3.6: Amino acid sequence comparisons of pfRan. 
Comparison of protein sequences from three members of RanITC4 subfamily 
with the pfRan amnio acid ssequence. Sequences are aligned relative to the human 
Ran/TC4 protein, the first member of the subfamily described (Drivas et al., 1990). 
Dd.TC4 is the Dicytostelium discoideum sequence (Bush and Cardelli, 1993) and Spi 
of Schizosaccharomyces pombe (Matsumoto and Beach, 1991). 
Dots indicate identical residues, and dashes indicate gaps introduced to maximise 
similarity within the alignment. The 5 regions involved in guanine nucleotide 
binding, (GI to G5), which are highly conserved between all members of the small 
GTPase superfamily are underlined. 
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3.4.3 The pfran gene has one intron 
In order to check by PCR whether there is a second intron following the first 
one, three non-degenerate oligonucleotide primers were synthesised (Fig.3 .4. A). 
Oligomer P1(20 bases, nucleotides 680-699) and P2 (19 bases, nucleotides 1304-
1322) which flank the whole coding sequence of the full cDNA clone. The third 
oligomers, was designed immediately after the intron, P3 (17 bases, nucleotides 807-
823). The primers were used in different combinations with DNA from plasmid clone 
C4. 1 and P. falciparum genomic DNA from clone 3137A as template. The PCR results 
are shown in figure 3.7. When primers (P1+P2) flanking the whole coding sequence 
of clone C4.1 were used in amplification reactions on the cDNA clone and genomic 
DNA size variation of about 165bp in the PCR product was found between the two 
templates. When primer P2 and P3 (immediately following the intron identified in the 
552 bp genomic PCR product) were used on the above templates there were no size 
different between the PCR products from both genomic and the cDNA clone C 4.1. 
The fission yeast homologue of the ran gene, the spil (uppressor of premature 
initiation of mitosis) gene, contains two introns. The first intron of S. pombe is in the 
same position as for the 165bp intron that has been found in the pfran genomic 
sequence. PCR products from genomic DNA and C4.1 cDNA clone using above 
primers showed that no second intron is present in the genome of the parasite 
(Fig. 3.7). 
3.4.4 Copy number of pfran gene 
Genomic P.falciparum DNA was digested with restriction enzymes (method 
2.2.5) and blotted onto a nylon membrane. Hybridisation was carried out with the 
C4.1 insert as a probe. The result is shown in Fig.3.8.A. 
All lanes contain DNA digested with restriction enzymes that do not cleave 
within the sequence recognised by the probe, (Acc I, Bgl II, Hinc II, Hind III, Msp I. 
Nhe I, Xba I or Xho 1), show hybridisation of the probe to a single fragment. DNA 
digested with Alu I, Dra I, Hinf I and Sau 3A, enzymes which cleave within the 
probe, yielded more than one hybridising fragment, whose sizes corresponded to the 
sizes predicted from the sequence. 
3.4.5 Chromosome mapping 
To characterise further the pfran gene, its chromosomal location was identified. 
This was achieved by blotting pulsed field electrophoresis gels (PFGE) (as described in 
method 2.2.7) of malarial chromosomes with the coding sequence from clone C 4.1. 
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Figure 3.7 : Pfran intron study. 
Amplification of P. falciparum genomic DNA of clone 3D7 and the pfran 
plasmid (clone C4. 1) using primer P1 and P2 which flank the entire coding region of 
clone C 4.1 (see fig. 3.4 A) and primer P3 and P2 (primer P3 is located immediately 
after the 165bp intron recognised in the 552bp PCR insert). The PCR reaction was 
carried out using both sets of primer on the genomic and the cDNA in order to check 
for the presence of another intron in the genomic sequence of P. falciparuin. 5d of 
amplified product was run on a 1.5% agarose gel in 1xTAE buffer. 
M. 	DNA molecular weight markers. 
Lane 1. amplification product from genomic DNA from clone 3137 using primers 
P1+P2. 
Lane 2. amplification product from clone C4.1 using primers P1+P2. 
Lane 3. amplification product from genomic DNA using primers P2+P3. 
Lane 4. amplification product from clone C4.1 using primers P2+P3. 
M 






Figure 3.8: Southern analysis of Pfran gene. 
An autoradiograph demonstrating that pfran is a single copy gene. 
Genomic DNA from P. j'alciparurn was digested with various enzymes, resolved, 
blotted and hybridised with thepfran specific probe. The enzymes used were: (Lanes 
1-12): Acci, Bgl II, Sau3A, MspI, Xhol, Dral, Hind!, Hind!!!, Alul, Hinfi, Xbal 
and N/tel. 
Chromosome assignment of the pfran gene. (I): Ethidium bromide-stained 
pulsed field gradient gel of P. falciparuin clones CIO and 1776, with chromosomes 
11, 12, 13, and 14 marked; (II): autoradiograph of the blot from the gel in panel (I) 
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The pfran gene was found to be located on chromosome 11 (Fig. 3.8.B) 
according to the definition of chromosome numbers proposed by Kemp el al., (1987). 
The blots were then stripped and reprobed with marker specific to chromosome 5 and 
chromosome 9 ( (pfindr-1 and insp-1) respectively (Foote el al., 1989; Kemp et al., 
1987b) (data not shown) to confirm the order of the chromosomes on that particular 
blot. 
3.4.6 Northern Blot analysis 
To obtain some information on how pfran mRNA levels are regulated during 
intra-erythrocytic development, total RNAs were isolated from synchronised stage 
specific asexual and sexual P. faiciparum cultures as described in method 2.2.20, and 
the Northern blots were probed with clone C4. 1. As shown in figure (3.9) a diffuse 
band of approximately 1.5-1.6 kb was observed. Signals are strongest on the schizont 
and trophozoite lanes (Fig. 3.9B, lanes 1 and 2) and very weak signals can be seen in 
RNA derived from early asexual stages and from gametocytes lanes (Fig. 3.9B, lanes 
3, 4 and 5). As an internal control for hybridisation to gametocyte mRNA, the same 
blot in figure 3.9A was stripped and hybridised to sequences from the gametocyte 
specific pfg27/25 gene (Alano et al., 1991). As shown in figure 3.9C, intense signals 
were only seen in lanes containing RNA from gametocytes. 
An independent Northern blotting experiment of total RNA prepared from 
asexual synchronous and asynchronous cultures from P.falciparum clone CIO and its 
parent line 1776 was probed with C4.1 fragment had confirmed the above result (Fig. 
3.10). 
3.5 Discussion 
Comparison of the deduced amino acid sequence of pfRan with Ran proteins 
from other species has shown about 70% identity. Furthermore, the consensus motifs 
(G1-G5) of GTPases of the Ras superfamily (Bourne et al., 1991) were identified in 
pfRan. Predicted molecular weight and possession of the five conserved guanine 
nucleotide binding regions clearly indicate that pfran is a member of the small GTPase 
superfamily. However, outside these conserved regions, there are no obvious 
homologies between the pfRan sequence and those of the other three main subfamilies 
of this group, the products of ras - like proto-oncogenes, the ypt/rab genes and the rho 
type genes (Bourne et al., 1991). Unlike cytoplasmic Ras-like GTPases that are 
targeted to the membrane, pfRan does not have the carboxyterminal cysteine Cys-A-A-
X ('A' is an aliphatic amino acid and 'X' is usually a methionine or serine residue) 
motif that mediate isoprenylation and membrane association in Ras family members. 
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Figure 3.9: Northern blot analysis of pfran gene. 
Total P. falciparuin RNA obtained from synchronous cultures of different 
developmental stages of clone 3D7 was fractionated in a 1.2% denaturing 
formaldehyde gel, blotted and hybridised to pfran gene probe and pfg27125 
gametocyte specific gene. A: Ethidium bromide stained gel (5kg of total RNA loaded 
per lane), B: and C: autoradiographs of the gel probed with pfran and pfg27125 genes 
respectively. 
Lane 1. schizonts. 
Lane 2. trophozoites. 
Lane  . rings 
Lane 4. mature gametocytes (stage V). 
Lane 5. young gametocytes (stage I and II). 
N. B. Gametocyte stages classification according to Hawking el al., 1971; Carter 
and Miller, 1979. 















Figure 3.10: Northern blot analysis of pfran gene. 
Total RNA prepared from parasite clone ClO and its parent line 1776 
respectively. 10tg of RNA separated by electrophoresis in a 1.2% denaturing 
formaldehyde gel, blotted to nitrocellulose filter and probed with pfran fragment. 
Ethidium bromide-stained gel: 
Lanes 1 and 5 total RNA isolated from asynchronous cultures of clone C10 and line 
1776. Lanes 2, 3 and 4 total RNA of rings, trophozoites and schizonts respectively 
obtained after culture synchronisation of clone dO. (rings; 87% pure, trophozoites; 
69% pure and schizonts 95% pure). 
Autoradiograph of the gel from panel A probe with the pfran specific fragment. 
Autoradiograph of the same gel from panel A hybridised with msp-1 specific probe 












However, the usual COOH-terminal Asp-X-Asp-Leu motif found in other 
members of Ran subfamily of Ras-like protein is absent in pfRan. pfRan shares 66-
72% amino acid identity with all members of the fourth small GTPase subfamily so far 
characterised, the Ran/TC4 type proteins. Although the homology between mammalian 
representatives of this subfamily is at least 95%, this drops to around 80% amino acid 
identity between human and yeast homologues and 68% identity between human and 
Dictyostelium RanITC4 proteins. The sequence homology argument for provisionally 
accepting pfRan as the P. falciparum representative of the RanITC4 small GTPases is 
therefore strong. Therefore, the argument that the pfran gene is a P. falciparum 
homologue of the Ran/TC4 subfamily of small GTPases therefore rests primarily on 
sequence homology data and not as yet on functional data. 
The pfran gene appears to be present as a single copy as inferred indirectly by 
the observation that in genomic DNA blots the cDNA probe hybridised to bands whose 
intensity on autoradiographs was within the range expected for a single copy gene. 
No further hybridising bands appeared after longer exposures with less stringently 
washed filters. Using standard calculations for the melting temperatures of mismatched 
DNA hybrids at these salt concentrations and temperatures it can be estimated that it is 
unlikely that a gene with nucleotide sequence homology to pfran of more than 80% 
exists within the P. falciparum genome. In other organisms where RanITC4 has been 
isolated, the gene is present in a single copy (Matsumoto and Beach, 1991). 
The size of the pfran mRNA supports the evidence obtained from cDNA and 
genomic DNA sequences that a much larger transcript is produced than would be 
required to encode the protein. It is becoming clear that many Plasmodium transcripts 
are considerably longer than required for coding purposes alone, and that this appears 
to be mainly a consequence of having exceptionally long 5' untranslated regions 
(Levitt, 1993; Chakrabarti et al., 1993 and Delves et al., 1990). The function of these 
long 5'UTR remains to be determined and the structure of ribosome binding sites in 
these organisms is very unclear. 
A Northern blot of total RNA prepared from different developmental stages of 
P. falciparum probed with clone C4.1 hybridised to a diffuse band of approximately 
1.5-1.6 kb. Transcripts produced from sexual and asexual stage parasites appear to be 
similar in size. Thus, it is likely that clone C4.1 represents a full-length (or nearly full-
length) cDNA of the mature pfran transcript. Signals were strongest on the schizont 
and trophozoite lanes indicating progressively accumulating mRNA as the parasite 
prepares for and then undergoes active nuclear division. Very low levels were 
observed in early asexual stages and in gametocytes. It cannot be excluded that these 
low signals may result from contamination of rings or gametocytes preparations with 
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small amounts of trophozoites or schizonts. Similar amounts of RNA were present in 
all lanes, as indicated by ethidium bromide staining of the gel prior to transfer. 
The results indicate that the steady-state pfran mRNA levels are 
developmentally regulated, in that mRNA levels are high during schizogony and barely 
detectable in the gametocyte stages. In S. cerevisiae, the Gsp/SRM- 1 complex 
(homologous to the mammalian Ran/RCC1 complex) is involved in mating type 
differentiation (Clark & Sprague 1989), a process which requires cell cycle arrest at the 
phase preceding DNA synthesis (the GuS boundary). In mammalian systems 
expression of a mutant RanITC4 allele interferes with DNA synthesis and therefore 
disrupts cell cycle progression (Ren et al., 1993). It is tempting to speculate that low 
levels of pfran mRNA in gametocytes may play a role in cell cycle arrest of these 
differentiating cells. Testing this hypothesis will require information on pfRan protein 
levels and activation state throughout the parasite life cycle. An antibody reagent would 
also permit temporal and spatial localisation of the protein within the parasitised cell and 
a search for associated proteins such as a homologue of the RCC1 protein. 
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CHAPTER 4 
FURTHER CHARACTERISATION OF Pfran. 
4.1 Introduction 
The identification and initial characterisation of the P. falciparum pfran gene 
has been described in Chapter 3. To characterise further the pfran gene three 
experiments were carried out. Firstly, preliminary cytological localisation studies on 
the Ran protein using antisera raised in rabbits were done. Secondly, in order to 
assign a role for the pfran gene in the cell cycle of P. falciparum functional 
complementation tests using the Schizosaccharomyces pombe temperature sensitive 
mutant were carried out. Finally, a series of experiments were carried out on nuclei 
isolated from synchronous cultures of the parasite to study the stage specific 
expression of the pfran gene. 
4.2 Antibody characterisation of Plasmodium falciparum pfra:z gene 
product 
4.2.1 Introduction 
Antibodies were raised to the non-conserved (variable) region of pfran to avoid 
potential cross-reactions with host GTPases. A DNA fragment was first subcloned 
into the plasmid expression vector pGEX and the expressed polypeptide was then 
purified and used to immunise rabbits. The resulting sera were then tested by Western 
blotting, immunoprecipitation and immunofluorescence assay (IFA). 
4.2.2 pGEX expression vector 
The structure of the pGEX plasmid expression vector is shown in Figure 
(4.1). pGEX is a plasmid that allows expression of foreign polypeptides as fusions to 
the C-terminus of glutathione-S-transferase (GST), a 26kDa cytoplasmic enzyme that 
is capable of detoxifying a variety of xenobiotics by the conjugation of reduced 
glutathione to electrophilic centres in such molecules (Mannervik, 1985; Smith and 
Johnson, 1988). The plasmid carries a laclq allele which produces high levels of the 
lac repressor (lOx more than the wild-type lad). The lac repressor binds to the Ptac  
promoter, repressing the expression of the GST fusion protein. This allows control 
over expression, since the synthesis of potentially toxic fusion proteins is minimised 
when the system is not induced. The Ptac promoter contains consensus sequences of 
-35 and -10 promoter regions and is a hybrid between the trp and lacUV5 promoters 
(Amann et al., 1983). Expression of fusion protein can be induced by isopropyl t3-D-
thiogalactopyranoside (IPTG) which inactivates the lac repressor. Fusion proteins 
expressed in this system often remain soluble within bacteria and can be easily purified 
Figure 4.1 : The pGEX-3X expression vector map. 
pGEX-3X is a fusion-protein expression vector that expresses a cloned gene 
as a fusion protein to glutathione S-transferase (GST). The lac repressor (product of 
the lacI gene) binds to the Ptac promotor, repressing expression of GST fusion 
protein. Upon induction with IPTG, derepression occurs and GST fusion protein is 
expressed. 
The gene of interest can be inserted into the polylinker located at the end of the 
GST gene. The polylinker sequences are shown below the map of the vector where 
the restriction endonuclease cloning sites are bracketed. The polylinker of pGEX-3X 
contains protease (factor Xa) cleavage site so the cloned protein can be released from 
the GST carrier. Modified from Smith and Jonhson, (1988) Gene 67,, 31-40. 
The pGEX poylinker sequences 
factor Xa 
pGEX 3X TCG GAl GFG ATC GAA GGT CdTGG ATC CC GG?  T TfA TCG TGA 
BamHI Smal EcoRI 
under non-denaturing conditions because of the affinity of the GST moiety for 
glutathione. 
DNA of interest can be inserted into a polylinker located at the 3' end of the 
GST gene. The DNA sequence of the polylinker of pGEX-3X encodes an amino acid 
sequence which contains protease cleavage sites so that the expressed fusion protein 
can be cleaved between the GST and the foreign moieties. 
4.2.3 Strategies used for subcloning a fragment of pfran into pGEX 
vector 
A strategy was devised to generate antibodies to a unique Ran-specific, non-
conserved, region of the protein encoded by the pfran gene. For this, it was necessary 
to identify a region which was suitable for subcloning and expression in a pGEX 
vector, and against which antiserum could be raised. In deciding which unique region 
to subclone, it was thought unwise to generate antibodies to portions of conserved 
regions because it seemed possible that such antibodies would cross-react with 
mammalian Ran proteins. A pfr an-s peciflc fragment was therefore identified near the 
3' end of the pfran gene. This region is not very conserved among the different 
Ran/TC4 genes. 
The main determinant for successful purification of foreign polypeptides using 
the pGEX system is the solubility of the fusion protein. The fusion protein is likely 
to be insoluble if it is much larger than SOkDa or if the protein contains regions that are 
strongly hydrophobic or charged (Smith and Corcoran, 1990). Since the size of the 
GST moiety is 26kDa the size of the foreign polypeptide should be no more than 15-
25kDa and thus encoded by an ORF of approximately 450-750bp. 
A DNA fragment which would yield approximately the ideal size from GST 
fusion was identified in the pfran gene. The chosen construct is illustrated in (Fig 
4.2). A 157bp fragment (nucleotides 1164-1321 of clone C4.1 which encodes the 
whole pfran gene Fig. 3.4, Chapter 3) from the pfran plasmid was amplified using 
oligonucleotide primers containing a BamHl restriction site for the forward primer and 
an EcoRJ restriction site for the reverse primer. This fragment, which contained the 
pfran stop codon was ligated with pGEX-3X at the BamHIIEcoRI sites. Positive 
clones were identified by the use of these restriction enzymes to analyse the DNA 
prepared from putative clones and cloning junctions were confirmed further by 
sequencing. 
We 
Figure 4.2 : The sequence of the pfran construct used for cloning into pGEX-3 for the pfRan antibody production 
Two oligonucleotides primers (primer 01701, forward and primer G1702, reverse) contain BamHI and EcoRl were used 
to amplify a 157bp fragment from the pfran gene. The amplified product was ligated into the BamHI/EcoRl site of the 
pGEX-3 expression vector and transformed with TO-1. The site of the primers are underlined. 
Human 	QA EAGGMH 
Hamster QA EAGGMH 
XenopuS QA AAGGMH 
Droso. DI SAGGMH 
S.cerv. SF AVGGMH 
- nümbe DL AVG1 
TVCLSKSGQVY ------- T 
TVCLNQSGQVY--- ----T 
TVCLGASGSIY ------- T 
NLVLTKSGDIY ------- T 
TLALDEESNVW ------- A 
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4.2.4.1 Expression and Purification of GST fusion proteins 
The pfRan construct was transformed into E. coli strain TOl and induced with 
IVTG. The proteins extracts from the bacterial cells were separated on an SDS-PAGE 
gel (Fig. 4.3) As shown in the figure, upon induction with IPTG the two clones, 
pGEX-4 and pGEX-7, were found to express a GST fusion protein of the expected 
size (33 kDa). 
The GST system has been designed so that soluble fusion proteins can be 
easily purified using glutathione attached to agarose beads (Pharmacia). In order to 
assess whether the expressed fusion protein was soluble, first small scale purification 
was carried out on construct pGEX-4 and pGEX-7 as described in method 
2.2.22.4.2. The results shown in figure (4.4), indicated that at least some of the 
fusion protein was soluble. Large scale purification was next carried out, as described 
in chapter 2 section 2.2.22.2, from clone pGEX-7 to obtain sufficient fusion protein 
to inject into rabbits for production of antiserum. The protein was purified on S-
linked glutathione-agarose beads. 
4.2.4.2 Production of antiserum to fusion protein 
In total two 5 month old male New Zealand rabbits were immunised. One 
rabbit was immunised with GST fusion protein expressing the pfran fragment 
(construct pGEX-7). The other rabbit was immunised with the GST protein only as a 
control, since the GST moiety was not separated from the expressed fusion protein. 
The rabbits were bled before the injection of the foreign protein. 
Approximately 500tg of the soluble fusion protein in lml of complete Freund's 
adjuvant were used per immunisation for each rabbit. The rabbits were boosted at 
three and six weeks after the initial immunisation with the protein in incomplete 
adjuvant. 
4.2.4.2 Western blotting analysis 
To identify which proteins were recognised by the immune sera, and to 
determine if the pfran construct was expressed, Western blots prepared from total 
parasite extract were incubated with antisera from the above experiments as described 
in method 2.2.22.6. 
Initially, the anti-pfran sera used to probe a Western blot prepared from the 
total protein extracts prepared from the 3D7A parasite strain were separated by SDS-
PAGE under reducing conditions and electrophoretically transferred onto 
M. 
Figure 4.3 
Coomassie-stained SDS-PAGE pattern of E. coli protein extracts. Proteins 
from an approximately equal number of cells were electrophoresed on each gel (SDS-
PAGE) lane. 
 
Lanes 1 and 2 of panel (A) are uninduced protein extracts from E. coli 
containing the plasmid pGEX-3 harbouring the pfran insert, insert No.4 and insert 
No.7 respectively, 
 
Lanes 1 and 2 of panel (B) are protein extracts from E. coli containing the 
plasmid pGEX-3 with the pfran insert, (insert No. 4 and No. 7), both induced with 
IPTG (final concentration 0.1mM). Lane 3 and 4 of panel (B) are protein extracts 
from two E. coli colonies containing the plasmid pGEX-3 without the pfran insert 
induced with IPTG. 
The heavily staining band in the 1Ff G-induced tracks (double arrow), which is 
larger than glutathione-S- transferase (single arrow), is the fusion protein. 
The molecular weights of size standards are indicated in kDa. 












Purification of clone No. 7 which expressed pfRan fusion protein and the GST 
moiety protein from the plasmid pGEX-3 without the construct. The purified proteins 
were used for immunisation of rabbits for production of pfRan antibodies. 
Protein extracts from the above two clones were first sonicated and treated with mild 
detergent (Triton X-100) and then pelleted. The pellet was kept for analysis and the 
supernatant was purified on S-linked glutathione agarose beads and eluted in reduced 
glutathione. For description of the purification technique used see method 2.2. 
22.4.2. 
Lane 1. Protein product of clone no.7 purified by agarose beads and eluted in reduced 
glutathione. 
Lane 2. Protein product of the pGEX-3 (without an insert) plasmid purified by 
agarose beads and eluted in reduced glutathione. 
Lane 3. The agarose beads after elution of the protein product of clone 7 in reduced 
glutathione. 
Lane 4. The agarose beads after elution of the pGEX-3 protein in reduced glutathione. 
Lane 5. the pellet kept after the detergent treatment of the pGEX-3 protein product. 
Lane 6. the pellet kept after the detergent treatment of the protein product of clone 7. 
N.B. the molecular weight (kDa) of size standards are indicated. 
kDa Mn 
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Figure 4.5 : Western blot analysis of pfRan srea. 
Extracts from the original protein from clone no.7 and the protein 
containing the GST moiety were used to immunise rabbits for production of 
antibodies against pfRan. Total protein extracts from P.falciparu,n cultures and from 
uninfected red blood cells were separated on SDS-PAGE and electrophoretically 
transferred onto nitocellulose filters. The blot was probed with sera from the hyper-
immune rabbit injected with protein from clone no. 7, containing the pfran insert. 
Lane 1. total parasite protein from P. falciparum 3D7 clone. 
Lane 2. the protein product of GST fragment. 
Lane 3. protein product of clone 7. 
Lane 4. protein extract from uninfected RBCs. 
Total protein extracts prepared from asexual and sexual 3D7 parasite were 
separated on SDS-PAGE and electrophoretically transferred onto nitocellulose filters. 
Strips of the blot were incubated with anti-pfRan and anti-PCNA sera. 
Lane 1. asexual parasite protein extracts incubated with anti-pfRan antisera. 
Lane 2. gametocyte protein incubated with anti-pfRan antisera. 
Lane 3. asexual parasite protein extracts incubated with anti-PCNA antiserum. 














Figure 4.6: Immunoprecipitation of P. falciparum total protein extract 
1251 radiolabelled total parasite (clone 3137) protein extracts precipitated with 
pfRan antibodies. Different dilutions of the sera were used: lane 1, 1:50; lane 2, 
1:100 and lane 3 1:500 dilutions. total proteins from uninfected RBCs were also used 
(lane 4). 







nitrocellulose filters (method 2.2.22.6). Strips of these blots were probed with the 
pre-immune as well as the immune sera. The immune sera recognise a band of 34 kDa 
in size in the original protein extracts used to immunise the rabbit, which corresponds 
to the expected size of the fusion protein (Fig.4.5A, lane 3). When the rabbit hyper-
immune serum was incubated with total parasite proteins extract a band of 27 kDa in 
size was observed (Fig. 4.5A , lane 1). Sera obtained by immunisation of a rabbit 
with the GST moiety only recognised a band of 25 kDa (Fig.4.5A, lane 2) The pre-
immune sera did not recognise any Plasmodiwn proteins (data not shown). 
When protein from synchronous culture transferred to nitrocelluose membrane 
and and incubated with antiserum raised to the pfRan-construct, one major band of 27 
kDa predominantly in the asexual stage extracts (lane 1, Fig. 4.5B) was seen, 
although a very weak band in the protein extracts from gametocytes can be seen also 
of the same size (lane 2, Fig.4.5B). Anti-PCNA serum (Kilbey et al., 1993) was 
used as a positive control in order to distinguish any bands that were due to the pGEX 
expression system and the immunisation protocol used. The PCNA serum recognised 
a band migrating at 32 kDa in the asexual extract only (lane 3, Fig. 4.5B). These 
results indicated that pfRan is present among the parasite proteins, predominantly in 
the asexual stages. 
4.2.4.3 Immunoprecipitation 
lodinated parasite proteins were precipitated with the pfRan polyclonal serum 
(method 2.2.22.7), and were then separated on SDS-PAGE under non-reducing 
conditions. Different dilutions of the serum (1:50, 1:100, and 1:500 dilutions) were 
used to precipitate the parasite proteins. Proteins extracted from uninfected RBCs 
were precipitated with the pfRan sera also as a control. After electrophoresis the gel 
was air-dried and exposed to X-ray film stored in a -70°C freezer. The film was 
developed after two weeks. Results are shown in Fig. 4.6. The serum recognised a 
27 kDa protein band even at the lowest concentration of the serum used (Fig. 4.6, lane 
3). No signals were seen with the control. 
4.2.4.4 Immunolocalisation of pfRan 
To attempt to localise the pfRan protein in the parasitised red blood cell and to 
determine further when it appears during the intra-erythrocytic cycle, 
immunofluorescence assays (IFA) were performed on acetone fixed thin smears of 
synchronous and asynchronous P. falciparum strain 3D7A infected RBCs as 
described in method 2.2.22.8. 
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The parasite nuclei were counter-stained with DAPI (at 1:40 dilution). The 
rabbit polyclonal immune serum made against the pfRan construct was used at a 
dilution of 1:100 and 1:200 (method 2.2.22.8). Antibodies bound to the parasite 
preparation were detected using fluorescein conjugated anti-rabbit IgG antibodies, 
which give a green fluorescence under U/V illumination. Results are shown in Fig 
4.8. 
A series of IFA experiments were carried out which consistently gave the same 
ffluorescence patterns. Appropriate control experiments, using the (9.8) merozoite-
specific monoclonal antibody ( a gift from Dr. J. McBride) and 12.F. 10, gametocyte-
specific monoclonal antibody (provided by Dr. R. Carter), were performed. No 
staining of infected or non-infected red blood cells was observed when the pre-
immune serum was used (Fig.4.7) or when the fluorescin-conjugated antibody was 
used alone. 
When immune serum was used, parasites were found to be stained with 
fluorescein. The fluorecein cells were also positive for DAPI stain, indicating that 
antibodies recognised parasitised cells, and showed the parasitic origin of the protein 
recognised by the rabbit serum. A diffuse pattern of staining of the ring, trophozoite 
and early schizont of the asexual forms was seen (Fig. 4.8 and 4.9). The sexual 
gametocytic forms also gave a diffuse pattern of staining although the pattern of 
fluorescence appeared to be localised in the intracellular parasite (Fig. 4.10). In the 
late schizont or segmenter stage of the parasite, the fluorescence appeared to be 
localised in the nuclei and the gaps between the developing merozoites (Fig 4.9). 
4.2.5 Discussion 
From the deduced pfRan open reading frame (Chapter 3), the predicted size of 
the expressed protein is likely to be around 25 kDa. Using Western blot analysis and 
immunoprecipitation, the rabbit antiserum raised against pfRan recognised a parasite 
protein approximately of 27 kDa in size. Western blot analysis also showed that the 
pfRan protein was mainly present in the asexual stage of the parasite which was 
consistent with the Northern blot analysis. 
The IFA indicated that pfRan is expressed mainly in the asexual parasite with 
some evidence of its presence in gametocytes. In addition, the IFA results indicated 
that pfRan is diffusely distributed in the parasitised cell localised both in the nuclei and 
the cytoplasm of the cell. Ideally these results need to be confirmed by ultra- structural 
studies using immuno-gold localisation, in order not to over-interpret them. However, 
some interpretations of these findings will be offered in the general discussion section. 
Figure 4.7 
Pattern of indirect fluorescence assay (IFA) staining produced by rabbit pre-
immune sera on blood films of P. falciparum asynchronous cultures (clone 3137). 
Acetone fixed smears of P. falciparum infected RBCs were incubated with the pre-
immune sera, followed by FITC-conjugated goat anti-rabbit IgG second antibodies. 
Parasite nuclei were counter-stained with DAPI. 
Infected cells analysed for presence of DAPI under U.V. illumination (x40). 
The same infected cells were analysed for presence of fluorescein. No specific 












Indirect immunofluorescence assay (IFA) of 3137 infected erythrocytes with 
anti-pfRan fusion protein. The slide containing acetone-fixed smears prepared from 
asynchronous cultures. The cells were fixed with acetone and reacted with a rabbit 
anti-pfRan fusion protein (dilution 1/100) followed by FITC-conjugated goat anti-
rabbit IgG. Parasite nuclei were counter-stained with DAPI. The same infected cell 
was analysed for presence of DAPI (Panel la-3a) and fluorescein (lb-3b). 
Panel lb. 2b, and 3b are fluorescent micrographs of pfRan antibody reacted 
with rings (R), trophozoites (T) and schizonts (S). 
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Figure 4. 9: 
Indirect immunofluorescence assay (IFA) of 3137 infected erythrocytes with 
anti-pfRan fusion protein. The slide contains acetone-fixed smears prepared from 
synchronised 3137 cultures, as described in materials and methods section. The cells 
were fixed with acetone and reacted with a rabbit anti-pfRan fusion protein (dilution 
1/100) followed by HTC-conjugated goat anti-rabbit IgG. Parasite nuclei were 
counter-stained with DAPI. The same infected cell was analysed for presence of 
DAPI (Panel la and 2a) and fluorescein (lb and 2b). 
Panel lb. and 2b are fluorescent micrographs of pfRan antibody reacted with 




Indirect immunofluorescence assay (IFA) of 3D7 infected erythrocytes with 
anti -pfran fusion protein. The slides containing acetone-fixed smears were prepared 
from synchronised 3137 gametocyte cultures. The cells were fixed with acetone and 
reacted with a rabbit anti-pfran fusion protein (dilution 1/100) followed by FITC-
conjugated goat anti-rabbit IgG. Parasite nuclei were counter-stained with DAPI. The 
same infected cells were analysed for the presence of DAPI (not shown) and 
fluorescein (la and 2 a and b). 
Panel (1) shows a fluorescent micrograph of pfRan antibody reacted with 
gametocytes (g). 
Panel (2a) shows a fluorescent micrograph of pfRan antibody reacted with 
gametocytes and gametes. 
Panel (2b) is the same micrograph as (2a) but with xlOO magnification to illustrate the 
morphology of the male gamete (indicated with arrows). 






4.3 Test for functional complementation of Schizosaccharomyces 
pombe pirni mutant. 
4.3.1 Introduction 
A fission yeast mutant piml(premature initiation of mitosis) has been isolated 
by Matsumoto and Beach (1991) in which the onset of mitosis is uncoupled from the 
completion of DNA replication. Pimi cells can undergo mitotic chromosome 
condensation and mitotic spindle formation without completion of S-phase. 
Overexpression of the wild-type allele of a second gene, spil(suppressor of pim) 
whose predicted protein product shares 81% identity with human RanITC4, has been 
found to suppress the pimi mutant phenotype (Matsumoto and Beach, 1991). It was 
therefore considered that it might be possible to test the function of P. falciparum pfran 
gene by assessing whether it can complement the pim genetic defect in the same way 
that the spil mutants do. 
4.3.2 Strategy used for the yeast complementation test 
To test for complementation, a PCR fragment containing the whole coding 
region of pfran gene was obtained by amplification of the pfran plasmid (clone C4. 1) 
which encodes the complete Pfran gene. Primer G5793 containing NdeI (forward) 
and primer G579 containing BamHJ (reverse) were used for amplification of the pfran 
construct as described in method 2.2.16. The PCR product was cloned into the 
NdeI/BamHI site of a Schizosaccharoinyces pombe thiamine-repressible pREP 1 
expression vector, Figure 4.11, (Maundrell, 1993), and the resulting plasmid was 
used to transform the temperature sensitive mutant of S. pombe pimi 1-46, 
(Matsumoto and Beach 1991). 
The cells were transformed by electroporation, as described in method 
2.2.23.3, and then selected on minimal medium plates containing thymine by 
incubation at 28°C for a period of 4-6 days until single isolated colonies were seen. 
The colonies were replicated in duplicate on minimal medium plates and grown at 
280C, and after 24 hours, one set of plates was shifted to 36°C to test for rescue of 
the pimi phenotype. Vector pREP! and plasmid containing the S. pombe pim gene 
(Matsumoto and Beach 1991) were used as negative and positive controls 
respectively. The final construct was sequenced on both strands to ensure that the 
correct reading frame was present in the construct and that no mutations had occurred 
during manipulation. 
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Sequence of plylinker 
CATATCTTCGACTCTACTAG GATCCCCGGG 
NdeI 	Sal! 	Xbal 	BamHI 	Smal 
Figure 4.11: pREP-1 S. pombe expression vector. 
The thiamine-repressible expression vector of S. pombe used for 
complementation test. The nmt-lpromotor and polyadenalation signal have been 
indicated. This plasmid permit thiamine-mediated control of transcription to be applied 
to cloned genes. Modified from Maundrell, 1993, Gene 123,127-130. 
4.3.3 Results and discussion 
In an attempt to assign a role for the pfran gene in the control of the malaria 
parasite life cycle, tests for complementation of Schizosaccharomyces pombe 
temperature sensitive piml mutant were carried out. Although the pfran fragment was 
successfully cloned into the yeast expression vector pREP 1, the pfran construct was 
not expressed in yeast mutant, and this prevented testing for possible functional 
complementation of appropriate mutant. 
Rescue of temperature sensitive piml as described above failed at both at 33°C 
and 36°C. However, Western blot analysis of lysates from both transformed and 
untransformed yeasts probed with anti-pfRan serum showed that the protein was not 
expressed at a detectable level in any of the transformants, even though a protein band 
of 27 kDa was clearly visible in the control lysate from P. falciparum (data not 
shown). Thus the failure of complementation may have been due to lack of 
expression. 
This result does not of course rule out a regulatory role for pfran in the cell 
cycle of P. falciparum since cross-species complementation tests may be inappropriate 
for organisms which are phylogenetically distant. Functional complememtation using 
yeast mutants have been carried out for the cdc2-homologue of P. falciparum and L. 
mexicana but without any reported success ( Mottram et al., 1993; Ross-MacDonald 
etal., 1994). 
4.4 Transcription of pfran in Plasmodium falciparum RNA isolated 
nuclei 
4.4.1 Introduction 
The technique of nuclear run-on is a sensitive in vitro method for studying the 
mechanism of transcription of specific genes and the processing of primary transcripts 
in eukaryotic cells. This approach starts with isolated nuclei and uses endogenous 
chromatin as the template for transcription. The advantage of this method is that, the 
activity measured reflects the activity of that nucleus in the cell, that is, the same genes 
are being expressed in the same relative amounts in the isolated nucleus as in the intact 
cell. 
The level of expression of pfran RNA during the intra-erythocytic stages was 
examined by Northern blot analysis and was found to be expressed in a stage specific 
manner as described in Chapter 3. To test whether this was due to transcriptional 
activity nuclear run-on experiments were carried out. 
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4.5.2 Strategy for transcriptional analysis 
The following genes used in this experiment: pfran gene (Sultan et al., 1994), 
pfrccl (this study, see Chapter 5), msp-1 gene encoding the major merozoite surface 
antigen, (Holder et al., 1985), Pfg25127 and Pfs230 genes expressed during the 
gametocyte stage (Alano etal., 1991; Williamson etal., 1993), and CS gene encoding 
the circumsporozoite antigen expressed during the insect and hepatocytic stages (Enea 
et al., 1984). Since most of the genes used in this experiment were cloned either into 
plasmid or phage vectors, a PCR amplifiction was performed using specific primers 
against these genes. The PCR products were purified (method 2.2.3) before aliquots 
were spotted on Hybond-N+ membrane using the dot-blot apparatus (method 2.2. 10) 
For comparison other genes of known stage specific expression were used. These 
were Pfcrk-1 (Doerig et al., in preparation), 0 tubulin (Delves et al., 1990), 
Topoisomerase II (Cheesman et al., 1994), PCNA (Kilbey et al., 1993 ), Polymerase 
a (Ridley et al., 1991) and Polymerase ö (White et al., 1993). 
Nuclei were isolated from synchronised cultures of (clone 3137) at different 
stages during the life cycle as described in method 2.2.21. Transcription was 
performed using labelled 32P-UTP, and the labelled nascent RNA was used as a probe 
for DNA fragments specific for the above mentioned genes. After hybridisation was 
completed the blots were exposed to X-ray film for variable periods of time. 
4.4.3 Results and discussion 
The results are shown in figure 4.12. It was observed that the pfran and 
pfrccl were mainly transcribed during the schizont stage (Fig.4. 12A lanes 1 and 2 
respectively). No transcriptional signals were seen in gametocyte (Fig.4. 12B lane 1 
and 2). Nuclear run-on for nuclei isolated from ring and trophozoite stages gave very 
faint signals even with longer exposures (data not shown). Signals were observed 
for the genomic DNA, msp-1 during schizont stage, and Pfg25127, Pfs230 during 
gametocytic stages. No signals were seen in the negative control lanes (pUC18, ? 
phage DNA and the TE buffer) and for the CS gene; figure 4.12. No signals were 
observed during the schizont stage for Pol a, Pol ö, and PCNA genes, although 
RNA studies have shown that these genes are expressed during the asexual stages. 
However, with longer exposure weak signals were seen (data not shown). The 
experiment on these genes is not conclusive and needs to be optimised further. 
The experiment is difficult to optimise because of the technical difficulty in 
obtaining reasonable amounts of intact nuclei from synchronous cultures of the 
parasite. However, the results indicate that both pfran and pfrccl are transcribed just 
before and during the S-phase of the P. falciparum cell cycle in accordance with the 
observations made on the presence of the proteins themselves. 
Figure 4.12 
Autoradiographs of nuclear run-on experiments showing stage specific 
transcriptional activity of pfran gene. Nuclei were isolated from schizont (panel A) 
and gametocyte (panel B) parasite stages. Nascent, 32P dUTP labelled RNA was 
used to probe equal concentration of DNA fragments containing pfran, pfrccl, msp-1, 
3D7 genomic DNA, pfg27125, pfs230, and pf-circumsporozoite genes. DNA from 
pUC18 and ?phage and TE buffer were used as internal controls. 
A. Nuclei isolated from schizont stage of synchronous culture of clone 3D7 
pfran. 	 6. pfg27125. 
pfrccl. 7. pfs230. 
msp-1. 	 8. circumsporozoite gene. 
P. falciparum genomic DNA. 9. pUC 18 plasmid DNA 
TE buffer. 	 10. X phage DNA. 
B. Nuclei isolated fromthe gametocyte stages of a synchronous culture of clone 3D7. 
pfran. 	 6. pfg27125. 
pfrccl. 7. pfs230. 
msp-1. 	 8. circumsporozoite gene. 
P. falciparum genomic DNA. 9. pUC 18 plasmid DNA. 
TE buffer. 	 10. X phage DNA. 
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CHAPTER 5 
CLONING AND CHARATERISATION OF THE 
P. falciparum RCC1 HOMOLOGUE. 
5.1 Summary 
In the previous chapter the molecular cloning and characterisation of the pfran 
gene, a member of the small GTPase superfamily (the P. falciparum homologue of 
RaniTC4) was described. Ran/TC4 encodes a protein which has been shown in yeast 
and mammalian systems to interact with RCC1 (regulator of chromosome 
condensation), a protein proposed to be required for the normal coupling of 
completion of DNA synthesis with initiation of mitosis. Genetic and biochemical 
experiments suggest that RanITC4 and RCC 1 are key components of a feedback-
checkpoint control which monitor the progress of DNA replication throughout the 
eukai-yotic cell cycle. 
In order to investigate the role of RCC1 and its interaction with pfran in the 
life cycle of P. falciparurn, it is necessary to isolate and characterise the RCC1 
homologue of P. falciparum. This chapter describes the cloning and partial 
sequencing of the P. falciparum RCC1 homologue (pfrccl). DNA sequence analysis 
carried out is partial, although quite extensive. This partial sequence codes for a 
protein of 925 amino acids, and although incomplete is almost twice as long as any 
previously sequenced RCC1 molecule. The N-terminal portion of the predicted 
protein, from amino acids 55-725, has around 20-30% homology to the RCC 1 
proteins of human, hamster, Xenopus, Drosophila, S. pombe, and S. cerevisiae. The 
characteristic feature of the RCC 1 proteins, the seven 60 amino-acid blocks of 
conserved repeats, are also found in the P. falciparum gene. Unlike the yeast and 
vertebrate RCC1 proteins, pfRCC1 has a C-terminal extension of 290 amino acids 
(amino acids 727-1017) with no homology to RCC1 repeats, but containing clusters 
of glutamic acid residues balanced by a lysine-rich sequence. The pfrccl has been 
mapped to chromosome 5 and is present as a single copy in the P. falciparum genome. 
The RCC1 transcript is approximately 8.5 kb in size. Northern blot analysis of total 
RNA from different stages of the parasite indicates that pfrccl is expressed mainly in 
the trophozoites. 
5.2 Introduction 
Genetic and biochemical analyses suggest that Ran/TC4 may play a key role in 
the regulation of cell cycle progression in eukaryotes, and that its function depends on 
its interaction with the product of a second gene, called RCC1 (regulator of 
chromosome condensation) (Matsumoto and Beach, 1991; Bischoff and Ponstingi, 
1991a). 
An RCC1 mutant was first isolated in a temperature-sensitive cell line (tsBN2 
cells) derived from baby hamster kidney (BI-IK) cells (Nishimoto et al., 1978). It has 
been observed that tsBN2 cells which are shifted to higher, restrictive temperatures at 
different points in the cell cycle display different defects: they are unable to pass the 
GuS transition if shifted during 01 phase, and subject to premature chromosome 
condensation (PCC) and entry into mitosis if shifted during S phase (Nishimoto etal., 
1978). Early investigations showed that the difference between the phenotypes of cells 
shifted in 01 and S phases was due to a requirement for mitosis-inducing factors that 
are not synthesised until cells undergo GuS transition (Nishimoto et al., 1981). 
Using DNA-mediated gene transfer to rescue the tsBN2 cell line, the human 
gene and cDNA encoding RCC1 were isolated and found to be located on 
chromosome 1 (Ohtsubo et al., 1987). Subsequent analysis of the mammalian RCC1 
protein has shown that it is a nuclear localised DNA-binding protein and that it is lost 
from the DNA during mitosis lead to activation of p34CdC2  and entry into mitosis 
(Ohtsubo et al., 1989). Later, it was shown that the tsBN2 defect in the hamster 
RCC1 gene is due to a single point mutation (Uchida etal., 1990). Because of this 
mutation, the RCC1 protein disappears in the tsBN2 cell line following a shift to a 
restrictive temperature. Upon loss of RCC1 function, the cdc2/histone Hi kinase is 
activated and the tsBN2 cells enter mitosis prematurely (Nishitani et al., 1991). The 
factors controlling the apparent degradation of RCC1 are not understood. 
Fission yeast mutants, in which the onset of mitosis is uncoupled from the 
completion of DNA replication have been isolated by Matsumoto and Beach (1991). 
These mutants, known as pim mutants, (for premature initiation of mitosis), undergo 
mitotic chromosome condensation and mitotic spindle formation without completion 
of S phase and without the cdc25 mitotic inducer, a gene product that activates the 
cdc2/cyclin B complex. The pimi gene product was later found to share 
approximately 30% homology with the human RCC1 protein, and the cells display a 
phenotype that has certain similarities to the tsBN2 cells. In addition it has been 
shown that both yeast and mammalian mutants enter mitosis from S phase, i.e. 
omitting the normal G2 interval ( Matsumoto and Beach 1991). The most distinct 
difference between the yeast and mammalian mutants is that a mammalian tsBN2 line 
transferred to a restrictive temperature in the 01 phase of the cell cycle becomes 
arrested in Gi and does not proceed to S-phase; in contrast, the pimi mutant appears 
to complete DNA replication and then arrests in mitosis (Matsumoto and Beach, 
1991). Matsumoto and Beach (1991), in the process of cloning pimi, isolated a 
multicopy plasmid suppressor which they have designated spil (for suppressor of 
pimi). spil is the S. pombe homologue of Ran/TC4 and pfran. Overexpression of 
the wild-type allele of spil suppresses the pimi mutant phenotype, although spil 
overexpression cannot rescue null mutants of pimi, indicating that spil cannot bypass 
the requirement for piml and that both proteins are required for efficient regulation of 
the cell cycle with respect to completion of DNA replication (Matsumoto and Beach, 
1991). 
RCC1 homologous genes have been isolated from Xenopus, Drosophila and 
yeast (Nishitani et al., 1990; Frasch, 1991; Aebi et al., 1990; and Matsumoto & 
Beach, 1991). The isolation of RCC1 homologues from other organisms has 
confirmed a requirement for RCC1 in the cell cycle and suggested that RCC1 might 
have a number of other roles in nuclear function. It is interesting that a very diverse 
collection of screens have yielded mutants in RCC1 homologues and the phenotypes 
associated with these mutations are highly pleiotropic (see Table 5.1). 
5.3. Strategy used for isolation of P. falciparuin RCC1 homologue 
In order to design oligonucleotide primers which permitted successful 
amplification of a genomic fragment encoding a possible RCC1 homologue in P. 
falciparum, a sequence alignment comparison was carried out between all RCC 1 
genes across species which are deposited in the databank. 
Two stretches of amino acids in the RCC1 gene from other species gene pim] 
were found to be most conserved, one between positions 58-63 and another between 
positions 182-192 (see Fig.5. 1). Two oligonucleotides were synthesised to code for 
these peptides. (i) G6037,+ a redundant 17 mer coding for AVGGMH amino acid 
residues and (ii) G5146,- an antisense 32 mer coding for WGNGQQFQLGR, 
designed according to the codon usage bias of P. falciparum (Weber, 1987; Saul and 
Battistutta 1988). 
Amplification of P.falciparum RCC1 was carried out (method 2.2.16) using 
these primers mentioned above. The template was genomic DNA from clone 3137A. 
Amplification was performed for 30 cycles (each cycle consisted of 30 seconds at 
94°C, 60 seconds at 45°C and 90 seconds at 72°C. Human DNA was used 
simultaneously, as an internal control in the PCR reaction. 
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Table 5.1 Homologs of RCC1: isolation methods and properties ( After Dasso, 1993) 
Species Name Isolation/ genetic screen Implied role 
Hamster (BHK RCC1 DNA-mutant (tsBN2 Required for GuS phase 
cell) cells) transition to prevent PCC. 
Chromatin-binding protein. 
Transcription and translation 
inhibited in RCC1's absence 
Human RCC1 Complement tsBN2 As above 
cells  
Human (HeLa RCC1 Recognised by anti- Chromatin-binding protein. 
cells) kinetochore antibody Mediates GTP exchange for 
Ran (spi). 
Xenopus laevis RCC 1 Sequence homology to Chromatin-binding protein. 
human RCC1 Required for DNA 
replication in vitro. 
Drosophila BJ 1 Chromatin-binding Maternally-expressed. 
melanogaster  protein Chromatin-binding protein. 
Schizosacchro- pimi premature mitosis Required for PCC. 
myces poinbe mutant Interacts with small ras-like 
GTP-binding protein spil. 
Saccharomyces SRM1 Mating 	rescue of a- Regulates mating pathway. 
cerevisiae factor receptorless Required for G 1/S phase 
mutant transition. 
Required for plasmid and 
chromosome stability. 
S. cerevisiae PRP20 Mutant defective in pre- Required for pre-mRNA 
mRNA processing splicing &3'end formation. 
Required for structural 
integrity of the nucleus. 
Required for correct trans- 
cription initiation and 
termination. 
S.cerevisiae MTR1 Mutant defective in Required for mRNA export 
mRNA export from nucleus. 
PCC= Premature Chromosome Condensation 
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Figure 5.1: 
Testing for RCC1 conserved regions in the DNA of P.falciparum. Amino acids 56-201 of human (Ohtsubo et al., 
1987), have been aligned with RCC1 homologs from hamster (Uchida et al., 1990), Xenopus (Nishitani et al., 1990), D. 
melanogaster (Frasch, 1991), S. cerevisiae (Clark and Sprague, 1989; Aebi et al., 1990) and S. pombe (Matsumoto and 
Beach, 1991). The highly conserved undecapeptide and hexapeptide (boxed in) were used to design oligonucleotide 
primers for PCR amplification of the corresponding region of P.falciparum RCC1 (see text). These peptides are lying 
within the conserved repeat number 2 of RCC1 proteins. The position, sequence and redundancy of oligonucleotides 




Human 	QA EAGGMH 
Hamster QA EAGGMH 
Xen opus QA AAGGMH 
Droso. DI SAGGMH 
S.cerv. SF AVGGMH 
S. pornbe DL AVGGMH 
56 
TVCLSKSGQVY-------T LGCGEQGQLGR VPELFANRG 
TVCLNQSGQVY-------T LGCGEQGQLGR VPELFANRG 
TVCLGASGSIY-------T SGCGEQGQLGR VPERFINRG 
NLVLTKSGDIY-------T VGCAEQGQLGR LSERSISGE 
TLALDEESNVW-------A WGNGQQNQLGR --KVMRFRL 
SAALLHDGRVY-------T WGNGQQFQLGR --RNLERRR 
primer G5146 \ 	201 
3' ACCCC(T/A)TF(A/G)CC(r/A)GT(F/C)GT(F/C)(F/A)(T/A)AGT(T/C)(G/A)A(f/A)CCF/A)GC 5' 
5.4 Results 
5.4.1 A fragment encoding a sequence homologous to the RCC1 
detected by PCR 
A DNA fragment of 480bp was detected using the above mentioned primers. 
No amplified band was detected from the control (human DNA) (Fig. 5.2). The 
amplified PCR fragment was subcloned directly into the pCRII cloning vector and 
plasmid DNA minipreps prepared from 2 positive transformants. These clones were 
sequenced, on both strands, by the dideoxy chain termination method (method 
2.2.18), using either pJFE14 vector specific primers or oligonucleotides homologous 
to specific parts of the gene. 
Sequencing revealed that the PCR fragment had an 84% AT content. The 
predicted protein encoded by this insert matched the human RCC1 protein only in the 
amino acid repeats; there was no homology outside these repeats. This finding ruled 
out the possibility that amplification had taken place on a template of human DNA 
origin, and suggested strongly that the PCR amplified fragment truly consisted of a 
portion of P. falciparum RCC 1 gene. 
5.4.2 Partial sequencing of the P. falciparum RCC1 gene 
The 480bp fragment was then used to screen a cDNA asexual library in order 
to obtain further sequences of the gene. Three positive cDNA clones were isolated, the 
longest of which (clone CIO) was about 3.0 kb long. Upon sequencing, this 
fragment was found to contain one major open reading frame of 2776 nucleotides 
which codes for a protein of 925 amino acids. The A+T content of the sequence is 
83% (Fig. 5.3). 
The clone CIO lacked the 5' and 3' termini of the gene, because of the 
absence of stop codons. The criterion for completion of the gene was to find at the N-
terminus of the gene a methionine codon (presumably the initiation codon) preceded 
by blocked reading frames, and to identify a stop codon at the 3' prime end of the 
gene. In order to obtain the remaining part of the P. falciparuin RCC1 gene three 
rounds of screening of the cDNA library with unique sequence probes from clone dO 
were carried out. However, this approach was unsuccessful. Genomic DNA libraries 
(Hindlil digested Ki DNA and Dral digested Ki libraries) were also screened, but 
again failed to produce clones with sequences beyond these identified in the clone 
CIO. Two oligonucleotides primers were designed in order to amplify a genomic 
DNA by inverse PCR (method 2.2.17). However, after several attempts this 
approach also failed to extend the clone beyond the previously identified sequence. 
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Figure 5.2 
Amplification of P. falciparum genomic DNA of clone 3137 using two 
degenerate primers (primers G6037 and G5146) in order to obtain the P.falciparum 
homologue. Different annealing temperature were tried until a single band was 
obtained. dH20 and Human DNA were used as controls. 5tl of the amplification 
products were loaded on a 1.5% agarose gel in 1xTAE buffer, run at 70V for 30 
minutes, stained with ethidium bromide and photographed on a U.V. trans-
illuminator. 
M. DNA molecular weight marker. 
Lane 1. PCR product from clone 3D7 genomic DNA with RCC1 primers, annealing 
temperature 45°C. 
Lane 2. PCR product from clone 3137 genomic DNA with RCC1 primers, annealing 
temperature 40°C. 
Lane 3. PCR product from clone 3D7 genomic DNA with RCC1 primers, annealing 
temperature 37°C. 
Lane 4. PCR product of amplification of human DNA with RCC1 degenerate primers 
Lane 5. dH20 (control). 
4 
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5.4.3 Comparison of the P. .falciparuin RCC1 protein sequence with 
other RCC1 protein homologues 
Alignment between the P.falciparum RCC1 predicted partial protein sequence 
and the human, Drosophila (BJ1), S. cerevisiae (SRM1), and S. pombe (Pimi) 
protein sequences is shown in figure 5.4. The protein data-bases Swissprot 
(Devereaux etal., 1984) was screened for protein with homology to the P.falciparum 
RCC1(hereafter known as pfrccl gene). In the conserved portion of the molecule, 
the seven repeats (Fig. 5.5), P.falciparum RCC1 has an amino acid identity of 69%, 
71%, and 74% with the RCC1 molecules from human, D. melanogaster, and yeast 
(S. pombe and S. cerevisiae) respectively (Fig. 5.4 and Table 5.2). PfRCC1 has 
overall amino acid identity around 10-15% with the human, Drosophila and yeast 
protein sequences. 
5.4.4 Structural analysis of the pfrccl 
A single open reading frame was found in the 3.0 kb cDNA clone CIO, 
consisting of 2776 base pairs, encoding 925 amino acids (Fig.5.3). The estimated 
molecular weight of this incomplete but probably near full size protein is 118 kDa, 
which is twice as big as other previously identified RCC1 proteins. Southern blot 
analysis of restriction enzyme digests of genomic DNA of P. falciparum hybridised 
with the C10 probes (Fig. 5.6) was consistent with the presence of a single copy of 
the gene. The data were also consistent with the restriction enzyme map obtained by 
computer analysis of the clone dO sequence. 
To investigate whether polymorphism occurred within the pfrccl gene, 
genomic DNA prepared from four, geographically different, isolates (102/1, T9/94, 
T9/96 and 7G8) was digested with three different restriction endonuclease enzymes 
(Alul, MspI and Taqi) separated on an agarose gel, transferred onto Hybond N+ 
membrane and probed with clone Cl. No fragment size polymorphisms were 
observed among these four isolates (Fig.5.7). 
In order to determine the location of the pfrccl gene in the P. falciparum 
genome, a blot of chromosomal DNA gel fractionated by pulsed-field gradient 
electrophoresis (method 2.2.7), was hybridised with pfrccl specific probe. In the all 
P. falciparu?n clones used (102/1, 10511, 106/1, 3137A, Dd2, and T9194), the pfrccl 
gene was found to give a hybridisation signal in the position corresponding to 
chromosome 5 (Fig.5.8). As a further confirmation, the same blots were stripped and 
probed with pfindr-1 probe, a known chromosome 5 marker (Foote et al., 1989). 
This gave a signal in the same position (data not shown). 
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Figure 5.3 
The nucleotides sequence of the partial pfrccl gene. The entire sequence of the cDNA 
clone ClO is shown. The open reading frame of the clone is indicated in the single-
letter code below the DNA sequence. The primers used in sequencing the clone are 
underlined. The nucleotide sequence data shown in this figure has been submitted to 
Genbank and DDBJ nucleotide sequence Databases under the accession number 
	
Primer H4254 	-> 
AAGGAAAAATTATATTCAAATATAAAAGAAAATGATAATAAACATGACTGGTTTACTCCA 60 
K E K L Y S 	I K E ND N K H D W F T P 
TTCCCTATGAAAATAGTTTTC€CTAAAAAAAATACAA.AAATAAAATTTATTTCTTGTGGT 120 
F PM K IV F P K K NT K 1K F IS C G 
<------Primer G9161 
GATATGCACACATTGGCTATCTGCACAGGTGGTGTTTTATATTCCTGGCGTTATAACAAT 180 
D M HT LAICTGGVLYSWGYNNN 
TTTGGTTGTATAGGAAATGGGACAAATCAAAATGTATATGAACAAAACCCGATATTTTTA 240 
F G CI G N G TN Q NV YE PT P1 FL 
GACCTCATTCGGTTGATAATAATGTTGATAATAATGATGATGATTATTATGATGATAAT 300 
E PH S V D N N G 	N ND D D 	D D D N 
AATAATAATAGTACATACAAATTTCATAAAAAGGAAGATCTCATAAAATGGGATAAAAAA 360 
N N N STY K F H K K ED S 	K W D K K 
AAAAATGTAGTCATACATTGCTCAGCAGGGAGTAAGCATAGTCTTGCTTGTAACCTACAC 420 
K N VV I H CS AG S K H S LA C N L H 
GGAGATATTTATAGTTGGGGTTATGGAGGTAATGTTAGATTGGGTCTTGGGAATATAAAA 480 
G 	I Y SW G Y G G N G R L G L G N 1K 
Primer G8696 ----> 
AGTTATAATAAGCCCCAATTAATTAAAGGATTAAGAAATAAAAGAATTCTTTATGTATGT 540 
S Y N K P Q L 	KG L RN K RI L Y V C 
GCAGGAAACTCTCATTCAGGATGTATAGATTCTAATTATTATGTATATCCGTGGGGAAAT 600 
AG T S H S G S 	D S 	Y Y V Y P W G N 
GGGAAATTTTACAAATTAGGTCATGGTAATGATGATATAGATATATATTATCCTAAATTA 660 
G K F Y K L G HG ND DID I Y Y P K L 
GTAGAATGTTTAAATCATAATAAGAAAGTATGTATGTTAAGTTTTGGGTGTTTTAATTCT 720 
V E CL N H N K K V C M L SF G CF N S 
TTGGCATTAA.ATGTTAAAGGAGATGTATATGTATGGGGTACATTTAATATAACAAATAAT 780 
LA L N V K G 	V Y V W G T F NIT N N 
TATGTAAATTATTATATTTCTAAATTACCTAAGCAAATTAATACAAATTATAAATGTATA 840 
Y V NY Y IS K L P K Q IN TN Y K CI 
TCTATACATGCTTCTACATATGTTTGCTTTGGTATTACGTTAGTAGGTGATTTAATTAGT 900 
S 	HASTY V C F G IT L 	G 	L 	S 
TTTGGGAATTATAAAAACTATTCCTATGAAAAAGAAATAAATGATAATGATTCAGATGAC 960 
F G NY K NY S YE K El ND ND SD D 
GATTTAATCAAATATTTAATAAATAAAGAAGTTGAAGAGCAACATTATAATGCGGATAAT 1020 
D L I KY LINK EVE E 	H Y N G 	N 
AAAAGTGTTCACACAAATAAGAATAACATCATATCATCATATATTGTAAAAAAGAAGGAT 1080 
KS V H TN K N Nil S S Y ID K K K D 
GTACATTTTGATATACATTATATAAAAGAAATGAGAGGCAAAATGTATAThAAAGATATT 1140 
VHF DI H Y I K E MR GK MY 1K DI 
GTAACACATTTTTATAATTTAGATACTATGACATATTATATGAATAAGATAAACAAGCAC 1200 
VT H F Y N L D TM T Y Y MN KINK H 
ATTGATAATGTTACCTTAAATAATAATGATAATTACTATACGTATGATAATATAAATGGT 1260 
ID N VT L N N ND NY Y T Y D N IN G 
TCCCATGGAAACATTTTTGAAAAGAACAAACTTGTCTTGAAGTCTAAAGTTAAAATAATA 1320 
S HG N IF E K N K L 	L K S K V K II 
GATGGAAGTGATCATTTTAGTGTATTTTTATTAGAAAGCGGGAAAGTATATACTGCTGGA 1380 
D G SD H F S V FL L ES GK V Y TAG 
- TATAATAAGAATGGAGAATTGGGAAATGGAGAATTTAATTTAAAGAAAAAATTTGGAGTG 1440 
Y N K N GEL G N GE F N L K K K F G V 
GGTATATTATTAAACATATGTGTAAACAAGATAATAAAAATTGCATGTGGATATAATTAT 1500 
PILL N IC V N K IlK II C G Y NY 
GTATTATGTGTAAGTGATGTGGGTTTAGTATATGGCTGGGGAAAAAATGATAAGAGCCAA 1560 
V L CV SD V G L 	Y G W G K ND K S  
Primer H1790 ----> 
TTGGGAATTGGGGTAATAAAAGATTTTTATGAACCTGTTCATTGTAAGAATTTGACAAAT 1620 
L GIG VI K D F YE P V H V K N L TN 
GTGATAAATATATTTGCTGGATATGACCATAGTGCTTGTATTATAAATAAGTTATTAGAT 1680 
V IN IF AG Y D H SAC Y Y N K L L D 
AAGGGTAACACGAATGGTGTGAATTATTATAGTTCAGACGAATGTGGAGATTTATATATT 1740 
KG N TN G V NY Y S SD E C G 	L Y I 
TGGGGTAATGCCGAAAGCGGAAAGGTCGGGTTAGGTGTTGATTATACCCAAGGATGTATA 1800 
W G N A ES GK V G L G V D 	T Q G CI 
TTATTACCTAGAAAAATTAATATAATAAATAAAATATATAAATGTTCTTTAGGTAATAGT 1860 
L L PR KIN lINK I Y K CS L G N S 
CATAGTTTATTTTTAACGAATACTAACGAATTATACGTTTGTGGAAGTAATAATAATGGT 1920 
H S L FL TNT N ELY V C G S 	N N G 
AGGTTAGGTTTATTTGAAAAATCTAAAATGGTTTGTAAATTTGTTAGTGTACCTACTAAA 1980 
R L GL FE KS K MV C N IV S V PT K 
GTTATATTACATAATAATATATATATTAAGGATATCCTAGCAGGTAATACATATAGTATA 2040 
V IL H N NI Y 1K DI LAG NT Y S  
ATATTATCTGTTGATGGGTTTATATATATTTTTGGAGAATTCATAAAAGGTAGTAATGGT 2100 
IL S V D G F I Y IF GE F 1KG S 	G 
AATAGTAATAATATGTCATGTAGGGTCATAAGCTTATATAATGAAATTACCAATGTTAAA 2160 
N S NN MS CE VI SLY N El TN V K 
TATATGAATGGGAATATGAACATCTTTTTTTTTTTCTTACATATGATTTTATTT 2220 
Y MN G K YE H L F F FL P Y D N K L F 
2280 
GIG N N K N C Q IL CD N EKE K NY 
ATAAAAAAACCTAAATTAATAACATATTTTTTAAAAGAAAATAATAAAATAATTGAATTC 2340 
1K K P K LIT Y FL KEN N K lIE F 
Primer H3738 ----> 
ATTTTTTCTTTTCATAATGTTACATTTATTCTTTTCTTTCAGTATTTGTATGG 2400 
IFS H F N VT F I Q F N N SE IF A W 
GGTTATACTAATAATTATCATTTATGTATAGGAATACCTAATAATATAAAATATTTAAAA 2460 
G Y TN NY H L CI G I P N N 1K Y L K 
CATCCTACGAAAATTATAAAAACATGGTTAACATATGATCAGAAAGATTTAGATTATAAT 2520 
HP T 	IlK T W L T Y D Q K DL D 	N 
Primer H4253 -----> 
GGAAGTTGTAGTGATATGGAATTGAATGAATATAATACTACTAATAATATGTCTTATAAT 2580 
G SC S D M EL NE Y NT TN N MS Y N 
2640 
NY 1K YIN El T L 	K K N IN PT E 
CTGTTTCAAAATGAATATACTTATTTTGGTTATTATGAAGGTCGTTTTATA 2700 
L F Q NE Y P Y F G Y YE E El EN F I 
<-----Primer H4252 
TATAATATAGTAATAATGAATAATATTATAAATTGGTGTCATTTACAAAATTTATTAAAA 2760 
Y NI VIM N Nil NW C H L Q N L L K 
AAAAAA.AAAAACTTT 2775 
K K K N F 
Figure 5.4: Amino acids comparisons of the P. fakiparum 12fRCC1 protein with the other eukarvotic RCC1 proteins. 
Sequence alignment of pfRCC1 with human RCC1 (Ohtsubo et al, 1987), Drosophila BJ1 (Frasch, 1991), S. cerevisiae 
SRMI (Aebi et al., 1990) and S. pombe Pimi (Matsumoto and Beach, 1991). The figure is derived from an analysis 
performed with the PILEUP alogrithm (Feng and Doolittle, 1987). Dots indicate gaps introduced to maximise the 
alignment. The amino acids within the seven conserved repeats are boxed in and their positions are numbered I-Vu. 
Numbers to the right of the sequence refer to residue position of the pfRCC1 protein (Clone ClO). 
1 	 40 
Rccl 	 • MSPKRI AXRRSPPADA 
BJl .......... .......... .......... .......... .......... ..... MPRRK ALTNNNNAGE 
SRM1 	.......... .......... .......... .......... .......... .... MVKRTV ATNGDASGAH 
pimi .......... .......... ......... M TSNRSTRSST KREEVSKNGV EKBELDESDV MKNGK.KPVK 
RccPf 	 KEKLYSNIKE NDNKHDWFTT 
41 	 I 	 110 
Rccl 	I .... PKSKK VKVSHR.... SH .... STEP GLVL[G1QGD VGQ1LLGENV ME ......RK KPALVSIPED 
BJ1 AEQQPPKAKR ARIAFBLELP KR... .RTVL GNVLIVCGINGD VGQILGILGEDI LE ......RX RLSPVAGIPD 
SRM1 RAXKMSKTHA SHIIN.AQED YKHMYLSVQP LDIFICWGITGS MCEILGILGPLA KNKEVKRPRL NPFLPRDEAK 
pimi RAXVSSLPKP VRVPGSAXRI NKIPELPTER LNVYIVFGISGS MNEILGIMGEEE MD.VVYRPRL NPILSTDKVG 
Pf 	FPMKIVFPKK NTKIKFISCG DMHTLAICTG GVLYtSWGIYNN FGC[]NGTNQ NVYEPTPIFL EPHSVDNNGD 
111 	 II 	 180 
Rccl VVQAEA .... .......... 	 .......... 	 ......... IG 	GMHjTVCLSKS IGQVYISFGICND EGArI1RDTS. 
BJ1 AVDISA .... .......... 	 .......... 	 ......... IG 	GMHINLVLTKS IGDIYISFGICND EGAILGIRDTS. 
SRM1 IISFAV .... .......... 	 .......... 	 ......... IG 	GMHITLALDEE ISNVWISWGICND VGAILGIRDTSN 
pimi VVDLAV .... .......... 	 .......... 	 ......... IG 	GMHISAALLBD IGRVYITWGIVND DYAILGIRLTKD 
Pf NNDDDYDDDN NNNSTYKFHK KEDSIKWDKK KNVVIHCSAIG_SKH]SLACNLH  IGDIYISWGIY NGR[JLGN.. 
181 III 	250 
Rccl .......... 	 . VEGSEMVPG KVELQE .... 	 .......... 	 ... KVVQVSA 
______ 
IGDSHITAALTD DIGRVFILWGISF 
BJ1 .......... 	 . EDGSESKPD LIDLPG .... 	 .......... 	 ... KALCISA IGDSHISACLLE DIGRVFIAWGISF 
SRN1 AKEQLKDMDA DDSSDDEDGD LNELESTPAK IPRESFPPLA EGBKVVQLAA ITDNMISCALFS NIGEVYIAWGITF 
pirnl QK ........DENGDKVDND L. .LEGTPSK VE.GALSHL. 	. . .RVTKVIC ISDNLITAAITD NIGCCFITWGITF 
Pf .......... 	 .......... 	 ....... IKS YNKPQLIKGL RNKRILYVCA LGTSBISGCIDS NIYYVYLPWGING 
251 Iv 320 
Rccl RDNNGV]I]LL EPMKKSMVPV QVQLDV.... PVVKVASIGND HILVMLTADIGD LYITLGICGEQG Q......... 
BJ1 RDSHGNIMGILT IDGNX.RTPI DLMEGT.... VCCSIASIGAD RILvILTTAIGK VFITVGICAEQG Q......... 
SRM1 RCNEGIILGIFY Q.DKIKIQKT PWKVPTFSKY NIVQLAPIGKD HIILFLDEEIGM VFIAWGINGQQN Q......... 
piml RCSDGVILGIYS DSQKRTAEPT QMRLP..... EICQLATIGTD HIIIALTTTIGK VYITWGINGQQF Q......... 





....... 1I1R VPELFANRGG RQGLERLLVP KCVMLKSRGS .......... 
BJ1 .......... .......... 	 ....... ILGIR 
LSERSISGEG RRGKRDLLRP TQLIITR ... 	 .......... 
SRM1 .......... .......... 	....... ILGIR .......... 	
..... KVMER 	FRLKTLDPRP 	.......... 
piml .................... ....... ILGIR .......... 	
..... RMLER RRLQGLTPQP 	.......... 
Pf LPKQINTNYK CISIHASTYV CFGITL.IVGID 











______ 	 ______ 	
V 	____ 	530 
.......... 	... RGRVRFQ DAFCIGAYFTF A.ISHEIG1 [1LSNYHQIL GI . . .TPGTES 
BJ1 .......... .......... 	..... PXPFE AIWAITNYCITF MRESQTIQVIWI 	
IATGILNNFKQIL AI ... HETKGK 
sRM1 .......... .......... 	... FGLRRVK YIASIGENHICF A.LTKDINKLVI 	
ISWGILNQFGQC GIVS.EDVEDG 
piml ...... .... .......... 	... LALKNII SVGAIGSYHISF A.IDNKIGRVYI 	
IAWGILNITRQIC GIEVEDEEEG 
Pf NNDNYYTYDN INGSHGNIFE KNKLVLKSKV KIIDIGSDH IFS VFLLESIGKVY] 	I_JYNKNGEIL_GjNGEFNLKKK 
531 VI 
600 
Rccl CFIPQNLTSF KNSTKSWVGF SG[GQHHjTVCM DSEIGKAYIS1 	RAEYGR11LG E. .G............. 
AEE 
BJ1 EF ... ALTPI KTELKDIRHI AGIGQHHITVIL TTDILKCSIVVGI 	RPEYGRILGILG D. .V............. 
KDV 
SRM1 ALVTKPKRLA LPDNVVIRSI AAIGEHHISLIL SQDIDDLYISCGI RLDMFEIVGIIP K. .DNLPEYT 
YKDVHGKARA 
pirni AVITKPTLVD ALEGYNVKSI TGIGEHHITLAL LEDIGRVLIAWGI RDDRHQILGIIP D. .NALPETV 
VKDEKGNNYY 
Pf FGVPILLNIC VNKIIKIAC. 	. .!GYNYjVLCV SDVIGLVYIGWG 	KNDKSQLJIG VIKDFYEPVH 
VKNLTNVINI 
601 VII 670 
Rccl KSIPTLISRL PA.VSSVACIG ASV1GYAVTKD ... 1WfX1 MGTNY. .Q[1 TGQDEDAWS. PVEMMGKQLE 
BJ1 VEKPTIVKKL TEKIVSVGCIG EVCISYAVTID ... IGKLYISWGI 	SGVNN. .QILGI 	VGDGDDELE. PIVVVSKNTQ 
SRM1 VPLPTKLNNV P.KFKSVAAIG SHE ISVAVAQN ... IGIAYISWGI 	FGETY. .AIVGI 	LGPFEDDTEV 
PTRIKNTATQ 
piml LSTPTIIPGL T.NVIQVVCIG THE INLAVTSD ... IGKVYISWGI 	SAENY. .EIVGI 	QGDNDEDVAV PTLVRSKAIK 





NRvvLsvssrG GQHITVLLVKD KEQS . 
BJ1 GKHMLLASGIG GQHIAIFLVKA DKQDQKENVP VXVSGSSSIS KKDKTPPQDN VDKEAENVDK QEQKENLPAX 
SRM1 DHNIILVGSIG GQFISVSGGVX LSDEDAEKRA DEMDD ................................... 
pimi EVAIRVAGAIG GQFISIIAGIP NASEEPVANG IKSEPENEKK LKTEETSKTD DSPVTDAKPD VTSNGEPSTA 
Pf YKCSL.... [QNSH]SLFLTNT NELYVCGSNN NGRLGLFEKS KNVCNIVSVP TKVILHNNIY IKDILAGNTY 
741 810 
Rccl 
BJ1 ASTSSKKNKT PPQDNADKEA ENADKQEQKE NLPAKASTSS KKIKTPPQDD AAEEVEEESA QEPTPKKAXK 
SRM1 
piml TSDSKDSDLE 	PSSTTA .... 	 .......... 	 .......... 	 .......... 	 .......... .......... 












Pf LKHPTKIIKT WLTYDQKDLD YNGSCSDMEL NEYNTPNNMS YNNYIKYINE ITLVKKNINT TELFQNEYTY 





Pf FGYYEEEIEN FIYNIVIMNN IINWCHLQNL LKKKKNF 
Table 5.2. Sequence homology of RCC1 proteins. 
The figure shown are the percent identities from pairwise comparison between the following organisms: P. 
falciparum (this study), human (Ohtsubo et al, 1987), D. melanogaster (Frasch, 1991), S. cerevisiae (Aebi et al., 1990) 
and S. pombe (Matsumoto and Beach, 1991). 
N.B. The figures were calculated by expressing the number of identities as a percentage of the total number of amino 
acids in the non-P.falciparum RCC1 in each case. 
P. falciparum 	Human 	D. melanogaster S. cerevisiae S. pombe 
P.falciparum 100 	 10 	 11 12 13 
Human 100 	 26 16 16 
D. melanogaster 100 15 17 
S. cerevisiae 100 26 
S. pombe 100 
Figure 5.5 
Schematic diagram showing the conserved repeats within the RCC 1 proteins. Consensus amino acids sequences at the 
start and end of each repeat are shown below the diagram. 
repeat I 	II 	III 	IV 	V 	VI 	VII 
5.4.5 RNA expression of the P. falciparum RCC1 gene 
In order to determine the size of the message and level of expression of pfrccl 
during the life cycle, Northern blots were probed with a specific probe from the pfrccl 
gene. Total RNA was isolated from synchronous cultures of different stages of the 
parasite using the method of Chomczynski and Sacchi (1987), as described in method 
2.2.20.1. The RNA was separated by gel electrophoresis (see method 2.2.20.2), 
blotted onto Hybond-N (method 2.2.20.3) and probed with a 1.2 kb fragment from 
clone CIO, washed and autoradiographed. As an internal control the same filter was 
stripped and probed with the P. falciparum actin specific probe (Wesseling et al., 
1989). 
The pfrccl was found to hybridise to one major band of approximately 8.5kb. 
The strongest signal was observed in the early trophozoite stage RNA lane (Fig. 5.9). 
The hybridisation signal was very weak in the schizont stage, and no signal seen in 
the ring and gametocyte stages lanes even longer exposures. 
5.4.6 Expression of pfRCC1 into pGEX vector 
In an attempt to raised polyclonal antibodies against the pfRCC 1 protein, a 
450bp pfrccl fragment was cloned into the BainHI/EcoRI digested pGEX-3 
expression plasmid as described in method (2.2.22.4). After transformation with the 
appropriate E. coli strain, three colonies were sequenced to confirm that constructs 
were in frame with the pOEX vector. However, after several rounds of induction 
these constructs failed to induced the expected protein even though the insert was in 
frame with the fusion protein sequence. 
5.5 Discussion 
P. Jalciparum, in common with probably all eukaryotic cells, does have a 
RCC1 gene homologue. The most striking feature emerging from the analysis of the 
cDNA clone (CIO) is that it predicts a size of the protein much larger (more than 117 
kDa) than that of any previously described RCC1 species. The seven conserved 
repeats which are constant feature of the RCC1 molecule are all found in the putative 
P. falciparum RCC1 (pfrccl) gene product and their order is also conserved. Each 
repeat is about 50-60 amino acids long, except for the fourth domain which appears 
to be longer ( about 120 amino acids). Increased size of the fourth repeat has also 




Southern analysis of pfrccl gene. 
A. An autoradiograph demonstrating that pfrrcl is a single copy gene. 
Genomic DNA from P. falciparum was digested with various enzymes, resolved, 
blotted and hybridised with pfrccl specific probe (cDNA clone C10). The enzymes 
used were: (Lanes 1-12): AccI, Bgl II, Sau3A, MspI, XhoI, Dral, Hincil, HindIll, 
Alul, Hinfi, XbaI and NheI. 
The DNA molecular weight marker is indicated in kb. 









Restriction digestion analysis of pfrccl gene for polymorphism among different P. 
falciparwn isolates. 
DNA prepared from 4 isolates (clone 102/1 a Sudanese isolate, T9194 and T9/96 Thai 
clones, and 7G8 a Brazilian isolate) were digested with four restriction endonucleases, 

















Figure 5.8: Chromosomal location of P. falciparum pfrccl gene. 
A. Left panel is ethidium bromide-stained chromosomes from different P. 
falciparum clones (clones: 3D7, Dd2, T9/94, and 102/1, 10511, 106/1) separated on 
0.8% agarose gel, blotted and probed with pfrccl specific probe (right panel). The 
signals obtained from all these clones were localised to chromosome 5. Size 
polymorphisms between different isolates can be seen in this chromosomal blot. 
B. Panel (I). Ethidium bromide-stained gel of chromosome from P. falciprum clone 
10511 and clone 106/1 separated on 0.8% agarose gel, blotted and probed with pfrccl 
fragment ClO. Panel (II) is an autoradiograph of the gel. The gene was found to be 
mapped to chromosome 5. As a further confirmation, the same blot was stripped and 
probed with pfindr-1 probe, a known chromosome 5 marker (Foote etal., 1989). This 
gave a signal in the same position (data not shown). 
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Figure 5.9: Northern blot analysis of pfrccl. 
Right panel is an autoradiograph of total RNA from synchronised culture of 
gametocytes (lane G), rings (lane R), trophozoites (lane T) and schizonts separated on 
1.2% denaturing formaldehyde gel, transferred to Nylon membrane and hybridised to 
pfrccl specific probe. The same filter was stripped and reprobed with P. falciparum 
actin gene as a control. The sizes of RNA markers are indicated in kb. 















In all RCC1 proteins so far identified, the N-terminal region outside the 
conserved repeats consists of positively charged amino acids. Similar amino acid 
sequences have been observed for the P. falciparum RCC1 homologue. Deletion 
mutagenesis has demonstrated that the basic N-terminal region outside the repeats is 
necessary for the human RCC1 protein to bind to DNA directly and that this region is 
also important for efficient transport in the nucleus (Seino et al., 1992). However, it 
has been shown that even in the absence of these residues, RCC1 retains a partial 
function in preventing premature chromosome condensation (PCC) in tsBN2 cells 
and in restoring DNA replication in RCC 1-depleted Xenopus extracts (Dasso and 
Newport, 1990; Dasso et al.,1991). 
Approaches to obtain the full coding length of the RCC 1 malarial homologue 
have not been successful. However, the sequence homology of clone CIO to the 
gene products of RCC1 from human, Drosophila and yeast containing the seven 
repeated motifs domain characteristic of the pfRCC1 polypeptide is highly significant 
and strongly suggest a conserved function for these genes. Immediately following 
the repeated domains, Clone ClO has a C-terminal extension which is 290 amino acids 
long. C-terminal extensions have been reported in other P. falciparum proteins such 
as DNA polymerase a (White et al., 1993). The Drosophila homologue, BJ1, also 
contains a C-terminal extension of 130 amino acids which is composed of a cluster of 
glutamic acids, followed by a lysine-rich sequence (Frasch, 1991). Although RCC1 
proteins from vertebrates and yeast lack the C-terminus extension, monoclonal 
antibodies binding to the BE C-terminus react with other RCC1 proteins from these 
species. It has been suggested that the glutamine-rich stretch near the C-terminus of 
BJ1 might be a histone-binding region because motifs with similar sequences have 
been found in nuclear proteins from Xenopus, particularly in the histone Hi-like 
protein B4 and the histone-binding proteins N1/N2 and nucleoplasmin (Frasch, 
1991). However, the C-terminus extension of the pfRCC1 partial sequence has no 
homology to any such proteins in the data-bases. Raising specific antibodies to the C-
terminal region of pfRCC 1 can be used for various biochemical studies such as 
histone-binding activity and this will help to elucidate the function of such long C-
extensions in this molecule. 
It has been suggested that BJ1, the Drosophila homologue, has evolved from 
two ancestral sequences by a duplication event, with the C-terminal repeats of more 
recent origin. The larger size of clone ClO and presence of the C-terminal extension 
might also suggest the same for the pfrccl homologue. Gene duplication is a known 
phenomenon in malaria parasites. A good example of an ancient duplication that 
resulted in the evolution of two gene products performing different but related 
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functions is the ribosomal RNA genes (Gunderson et al., 1987; McCutchan et al., 
1988). Another example of duplicated genes is the histidine rich proteins (1-IRPII and 
HRPIII) (Wellems et al., 1987). It has been suggested that the duplication of genes 
allows the organism to evolve into a more complex state to deal with environmental 
pressure or to develop an advantage in survival (MaConkey et al., 1990). For 
example, it has been suggested that gene duplication may arise in Plasmodium as a 
response to selective pressures e.g. the duplication of gene encoding dihydrofolate 
reductase-thymidylate synthase DHFR-TS in some pyrimethamine resistant strains 
(Inselburg et al., 1987). 
The size of the transcript of the pfr ccl gene is found from Northern blot 
analysis to be approximately 8.5 kb. This is three times larger than the size of 
sequenced clone CIO which possibly encodes the bulk of the P. falciparum RCC1 
sequence. This large transcript of the pfrccl gene might be explained by the 
possibility of the existence of a long 5' untranslated region (5'UTR) in the gene which 
has been observed in many P. falciparu,n transcripts (Levitt, 1993, Sultan et al., 
1994). In addition, identification of such a long C-terminus extension indicated that 
there might be more coding sequence in this region. Work to obtain the full coding 
sequence of the P. falciparum RCC 1 homologue is under way in our laboratory. 
From the Northern blot analysis carried out on the stage specific RNA of the parasite, 
it was observed that the level of expression is high at the trophozoite stage. There 
were no signals observed for RNA from ring and gametocyte forms. This result 
indicates that the steady state expression of pfrccl mRNA is developmentally 
regulated, and that RCC1 protein is probably required during nuclear division of the 
parasites. This result is consistent with the data from Xenopus and Drosophila. In 
Xenopus oogenesis and early development, RCC1 protein and mRNA are both very 
abundant, with the mRNA declining during the adult stages, a result which indicates a 
requirement for the protein in the nuclei of the early embryo (Nishitani et al., 1990). 
In Drosophila, BJ1 mRNA levels are high in oocytes and the maternally expressed 
mRNA is abundant through the first two hours of development, after which total BJ1 
mRNA levels decline rapidly (Frasch, 1991) 
To understand better the function of the pfrccl gene product in P. falciparuin 
antibodies raised against the protein are needed. This will help to localise the protein in 
the parasite and see whether the pfRCC1 antibodies co-precipitate the pfRan protein, 
as it has been the case with the human antibodies against the RCC1 protein. In 
addition, obtaining the full coding sequence of pfrccl gene will help in understanding 





The aim of the work presented in this thesis has been to attempt to begin to 
understand the molecular mechanisms that regulate the parasite cell cycle during the 
intra-erythrocytic proliferation of the human malaria species Plasmodiumfalciparum. 
In this study two genes known to be involved in cell cycle regulation in other 
eukaryotes have been cloned and partially characterised. It was hoped that studying 
the functions of the proteins encoded by these two genes would help elucidate the cell-
cycle pathways which the parasite undergoes in infected erythrocytes. Although it is 
perhaps more often said than done, such pathways could present alternative targets for 
anti-parasite therapeutics. 
6.1 pfran and pfrccl are the homologues of their namesakes. 
In an attempt to identify and study proteins that are known to be important 
regulators of the cell cycle in better studied, higher eukaryotes, the P. falciparum 
homologue of the Ras-related nuclear protein RanITC4 has been isolated and 
sequenced (Sultan et al., 1994). The predicted protein sequence of pfRan is 214 
amino acids long and contains the GTP-binding motifs found in all the Ras 
superfamily of GTPases. PfRan has around 70% amino acid identity with other 
RanITC4 proteins. These two features are significant enough to admit pfRan as a 
member of the small GTPase protein superfamily and almost certainly the RanITC4-
type subfamily. It has been shown recently that the P.falciparum recombinant PfRan 
binds GTP in a similar way to other Ras-like proteins (Dontfraid and Chakrabarti, 
1994). This further strengthens the argument that pfRan is a GTPase. A second 
protein that has been isolated as a complex with RanITC4 and shown to stimulate its 
rate of nucleotide exchange in vitro, is the RCC1 protein (Bischoff and Ponstingi, 
1991a). I have isolated and sequenced a 3.0kb cDNA clone encoding a protein 925 
amino acid in length. Sequence comparison with other RCC1 proteins has shown that 
the clone encoded a protein with significant homology to the other family members 
especially in regard to the organisation of the seven conserved, approximately 60 
amino acids, repeats. Although the ends of the gene have not yet identified, the high 
level of sequence and repeat organisation conservation make the argument that this 
gene is the Plasinodiumfalciparuin homologue of the RCC1 gene quite convincing. 
A striking feature of the Plasmodium falciparum RCC1 gene is its long C-
terminus extension following the conserved repeats. Although this region has no 
significant homology to other protein so far found, this could change as the complete 
sequence emerges. The BJ1 Drosophila homologue has a similar extension at the C-
terminus, which has some homology with histone 113  and the Xenopus nucleoplasmin 
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proteins B4 and N1/N2. This has led to a suggestion that it might be the histone-
binding region (Frasch, 1991). 
6.2 What do Ran and RCC1 do in eukaryotic cells? 
All the diverse RCC 1 homologues are abundant nucleosome bound proteins 
found within the nucleus during interphase (Frasch 1991) yet disappearing or 
degraded at mitosis. Although different genetic screens were used to isolate the 
different types of RCC1 mutant in different organisms, the mutations appear similar. 
The mutants show chromosomal instability, DNA synthesis defects and often a 
decrease in overall protein and RNA synthesis and nuclear transport. In vitro 
mutagenesis studies have proved that the basic amino terminal region is essential for 
human RCC1 to directly bind DNA (Seino et al, 1992). Although RCC1 is expressed 
in all dividing mammalian cells its expression is not tightly coordinated with the cell 
cycle and it is possible that post translational modifications regulate RCC1 activity 
during the cell cycle. 
The interaction between RCC1 and Ran has been confirmed genetically by 
Matsumoto and Beach (1991). They first isolated RCC1 as a premature mitosis mutant 
and then isolated Ran as a multicopy plasmid supressor of these premature mitosis 
mutants. However, Bischhoff and Ponstingl (1991a) noted that while auto-immune 
serum co-precipitates RCC 1 and Ran there is a 25 fold exess of Ran over the (quite 
abundant) RCC1. Ran is in fact extremely abundant (0.36% of total HeLa cell 
protein, 100 x more abundant than Ras protein), and this high concentration appears to 
be strictly required in that S. pombe mutants with one half normal amount of Ran have 
severe defects in nuclear structure and cell cycle regulation. 
Additional functions accounting for this puzzling excess of Ran have been 
proposed by Moore and Blobel (1994). They showed that two cytosolic fractions 
(fraction A and fraction B) from Xenopus oocytes were sufficient to support protein 
import into nuclei of digitonin-permeablised cells. Fraction A was necessary for 
recognition of the nuclear localisation sequences (NLS), whereas fraction B mediated 
the subsequent passage of bound substrate into the nucleus. After purification, two 
interacting components were found to be required for full activity of fraction B, and 
one of these components was the 25kDa Xenopus homologue of RanITC4. This 
strongly supports a role for Ran in nuclear import and micro-injection studies have 
indicated that molecules such as Ran are capable of diffusing through nuclear pores 
followed by nuclear binding (Forbes, 1992). There is a known intra-nuclear binding 
site for Ran i.e. RCC1. However, Ran does not contain consensus nuclear 
localisation sequences (NLS). Such sequences are composed of either a short stretch 
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of basic amino acids or two basic domains separated by about ten amino acids 
(Dingwall and Laskey, 1991). The large excess of Ran over RCC1 still seem to leave 
the question of why Ran is primarily intra-nuclear with an unsatisfactory answer. 
Ran and RCC1 seem to be involved in every aspect of nuclear structure and 
function that is examined in detail and it would be possible to quote recent hypothetical 
models for their role in eukaryoyic cell biology at even greater length. However, one 
view, from a leading cell biology laboratory, is that the extremely pleiotropic effects of 
Ran or RCC1 disruption stem from their key role in intra-cellular import/export 
pathways (Moore and Blobel 1994). The observed effects on the cell cycle are then 
explained by the disruption of transport of critical substrates that coordinate and 
catalyse cytoplasmic and intra-nuclear events. However, in the absence of any real 
evidence of what kind of cell cycle Plasmodium falciparum has, it is wise to curtail 
further speculation and complete a discussion of the actual data gathered here which 
might help understand pfRan and pfRCC1 function. 
6.3 When and where are pfRan and PfRccl expressed in Plasmodium 
falciparurn? 
Transcription of the pfRan gene is strongly up regulated around the period of 
trophozoite development (i.e. around 24 hours after invasion). The parasites spend 
between 6-10 hours in the trophozoite stage then move into schizogeny around 30-34 
hours post invasion. Northern blots indicated that steady-state levels of pfran were 
low in rings, high in trophozoites and schizonts and very low or absent in 
gametocytes. Assays of actual transcriptional activity (nuclear run-on) tend to confirm 
that these steady-state levels also represent ongoing transcription since pfran RNA was 
only found in the nuclei from trophozoite and schizont stages. The steady state levels 
of pfran RNA reach a peak at the trophozoite and schizont stages that is, when DNA 
synthesis occurs during development of the parasite in the host cells. This is 
consistent with a requirement for Ran protein during S-phase of the cell cycle as 
established in other eukaryotes (Bischoff and Bonstingl, 1991b; Matsumoto and 
Beach, 1991). 
In contrast to other GTPases of the Ras superfamily which play a wide variety 
of roles in the cytoplasm, Ran/TC4 has been shown to be the only member of the 
Ras-superfamily of the small-GTP binding proteins to be localised primarily inside the 
nucleus (Bischoff and Ponstingl, 1991a). Ran/TC4 represents 0.36% of the total 
protein in HeLa cells and about 80% of this is nuclear-localised (Bischoff and 
Ponstingl, 1991b). Western blotting with anti-Ran antibody was not carried out on 
protein extracts from synchronised cultures. The relative accumulation of pfRan 
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protein during the intra-erythrocytic cycle was not therefore confirmed in this way. 
However, immunofluorescence staining of the morphologically distinct forms with 
anti-pfRan antibody revealed a somewhat surprising result. Distinct and specific 
fluorescence indicate the presence of pfRan protein in both the nucleus and cytoplasm 
of ring forms. Similar fluorescence pattern indicates the presence of pfRan in both 
early trophozoites, late trophozoites, and schizonts. In all of these stages fluorescence 
is not confined to the nucleus but distinctly present in both nucleus and cytoplasm. 
These observations are consistent with function of pfRan in 'trafficking' RNA 
between nucleus and cytoplasm (Moore and Blobel, 1994). 
In addition, the IFA results has shown that pfRan protein is present in all 
stages (sexual and asexual) of the parasite in approximately equal amounts. However, 
the Northern blot analysis has shown that the highest amounts of pfran mRNA are 
present during the trophozoite and schizont stages with much lower message levels 
present during the gametocyte and ring stages. Antiserum raised against pfRan 
recognised a major band of 27 kDa predominantly in the asexual stage extracts 
although a very weak band in the protein extracts from gametocytes was detected in 
Western blots. 
Less work has been carried out on.pfRccl and I do not yet have an antibody 
against this protein. RNA expression studies have shown that the pfrccl is expressed 
mainly during the trophozoite stage. This might suggest that this gene is required, in 
association with the pfran gene, somehow during the DNA replication which peaks at 
the late trophozoite of the life cycle of the malaria parasite. 
The apparent abundant quantity of pfRan in gametocytes, probably in both 
sexes but certainly abundant in male gametes (Chapter 4, Fig.4. 10) are slightly 
puzzling in view of the low or absent levels of pfran gene transcribed in these stages. 
The conclusion must therefore be that the protein was accumulated in the earlier stages 
of gametocytic development before morphologically distinct gametocytes appear. The 
protein could be present in both the sexual and asexual stages but performing different 
functions during the different developmental stages of the parasite. Since the IFA 
showed that the pfRan protein is present throughout the intra-erythrocytic cycle of the 
parasite its GTP versus GDP bound status or possible post-translational modification 
may be the mechanism that regulate the in vivo activity of the pfRan protein. If pfRan 
serves a true cell cycle-regulatory role in malaria parasite, one would expect such 
changes to occur in association with DNA replication and /or mitosis. Chromosomal 
DNA replication in P. falciparum starts in trophozoite stage (Gritzmacher and Reese, 
1984; Inselburg and Banyal, 1984) and is followed in schizogony by four or five 
rapid rounds of mitosis and DNA synthesis, finally yielding a schizont containing 16- 
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32 merozoite, each with a single nucleus. However, even individual schizonts, despite 
their syncytial nature, rapidly lose synchrony of division (Read et al., 1993), so 
analysis of the role of any postulated cell cycle regulatory molecules in the actively 
dividing schizont will probably require an expanded panel of antibodies against 
proteins known to play key roles in the eukaryotic cell cycle. 
6.4 Future work 
Two evolutionarily conserved genes, pfran and pfrccl that are proposed to 
function in regulation of the cell cycle in eukaryotes, have been isolated and 
characterised in P. falciparum during the course of this study. Work is underway to 
complete the missing part of the Pfrccl gene sequence and to raise antibodies to this 
protein for further analysis. The RCC1 protein has been shown to bind chromatin in 
other eukaryotic cells probably with a strict one RCC 1 molecule to one nucleosome 
ratio. Therefore, antibodies against the pfrccl would be very helpful in understanding 
the precise events during mitosis. In addition, functional complementation experiment 
might be performed on S. pombe pimi mutants to elucidate its role in the cell cycle. 
The aim of cell cycle control studies in malaria parasites should be try to 
understand the mechanisms that regulate parasite development. This will be without 
any doubt a useful approach to a rational chemotherapy, perhaps by identifying key P. 
falciparum specific cell cycle events. 
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threat to health than Edge Hill virus itself. Two mono-
clonal antibodies, 1137 and 4G2. which react with epi-
topes common to Edge Hill and dengue viruses, en-
hanced infection of a human monocvtic cell line (U-937) 
by dengue virus (HENCHA[. etal., 1985. Most isolations 
of Edge Hill virus have been made in the north-east re-
gion of Australia (DOHI(RT)', 1972 1 where dengue 1 ap-
pears to have become endemic and the first cases of 
dengue 2 infection for almost 50 years were diagnosed in 
1992. 
Apart from drawing attention to the possibility of 
clinical infections with Edge lull virus, this report raises 
2 other significant issues. Diagnostic laboratories which 
do not routinely test for antibody against Edge Hill virus 
should he aware of the close serological relationship be-
tween it and dengue 2, even in 1gM assays which are 
often virus specific (ScoTT ci al.. 1972), and consider-
ation max' need to be given to the possibility of antibody 
against Edge Hill virus enhancing subsequent dengue in-
fections in residents of areas where only a single dengue 
serotype is in circulation. 
We thank Drs Madden and Chew for providing clinical data 
and Jenny Haig and Christine Aitken for excellent technical as-
sistance. This studv was supported, in part. bv a donation from 
Dr T. B. Lynch, Rockhampton. 
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Abstract 
We have isolated 20 clones of Plasmodiumfalciparum from isolates from patients attending a village clinic in 
Sudan during 10 d in October—November 1989. The clones were genetically diverse, having highly variable 
molecular karyotypes and a wide range of drug responses. Chloroquine-sensitive (50%  inhibitory concentra-
tion [ICso] in the 4-15 nM range) and chloroquine-resistant clones (IC50 in the 40-95 nM range) co-existed in 
the population, but no obvious amplification of the P-glycoprotein homologue gene, Pghl (previously 
known as the multi-drug resistance gene, mdrl) marked the chloroquine-resistant clones. Chioroquine re-
sistance was reversible by verapamil in these clones, although they varied in their susceptibility to verapamil 
alone. These observations indicate that the biochemical characteristics of the Sudanese chloroquine-resistant 
P. falciparum are similar to those reported from south-east Asian and Latin American isolates, which is con-
sistent with there being a similar molecular basis for this phenomenon. 
Introduction 
Chloroquine is the only antimalarial drug available at a 
cost accessible to even a minority of the Sudanese people 
and as such constitutes the major element of malaria con-
trol in Sudan and similar African countries (PETERS, 
1987). The emergence of chloroquine-resistant Plasmo-
dium falciparum in the Eastern Province since around 
1986 (BAY0uMI et al., 1989) is causing acute problems as 
the episodic, post-rainy season malaria epidemics charac-
teristic of sub-Sahelian Sudan cease to be controlled by 
this drug. 
The mode of action of chloroquine and the mechanism 
of resistance to the drug are unclear, and several oppos-
ing viewpoints exist (HOMEWOOD et al., 1972; KROG-
STAD et al., 1987; GINSBURG, 1988; WARHURST, 1988; 
FOOTE et al., 1990; WELLEMS et al., 1990). Studies in 
vitro on chloroquine resistance in different laboratories 
have made use of different long-term cultured lines of P. 
falciparum originating mainly from south-east Asia or the 
Amazon basin. Conclusions drawn from the analysis of 
such isolates may not accurately reflect the present situ-
ation in an area such as Sudan. Although currently 
spreading rapidly, chioroquine-resistant P. falciparum 
was not reported in Sudan until 25 years after its appear -
ance in south-east Asia and South America, and several 
years after its appearance in East Africa (AL TAWIL & 
AKOOD, 1983). Chioroquine is essentially the only anti-
malarial drug available in most of Sudan, and for econ-
omic and climatic reasons usage has not been as heavy as 
in more prosperous areas with more stable malaria trans-
mission. 
In order to study the genetic basis for the spread of 
chioroquine-resistant P. falciparurn, we have recently 
characterized 29 isolates from a single village in eastern 
Sudan with a developing problem of chloroquine-resis-
rant malaria (BABIKER el al., 1991a, 1991b). Since most 
of these isolates proved to be mixtures of genetically dif -
ferent parasites, we have now obtained cloned lines from 
some of the isolates, in order to define parasite genotypes 
and their biochemical profiles of drug resistance. We 
showed that the clones had highly variable molecular ka-
ryotypes and wide ranges of drug responses. Chioroquine 
resistance is reversible by verapamil, but no obvious am-
plification of the P-glycoprotein homologue gene, Pghl 
(previously known as the multi-drug resistance gene, 
mdrl) marked the chloroq uine-resistant clones. 
Address for correspondence: R. A. Bayoumi, Biochemistry De-
partment, Faculty of Medicine and Health Sciences, U.A.E. 
University, Al-Am, P.O. Box 17666, United Arab Emirates. 
Materials and Methods 
Study area 
The study area in Asar village, 20 km from Gedaref in 
the Eastern Province of Sudan, has been described else-
where (BABIKER et al., 1991b). Malaria transmission is 
seasonal and reaches a peak in October or November fol-
lowing the rainy season. The main Plasmodium species 
present is P. falciparum. Chloroquine resistance was first 
reported in this region in 1986 (BAY0uMI et al., 1989). 
Isolation and characterization of P. falciparum clones 
The initial isolates were obtained with informed con-
sent from villagers attending a local clinic during the Oc-
tober—November malaria season of 1989. Clones were 
obtained using the limiting dilution method (ROSARIO, 
1981), from a selection of isolates known to exhibit a 
range of sensitivity to chloroquine and to pyrimeth-
amine. Certain of these isolates were known to be mixed 
infections by their possession of more than one allele of 
genes for antigens and other proteins (BABIKER et al., 
1991a). Following the cloning procedure, the resulting 
cultures were shown to be pure clones by ensuring that 
each haploid clone was monoallelic for each of 2 highly 
polymorphic antigens (merozoite surface protein [MSP]-
I and MSP-2) when tested in immunofluorescence assays 
with a panel of allele-specific monoclonal antibodies 
(CONWAY & MCBRIDE, 1991). 
Pulsed .field gels 
P. falciparum chromosomes were separated by pulsed 
field gradient gel electrophoresis (PFG) as described pre-
viously (BABIKER etal., 1991b), with a basic regime of 22 h, 
120s pulses, 140 V followed by 22 h, 180s pulses, 140 V, 
and finally 24 h, 300s pulses, 120 V. Southern blotting, 
dot-blotting and hybridization were performed using 
standard techniques (SAMBROOK etal., 1989). 
Measurement of drug sensitivity 
Hypoxanthine incorporation assay. Chioroquine-induced 
inhibition of uptake of [ 3 H]hypoxanthine by the clones 
was measured using the methods of DESJARD1NS et al. 
1979) and GEARY et al. (1983). Tests were carried out on 
unsynchronized cultures, diluted in RPMI medium con-
taining 101/b human serum to 1 9/6 parasitaemia and 1% 
haematocrit, in a final volume of 02 mL in microtitre 
plate wells. [ 3H]hypoxanthine was added to a final con-
centration of SuCi/mL. Chioroquirse sulphate was added 
to final concentrations ranging from 10 to 160 n.s. After 
40-44 It incubation, cells were lysed, washed and har-
vested on to fibre glass filters. Filters were then baked 
and counted in a PPO/POPOP*/toluene  scintillation fluid 
supplemented with 30% Triton X-100. Results were ex-
pressed as percentage inhibition compared to the incor-
poration of label in control wells without drug. The con-
centration of chloroquine which produced 50% 
inhibition of parasite growth (ICco) was obtained from 
the regression line of dosei response curves of parasite in-
hibition plotted against the logarithm of drug concentra-
tion. 
Microscopical determinations. Clones were cultured in 
micromre plates in serial dilutions of chloroquine, meflo-
quine and pyrimethamine in complete RPMI medium 
for 72 h, essentially according to the method of THAI-
THONG et al. (1983). Each well contained 100 uL, at l°h 
parasitaemia and 5% haematocrit. After 72 h, thin blood 
films were made from each well, and the viability as-
sessed by microscopical examination. The results were 
expressed as the minimum inhibitory concentration 
(MIC) which killed all, or nearly all, of the parasites. 
Effect of verapamil 
Drug sensitivity of the parasites to chloroquine, meflo-
quine and pyrimethamine was assessed with and without 
the addition of 1 um verapamil to the cultures. The effect 
of verapamil alone over a wider range of concentrations 
(0-5 [tm) was also tested on some clones. 
Chemicals 
[ 3 H]hypoxanthine (40 Ci/mmol) was obtained from 
Amersham International Ltd, UK; chioroquine sulphate 
(Nivaquine®) from May and Baker Ltd, UK; pyrimeth-
amine from Wellcome, UK; mefloquine from Hoffman 
La Roche, Switzerland; and verapamil from Sigma 
Chemical Company. Glass fibre filters were obtained 
from Titertek.  
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of results were obtained. 
All the clones from a single isolate possessed chro-
mosomes of identical size, as observed in isolate SUD 
111. This suggests that, at the time of cloning, the para-
sites in these samples were of a clonal type, due either to 
a clonal-type infection in the patient or to selection of a 
predominant clone during initial culturing of the un-
cloned isolate. 
The clones of a single isolate varied in the size of 
only one or 2 chromosomes. This was most probably due 
to deletions or accretions in the chromosomes concerned 
during asexual growth in culture of a clonal-type parasite 
(WELLEMS et al., 1988). This was seen in isolate SUD 
105, in which the 4 clones obtained were karyotypicallv 
identical, except that clone 7 had a 300-400 kilobase (kb) 
deletion of chromosome 10, and clones 9 and 11 both 
had 200 kb accretions in chromosome 4. These related 
clones had identical drug sensitivities and possessed the 
same MSP-1 and MSP-2 alleles. 
Several quite different karyotypes were obtained 
from a single isolate. This result can be presumed to have 
been due to the patient's harbouring a mixed infection at 
the time the parasites were obtained. The clones derived 
from patients SUD 106 and 124 illustrate this situation. 
While SUD 106/7 and 106/10 differed from other clones 
of the same isolate, they were identical to each other, ex-
cept in the size of 2 chromosomes. 
Identical clones have never been isolated from differ-
ent individuals, a result consistent with the extremely 
diverse genetic profiles of malaria isolates in general 
(CREASEY, 1990) and in particular the uncloned Asar iso-
lates from which these clones were derived (BABIKER et 
al., 1991a, 1991b). 
An autoradiograph of a Southern blot of gel 1 A probed 
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Fig. 1. Karyotvpie diversity in some examples oIP. Jalciparum clones from Asar village, eastern Sudan. A. Ethidium bromide stained chromosomes separ-
ated on a 0 - 8°o agarose gel using a UiEF electrophoresis apparatus. Seven of the parasites tested are Asar clones. 2 of which. 1121 and 124.11. were not 
included in the study see the Table for the drug sensitivity phenotypes). T994 is a Thai clone. Chromosomes 4 and 5 are marked, and approximate chro-
mosome sizes in kilobases are indicated on the right. B. Alter Southern blotting, gel A was successively probed with gene markers for chromosomes 4 and 5, 
the I'gli I gene and the DHFR gene respectively. The 2 autoradiographs from the same blot have been superimposed before photography for comparison 
and signal intensities are not proportional to gene copy number. 
Results 
Clone characterization 
All the clones were confirmed as pure by their pos-
session of single alleles of MSP-1 and MSP-2, using 
monoclonal antibody typing (results not shown). 
The clones were examined for chromosomes by pulsed 
field electrophoresis. Results for a representative sample 
of clones are shown in Fig. IA. When clones from indi-
vidual isolates were compared, the following 3 categories 
2 ,5-Diphenvloxazole 1 ,4-bis[5-phenyl-2-oxazolyl]benzene 
with the genes encoding the P. falcipar-um dihydrofolate 
reductase (DHFR gene) located on chromosome 4, and 
Pghl located on chromosome 5 is shown in Fig. lB. In 
each clone the DHFR probe always hybridized to the 
fourth smallest chromosome, which, however, differed 
in size among the clones. The Pghl probe hybridized to 
the fifth smallest chromosome in only 2 clones (SUD 
1285 and SUD 128/4). These results illustrate clearly the 
considerable size polymorphism of these 2 chromosomes, 
especially of chromosome 5, among this group of iso-
lates. 
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Although there were differences in the relative intens-
ity of hybridization of the probes shown in Fig. 1, deo-
xyribonucleic acid (DNA) transfer from pulsed field gels 
is not reliably quantitative and the amount of DNA per 
lane in this gel was not constant. Using more quantitative 
dot-blots and Southern blots of DNA digested with re-
striction enzymes, we have not been able to detect 
DHFR or Pghl gene amplification in DNA samples of 
any of the clones, whether drug-resistant or drug-sensi-
tive. 
Chioroquine sensitivity 
Drug resistance measurements, even with identical 
clones, may show considerable inter-laboratory variation. 
To increase confidence in assessing the drug response of 
a given clone, we have, therefore, employed and com-
pared 2 different assays in this work. ICo values above 
35 nM, as assessed by [ 3 H]h),ypoxanthine incorporation, 
and MIC values of 16x 10 as assessed microscopi-
cally, were taken to indicate clear chloroquine resistance. 
The drug responses of the 20 clones are presented in the 
Table. They are listed in ascending order of ICo values, 
Table. Drug sensitivity phenotypes of twenty P. faiciparum clones 
derived from patient blood samples collected in the village of Asar, 
Sudan, during October and November 1.989 
ChloroquineChloroqum& Mefloquine' Pyrimethamine1 
1C,' MIC' MIC' MIC' 
(X 10 -9.M) (x  to- 7M) (X10 	'M) (M) 
Verapamil No Yes No Yes No Yes No Yes 
Experimental clonesd 
SUD 105/1 4 3 8 4 4 4 i0' lO- 
SUD 10519 6 5 8 4 4 4 iO
7 l0' 
SUD 105/11 7 4 8 4 4 4 1O 10 	
' 
SUD 106/10 7 4 2 2 4 4 10 106 
SUD 105/7 8 4 8 4 4 4 l0' l0' 
SUD 106/9 9 8 4 4 4 4 10 lO 
SUD 106/7 13 4 4 2 4 4 lO s' 10 6 
SUD 106/11 ii 5 4 4 4 4 10 10 
SUD 106/I 15 6 2 2 4 4 10I 10 -6 
SUD 1286 43 10 8 4 4 2 i0 I l0 
SUD 128/4 45 11 8 4 4 2 10 I 10 	' 
SUD 124/8 58 19 16' 4 2 2 10 	' lo-sr  
SUD 128/1 64 18 8 4 4 2 10 	1 io - 
SUD 1236 64 18 16 8 8 8' 10" 10' 
SliD 1246 65 28 16 4 2 2 10 - ' 10' 
SliD 124/1 73 27 16 8 2 2 10' 10.61 
SliD 126/1 83 18 161 1 2 2 10 lO 
SUD 102/I 85 12 16 8 2 2 10 iO 
SUD 12211 92 23 16 4 2 2 10 l061 
SUD Ill/I 95 21 16 8 2 2 10" 10 
Control clones 
31376 8 3 4 2 4 2 10' to 
Dd2' 57 15 16 8 16 8 10 1 10 
'All values are means of 3 or more separate experiments, with ('yes') and 
without (no') verapamil (I tiM). 
'Concentration giving 50% inhibition of parasite growth. 
'Concentration killing all parasites within 72 h. 
'Clones with the same one hundred number before the solidus were 
isolated from a single patient sample. 
'A few parasites were still viable at the indicated concentrations. 
Reduced parasisaemia at the indicated concentrations. 
'Control' chloroquine-sensitive and chioroquine-resistant clones. respec-
tivelv, 
with the chioroquine-resistant Dd2 and chioroquine-sen-
sitive 3D7 laboratory-adapted clones as reference con-
trols. 
On the whole, the 2 tests of sensitivity in vitro to chlo-
roquine gave comparable results. No clone with an MIC 
of 16< 10 7M chloroquine had an IC50 <50 nM Simi-
larly, no clone with an 1050 value <35 nt has an MIC 
>8'X l0-7M.  Certain ambiguities remain, in that some 
clones of isolate SUD 105 which appeared very chloro-
quine-sensitive in the ICco test, showed intermediate sen-
sitivity in the MIC test. Apart from this, the combination 
of both tests appeared to allow differentiation of the para-
sites into a sensitive group comprising all the SUD 105  
and SUD 106 clones, and a resistant group consisting of 
all the other clones. No clone had chloroqwne sensitivity 
in the ICo range 15-43 rim. 
Resistance to mejioquine and pvrimethamzne 
Most of the clones were sensitive to mefloquine (Table), 
in agreement with the results of tests on the original 29 
uncloned isolates from Asar village (BABIKER et al., 
1991b). Again in accordance with our earlier results, 5 
clones (SUD 124/1, SUD 124/5, SUD 124/8, SUD 123/5 
and SUD 111/1) were highly resistant to pyrimethamine. 
One clone, SUD 123/5, was resistant to both chloro-
quine and pyrimethamine and showed a slight decrease 
in susceptibility to mefloquine. However, none of the 
other clones was resistant to all 3 drugs. Mefloquine re-
sistance is clearly not linked to chloroquine resistance. 
While high level primethamine resistance was found 
only in chioroquine-resis tan t clones, many of the latter 
were sensitive to pyrimethamine. 
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Fig. 2. The effect of I 'ist verapamil on the response of 4 Sudanese and 2 
standard laboratory-adapted P. /alciparum clones to chloroquine. Closed 
circles (, without verapamil; open circles (C), with verapamil. SUD 
105:11, SliD 1061 and 3137 were chloroquine sensitive, SUD 1261I, 
SliD 128'l and Dd2 were chloroquine resistant. Points represent the 
average of simultaneous duplicate experiments. Similar curves have been 
obtained for all clones tested. 
Effect of verapamil 
Verapamil, a calcium channel blocker, has been re-
ported to reverse chloroquine resistance in some isolates 
of P. falciparum (MARTIN ci al., 1987). We tested the ef-
fects of verapamil on our clones (Table) to ascertain 
whether veraparnil reversibility was also characteristic of 
the chloroquine-resistant parasites studied here. 
Examples of drug tests where the capacity of increasing 
concentrations of chioroquine to inhibit [ 3 H]hypoxan-
thine uptake has been measured, with and without the 
addition of I ut verapamil, are shown in Fig. 2. Clones 
SUD 105:11, SUD 106.1 and 3D7 were chloroquine-sen-
sitive. Verapamil did not shift the inhibition curve of the 
3D7 reference control, although it slightly increased the 
toxicity of chioroquine to the drug-sensitive Asar (SUD) 
clones. Clones SUD 1261, SUD 128l and Dd2 were 
chioroquine-resistant, and verapamil clearly increased 
their chloroquine sensitivity, although not to the levels of 
the naturally sensitive clones. 
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VERAPAMIL CONCENTRATION (5M) 
Fig. 3. The effect of verapamil alone on ( 3 H)hypoxanthine uptake over 
40-44 h by 2 Sudanese and 2 standard laboratory-adapted P. falciparum 
clones. Dd2 and SUD 1245 were chloroquine resistant and 3D7 and 
SUD 106,7 were chloroquine sensitive. Points represent the average of 
duplicate experiments carried out simultaneously on the same microtitre 
plate. Three separate experiments gave the same rank order of drug sen-
sitivities. 
It has been reported (MARTIN et al., 1987) that vera-
pamil itself has intrinsic antimalarial activity. An 
example of the effect of verapamil alone on the capacity 
of parasites to incorporate [ 3 H]hypoxanthine is shown in 
Fig. 3. Dd2 and SUD 124/5 were chioroquine-resistant, 
and SUD 106/7 and 3D7 were chloroquine-sensitive. 
There were large intrinsic differences in their suscepti-
bility to the antimalarial effect of verapamil, Dd2 being 
particularly sensitive. 
The sensitivity of some of the Sudanese clones to me-
floquine and pyrimethamine also appeared to increase on 
addition of verapaniil (Table), although to only a limited 
extent. 
Discussion 
In our initial survey of uncloned P. falciparum isolates 
from Asar village, we found that no 2 isolates were gene-
tically identical and that it was possible to detect several 
obviously mixed isolates (BABIKER et al., 1991a, 1991b). 
The molecular karyotypes of the clones derived from 
these isolates have further confirmed the highly diverse 
nature of this small parasite population. Mapping of 
DHFR and Pghl markers on to chromosomes demon-
strates that comparisons of chromosome separations 
stained with ethidium bromide underestimate the true 
extent of karyotypic diversity. More detailed genome 
maps would undoubtedly reveal more radical differences 
in genome organization between these clones which, it 
should be emphasized, represent only a small sample of 
the total population of P. falciparum in this small com-
munity. 
In general, our results indicated that the biochemical 
characteristics of the Sudanese chioroquine-resistant P. 
falciparum are similar to those reported for south-east 
Asian and Latin American isolates, and are consistent 
with there being a similar molecular basis for the phe-
nomenon. The use of genetically pure clones from the 
1989 transmission peak permitted a clearer differentia-
tionof some of the characteristics of the drug resistant P. 
falciparum in this village, as follows. 
(i) clones of P. falciparum exhibiting low, intermediate 
and high level chloroqujne resistance co-existed with 
highly sensitive parasites in the population of this village. 
The reversibility of chioroquine resistance of P. 
falciparurn by verapamil (MARTIN et al., 1987) also ap-
peared to be characteristic of the chloroquine resistant 
malaria currently spreading in Asar. However, verapamil 
has an antimalarial effect of its own, as shown by MAR-
TIN et al. (1987) and in our work. The addition of vera-
pamil increased the sensitivity of these clones not only to 
chioroquine but also, in some instances to mefloquine 
and pvrimethamine. 
The Pghl gene has been reported to be amplified 
in some, but not all, chioroquine-resistant P. falciparum 
isolates (FooTE etal., 1989). However, we have not been 
able to detect Pghl gene amplification in DNA samples 
from either chioroquine-resistant or chloroquine-sensi-
tive Sudanese P. falciparum clones. 
In accordance with our earlier findings with the 
uncloned isolates, 5 clones were highly resistant to pyri-
methamine. This result is of interest, since pyrimeth-
amine was not widely used in Sudan before 1986. Since 
then, however, Fansidar (pyrimethamine/sulfadoxine) 
became available through relief agencies. This may ex-
plain the appearance and selection of mutants resistant to 
this drug. It may also be relevant that clinical pyrimeth-
amine resistance was noted in Sudan as early as 1954 
(PHILLIPS, 1954) and, more recently, in the Sennar re-
gion (IBRAHIM etal., 1991). Only a few parasites in this 
and our previous survey (BABIKER et al., 1991b) showed 
any degree of resistance to mefloquine. 
In the survey of the uncloned isolates, some were 
found to exhibit resistance to all 3 drugs. However, none 
of the clones examined in this work was multi-drug resis-
tant, with the possible exception of clone SUD 123/5. 
Since clones resistant to both chloroquine and, at a high 
level, to pyrimethamine coexisted in this community, 
and many patients were infected with more than one 
clone, it is certainly possible that genetic recombination 
during mosquito transmission could increase the fre-
quency of multi-drug resistant clones. 
These results suggest that chloroquine-resistant P. fal-
ciparum in this small village (and presumably the rest of 
Sudan) is not a distinct parasite 'strain'. Rather, it ap-
pears that genes conferring resistance to this drug are in-
creasing in frequency in the parasite population, prob-
ably due to the continuing use of chloroquine in the area. 
While clinical chloroquine resistance has increased in fre-
quency among patients attending the nearby Gadaref 
District Hospital during 1986-1990 (unpublished data), 
most patients in the village appeared to be cured by 
standard chloroquine therapy. Whether the situation is 
slowly deteriorating and chioroquine will soon be clini-
cally useless remains to be seen. 
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similar to those reported previously (WARRELL et al., 
1982; WHO, 1990). However, a considerably larger 
study would be needed to detect anything other than a 
major increase in mortality. 
Use of a quinine loading dose regimen in severe mala-
ria was not associated with serious quinine toxicity. In 
particular there was no residual blindness or deafness 
and no serious cardiovascular adverse effect. There is no 
evidence that these regimens are associated with toxicity 
more than other parenteral regimens that do not include 
a loading dose. On the other hand, there is evidence that 
rapidly achieving therapeutic blood concentrations of 
quinine produces faster clinical and parasitological re-
covery (WHITE et al., 1983a; FARGIER etal., 1991; PAs-
VOL et al., 1991). For these reasons, the quinine loading 
dose regimen has become standard practice in Thailand 
and many other countries during the past decade. The 
lack of toxicity of quinine regimens for severe malaria 
which consistently produce total plasma concentrations 
over 10 mg/L and often produce free concentrations over 
2 mg/L (WHITE etal., 1982; DAVIS etal., 1988) contrasts 
with experience in self poisoning, when such quinine 
concentrations regularly produce toxicity (BOLAND et 
al., 1985; DYSON et al., 1985). The pharmacodynamic 
effects in the 2 situations are clearly different. However, 
further increase in the dose of quinine in severe malaria 
to combat resistance would risk producing major tox-
icity, and it is unlikely that this would be tolerated. 
The results of this study show that quinine can still be 
relied upon in severe multi-drug resistant falciparum ma-
laria, but this will probably change as resistance con-
tinues to increase. New antimalarial drugs for severe ma-
laria are therefore needed urgently. 
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Genetic evidence that RI chioroquine resistance of Plasmodium falciparum is 
caused by recrudescence of resistant parasites 
Hamza Babiker 1 ' 2 , Lisa Ranford-Cartwright', Ali Sulta&' 3 , Gwiria Satti 3 and David Wallikert 1 lnstitute of Cell, 
Animal and Population Biology, University of Edinburgh, West Mains Road, Edinburgh, EH9 3JN, Scotland, UK; 
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Abstract 
Isolates of Plasmodiumfalciparum from patients in a Sudanese village exhibiting RI resistance to chloroquine 
have been typed for allelic variants of 2 merozoite surface antigens, MSPI and MSP2. Blood forms were 
taken from each patient before chioroquine was administered, and after parasites had reappeared following 
treatment. Each patient was found to be infected with genetically different parasites. However, in each pa-
tient the parasites of the recrudescent infections possessed the same alleles of each gene as those of the pri-
mary infection. The results show that the parasites which reappeared after chioroquine were a genuine 
recrudescence of the primary forms, and not derived from a new infection. 
Introduction 
Chloroquine resistance in Plasmodium falciparum is 
conventionally defined as RI (low), Rh (intermediate) or 
RI!! (high), depending on the clinical response of pa-
tients to a standard course of treatment with the drug 
(BRUCE-CHWATT, 1986). In RI resistance, parasites are 
temporarily cleared from the blood following chioro-
quine treatment, but reappear several days after the 
treatment is terminated. These parasites are usually con-
sidered to represent a recrudescence of the initial para-
sites which are resistant. Alternatively, they could be due 
to reinfection of the patient with fresh parasites. Such 
parasites might exhibit a different drug response from 
those of the primary infection, since it is well known that 
mixtures of resistant and sensitive parasites occur within 
a single region (see, e.g., BABIKER etal., 1991b). 
During surveys of P. falciparum among inhabitants of 
a village in eastern Sudan in 1989 and 1990, it was found 
that many isolates exhibited resistance in vitro to chioro-
quine (BABIKER et al., 1991h). Some patients who had 
been treated with chloroquine following diagnosis were 
found to exhibit parasites as well as febrile symptoms 
after periods of one to 4 weeks following treatment. In 
the study reported here, we typed parasites of the re-
crudescent and primary infections of these patients for 2 
highly polymorphic antigen genes, using the polymerase 
chain reaction (PCR) combined with the use of non-radio-
labelled chemiluminescent gene probes. We showed that, 
in each patient, the recrudescent parasites possessed the 
same alleles of these genes as the primary parasites. The 
work thus showed unequivocally that the secondary 
parasites were a genuine recrudescence, and not the pro-
ducts of a new infection. 
Subjects, Materials and Methods 
Study area and patients 
Details of the study area, Asar Village in eastern 
Sudan, have been given previously (BABIKER et al., 
1991a, 1991h). In this area, malaria transmission occurs 
from September to November, following seasonal rains. 
The principal parasite is P. fakiparu,n, causing more 
than 90% of the malaria cases (EL-GADDAI., 1986). Drug 
tests in vitro have shown that the parasite population of 
Asar contains a diversity of chioroquine-resistant and 
chioroquine-sensitive forms (BABIKER etal., 1991b). 
Blood films were prepared from patients attending a 
daily clinic in Asar throughout the transmission seasons 
of 1989 and 1990. On diagnosis of P. falciparwn, venous 
blood samples were immediately taken from each pa-
tient, with their consent, and cryopreserved in liquid ni-
trogen (BABIKER et al., 1991a). Each patient was then 
treated with a standard dose of chloroquine of 25 mg/kg 
over 3 d and examined daily for clearance of parasitae-
mia, which occurred by day 7 or earlier if the parasites 
were sensitive to the drug. Six patients returned to the 
clinic with febrile symptoms after periods ranging from  
10 to 30 d, all of whom proved to have P. falciparum in 
their blood. A further sample of blood was taken and 
cryopreserved. The patients were then treated with Fan-
sidar (sulfadoxine/pyrimethamine), to take account of 
the possibility that the parasites could be resistant to 
chioroquine. 
Tests in vitro for chioroquine resistance 
The isolates which caused the primary infections in the 
6 patients who later returned to the clinic were estab-
lished in culture in vitro and tested for chioroquine re-
sponse, using graded doses of the drug in microtitre 
plates (BABIKER ci al., 1991b). The minimum inhibitory 
concentration (MIC) which killed all, or nearly all, the 
parasites was estimated by microscopical examination of 
Giemsa-stained blood smears. 
Genotvping parasites 
Parasites were characterized for alleles of genes deter-
mining 2 polymorphic merozoite surface proteins, 
denoted MSPI and MSP2. Both these genes contain re-
gions encoding tandemly repeated amino acids, which 
may vary in both number and sequence in different al-
leles (TANABE ci al., 1987; SMYTHE ci al., 1991). Vari-
ations in the length of these regions can be readily identi-
fied as size differences on agarose gels of fragments 
amplified by PCR, using primers recognizing conserved 
sequences flanking the repeats (FOLEY etal., 1992; RAN-
FORD-CARTWRIGHT ci al., 1993). The sequence vari-
ations in this region of MSPJ can be grouped into 3 
types. denoted Ki, MAD20 and R033 after the isolates 
from which they were originally described (KIMURA ci 
al., 1990). For MSP2, 2 types of sequence have been 
found, denoted ICI and FC27 (SNEWIN ci al., 1991). 
PCR amplification of MSP1 and MSP2 genes. P. falci-
parum deoxyribonucleic acid (DNA) was first isolated 
from each sample of parasitized blood using the method 
of FOLEY ci al. (1992). PCR was used to amplify the re-
peat region of MSI'l, denoted block 2 by TANABE etal. 
(" 1987), and the central region of MSP2 which includes 
repeat sequences (FENTON ci al., 1991; SMVTHE ci al., 
1991). Details of the primers used, the PCR conditions, 
and electrophoresis of the amplified products have been 
given by R.NFoRD-CARTwRft;HF etal. 1993). Southern 
blots of the gels were made on to Genescreen nylon 
membranes (SAMBROOK etal., 1989). 
Probing of PCR-amplified products. Oligonucleotide 
probes were made which recognized Ki-, MAD20- and 
R033-type sequences of MSPI. and Id- and FC27-type 
sequences of MSP2. The sequences of the MSPI probes 
have been given by SNEWtN ci al. (1991). The sequences 
of the MSP2 probes were IC!: 5'-GCAGAAGCATC-
TACCAGTACC-3' and FC27: 5'-CACCTTCACCACC-
CATCAC-3'. The oligonucleotides were labelled using 
the Amersham Enhanced Chemiluminescence (ECL) 3' 
oligolabelling kit. 1 x 10-10 moles of each oligonucleotide 
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were labelled with fluorescein- ll-d-uridine triphos-
phate by incubation with terminal transferase for 60-90 
min at 37°C, according to the manufacturer's instructions. 
Hybridization of the labelled oligonucleotides with 
Southern blots was carried out according to the manufac-
turer's instructions, with the following modifications. 
Hybridization was for 1 h at temperatures of 56°C, 68°C 
and 74°C for MSPI probes MAD20, R033 and Ki re-
spectively, and 56°C and 59°C for MSP2 probes FC27 
and IC  respectively. The probes were used at concentra-
tions of 5-10 nglmL of hybridization solution. The blots 
were first washed with standard saline citrate 
(lx SSC)/0. 1% sodium dodecyl sulphate (SDS) at room 
temperature, followed by higher stringency washes with 
0. 1 X SSC/0 l%SDS for 30 min at the same hybridization 
temperatures. Hybridized oligonucleotides were detected 
using the Amersham ECL detection kit. Each blot was 
exposed wet, wrapped in Saranwrap 5 , to ECL-Hyper-
film (Amersham) for 1-2 min before being developed. 
Following each hybridization, the probes were stripped 
from the membranes by boiling in 0. 1 x SSCI1%SDS for 
15 mm, followed by rinsing in 5 x SSC for 5 min with 
continuous agitation (SAMBROOK etal., 1989), and stored 
in Saranwrap at -20°C for eventual hybridization with 
other probes. 
Table 1. Chloroquine responses in vitro of P. falcipar-
urn parasites from initial infections from six patients, 
taken before commencement of drug treatment 
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'Minimum inhibitory concentration (which kills all, or 
nearly all, parasites. 
bChloroquine  sensitive. 
cChloroquine  resistant. 
Results 
Tests for chioroquine response 
Tests in vivo. All the 6 patients who exhibited recrude-
scences showed an RI type of chioroquine resistance re-
sponse. In 2 patients, parasitaemias were cleared, but re-
appeared within 7 d. The other 4 patients showed late 
recrudescences, 2-3 weeks after completion of treatment. 
Tests in vitro. The chioroquine response of parasites 
from the primary infections of each of the 6 patients was 
tested in vitro (Table 1). The MICs ranged from 04x 
10-6M to I6xlO-6M, compared to 02x10 6M for the 
drug-sensitive control clone 3D7. 
MSP 1 and MSP2 characterization or parasites 
PCR followed by hybridization of blots with non-radio-
labelled probes was used to identify MSPI and MSP2 al -
leles of the parasites from the 6 patients who had re-
crudescences of P. falciparum following chioroquine 
treatment, as well as from 64 further patients in the vil-
lage. 
Parasites from chioroquine-treated patients. The MSPJ 
and MSP2 alleles of the parasites from these patients are 
shown in Table 2. The Figure illustrates the MSP2 al-
leles of primary and recrudescent isolates from 3 of these 
patients. Each patient was found to contain parasites 
with different combinations of alleles of the 2 genes. The 
recrudescent parasites in each patient possessed alleles 
identical to those of the parasites of the primary infec-
tions. 
In one patient (no. 123/89), 2 alleles of MSPI were 
seen in both primary and recrudescent samples, showing 
that this infection contained a mixture of at least 2 geneti-
cally distinct chloroquine-resistant parasite clones. In the 
other 5 patients, only single alleles of each gene were de-
tectable, suggesting clonal-type infections in each case; 
however, it cannot be entirely excluded that these pa-
tients contained mixtures of parasites which by chance 
were identical at the MSPI and MSP2 loci, but differed 
at other loci not examined in this work. 
Parasites of other patients in the village. Seventy patients 
from Asar, including 6 showing recrudescent infections, 
were examined for MSPI and MSP2 alleles. Eleven al-
leles of MSPJ were found among these isolates, charac-
terized by PCR products ranging in length from 470 to 
580 base pairs (bp), as well as by Ki-, MAD20-, or 
Table 2. Alleles of MSPJ and MSP2 genes of P. falciparum from primary and recrudescent (R) infections in patients 








Size 	Sequence  
MSP2 alleles 
Size' 	Sequence  
107/89 30 25.10.89 470 R033 650 ICI 
107/89-R 24.11.89 470 R033 650 IC]. 
123/89 17 31.10.89 540 MAD20 540 ICI 
470 R033 
123/89-R 23.11.89 540 MAD20 540 ICl 
470 R033 
101/90 8 7.10.90 530 KI 580 FC27 
10 1/90-R 26.10.90 530 Kl 580 FC27 
103/90 15 20. 10.90 470 R033 540 FC27 
103/90-R 9.11.90 470 R033 540 FC27 
120/90 50 29. 10.90 470 Kl n.d. nd. 
120/90-R 13.11.90 470 Kl 580 FC27 
124/90 20 1.11.90 470 R033 n.d. nd. 
124/90-R 10.11.90 470 R033 540 ICI 
'Estimated number of base pairs of DNA fragments of each allele amplified by the polymerase chain reaction on agarose 
gels; n.d.=not determined. 
'The probe which hybridized with each amplified fragment; n.d.=not determined. 
SSC was prepared at 20x normal strength as sodium chloride 
3m and trisodium citrate 03M, pH 70, and then diluted to 5x, 
lx and 01x as required. 
R033-type sequences. Sixteen alleles of MSP2 were 
found, with PCR products ranging in size from 470 to 











Key: = ICI — FC27 
Figure. MSP2 alleles in isolates from 3 patients with P. falczparam mala-
ria, classified by size and sequence. Primary and recrudescent (R) isolates 
from each patient were run side by side. Tracks I and 8, size markers; 2, 
10190; 3, 101:90-R; 4, 12389; 5, 123/89-R; 6, 10789; 7, 107:89-R. 
A. Polvmerase chain reaction fragments separated on 1.6 9/6 agarose gel 
and stained with ethidium bromide bp=base pairs); the fragments were 
blotted on to a nylon membrane and hybridized separately with the allele-
specific ICI and FC27 probes. B. Film exposed to blot hybridized with 
FC27 probe. C. Film exposed to blot hybridized with ICI probe. 0. 
Schematic representation of the results. 
Only 2 of the 70 patients examined contained parasites 
with an identical combination of MSPI and MSP2 al-
leles; these isolates were from 2 children (sisters) from 
the same household, who presented at the clinic on the 
same day. 
Discussion 
This work has demonstrated that parasites reappearing 
in the blood of patients suspected of having chioroquine 
resistant (RI) P. falciparum possess the same alleles of 
MSPI and MSP2 as the parasites of the corresponding 
primary infections. Tests in vitro have confirmed that the 
primary parasites were slightly or moderately chioro-
quine resistant when compared to a control drug sensi-
tive clone. We conclude that the recrudescing forms were  
derived directly from those of the resistant primary para-
sites, and not from a reinfection with new parasites. 
Extensive polymorphisms of the MSPI and MSP2 
genes occur among the parasites of Asar village. In our 
previous study, 8 alleles of MSPI and 4 of MSP2 were 
detected in the samples collected in 1989 (BABIKER etal., 
1991a), using a panel of monoclonal antibodies specific 
for each antigen. In the current work, 11 alleles of MSPJ 
and 16 of MSP2 have been identified by the PCR/hy 
bridization technique in samples collected in the 2 years 
1989 and 1990. Most of the epitopes recognized by the 
monoclonal antibodies were not in the repeat regions of 
the antigens, and so no clear correlation could be made 
between the polymorphisms revealed by each technique. 
However, the combined results of the 2 studies show that 
the number of allelic variants of these antigens in the 
parasites of Asar is very high. 
The existence of 11 alleles of MSPI and 16 of MSP2 
means that 176 (lix 16) possible combinations of the al-
leles of each gene could occur among the parasites in the 
village. Although some alleles of each gene are more fre-
quent than others (unpublished observations), the prob-
ability that 2 parasite clones taken at random from the in-
habitants will have identical alleles at these loci is very 
low. Among the 70 isolates examined, only 2 had the 
same allele combinations, and these were from 2 sisters 
sleeping in the same house who had most probably been 
infected by the same mosquito on the same day. The 
probability that a single person will become reinfected 
from mosquitoes with parasites with MSPJ and MSP2 
alleles identical to those of the primary infection is also 
exceedingly low. For these reasons, we conclude that the 
parasites reappearing in the blood of the 6 chloroquine-
treated patients discussed in this paper were a genuine 
recrudescence of the primary parasites, and not a reinfec-
tion. 
It was also of interest that the parasites in the 6 pa-
tients caused febrile episodes on each occasion they 
presented at the clinic. The causes of a new episode of 
malaria illness in a single patient are not understood, al-
though one possible explanation is infection with a novel 
'strain' of P. falciparum, to which the patient has not 
been previously exposed. (LINES & ARMSTRONG, 1992). 
It seems clear that this was not the case with the patients 
examined in the present study. 
The method described here of genotyping P. falcipa-
rum for MSPI and MSP2 alleles is similar to some of 
those previously described (e.g., by KIMuRA et al., 1990 
and MERCEREAU-PUIJALON et al., 1991), except that we 
have made use of fluorescein-labelled probes in the hy-
bridization work. As discussed elsewhere (e.g., by 
FoLEY et al., 1992), the PCR technique is particularly 
sensitive and useful for this type of work, since it can be 
carried out with low numbers of parasites without the 
necessity of culturing them. Fluorescein-labelled probes, 
as used here, have obvious advantages over radio-labelled 
material. They are easy to make, and probably cheaper in 
the long term because they can be stored for long periods 
without loss of activity. They are particularly suitable for 
use in countries where radioactivity is difficult to obtain, 
and they have none of the hazards associated with the 
handling and disposing of radioactivity. The method is 
thus of great potential value in field surveys of genes in 
populations of parasites such as Plasmodium. 
The prevalence of chloroquine resistance in Asar was 
found to be high in 1989 (BABIKER el al., 1991b), resis-
tant P. falczparum having been detected in this area since 
1986 (BAYOUMI etal., 1989). RH and Rill types of chlo-
roquine resistance are easy to diagnose and alternative 
antimalarial drugs can be prescribed immediately. How-
ever, symptoms caused by recrudescent RI parasltaemlas 
may frequently be confused by clinicians with other con-
ditions, for which quite different treatments may be de-
scribed. Thus, patients infected with RI chloroquine-re-
sistant P. falciparum may harbour their parasites for a 
long time, with obvious epidemiological significance, es- 
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pecially it they have gametocytaemia. Correct diagnosis 
of recrudescent RI parasites is therefore important, and 
has a practical impact on management of P. falciparum 
malaria in areas where resistance occurs. The techniques 
described here for characterizing parasites are at present 
expensive and need well-trained personnel; however, 
PCR technology is already finding a place in the diag-
nosis of malaria (see, e.g., JAUREGUIBERRY et al., 1990), 
and we envisage that the methods used here might event-
ually be developed for field use. 
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Abstract 
In order to study the sensitivity in vitro of Tiypanosoma brucei gambiense to pentamidine, 5 x 10 parasites 
were exposed to 0, 0. 1, 1-0, 2-0, 10, 100, 1000 and 10 000 tsg/L of pentamidine isethionate for up to 10 d. 
The viability of parasites was determined each day by microscopy. Multiplication was retarded during con-
tinuous exposure to 2 tg'L. After 4 d no further multiplication took place, although the trypanosomes re-
mained alive for another 3 d. The parasiticidal effect was more pronounced when higher concentrations 
were used; when exposed to 10 and 100 ttg!L, all parasites were dead after 4 and 3 d, respectively. Despite 
exposure to 1000 .tg/L, 74% of the parasites were still alive the next day. 10 000 igL killed all parasites 
within 24 h of exposure. Our results show that the time period of exposure to pentamidine plays a major role 
in determining the sensitivity in vitro of T. b. gambiense, and we suggest that prolonged exposure in vivo may 
be more important than attaining high but brief peak concentrations. 
Introduction 
Pentamidine has been used for many years in the treat-
ment of Trypanosoma brucei gambiense sleeping sickness 
without involvement of the central nervous system. 
Nevertheless, no uniform recommendation for treatment 
exists. We are in the process of evaluating dosage 
regimens, to be based on proper pharmacokinetic charac-
terization of the drug. During the course of this work we 
have found little information on the minimum concentra-
tion and time required to eliminate parasites. Without 
such knowledge it is not possible to utilize pharmaco-
kinetic data properly. We now report on the effect of 
duration of exposure and concentration of pentamidine 
on the response in vitro of 1'. b. gambiense. 
Materials and Methods 
Parasites 
The trypanosomes were isolated in 1990 from a patient 
with T. b. gambiense infection and involvement of the 
central nervous system (isolate MHOM.!CI 190 Dal 1442). 
After cryopreservation they were kept in Hepes-buffered 
minimum essential medium (MEM) with Earle's salts 
(Gibco, Paisley, Scotland, UK) in 24-well tissue culture 
plates (Costar, Cambridge, Massachusetts, USA). The 
medium was supplemented with 04% MEM non-essen-
tial amino acids (Gibco), 35%  foetal calf serum (Gibco), 
15-5% horse serum (Gibco), 2 MM L-glutamine, 2mM so-
dium pyruvate. 10 mm glucose, 400 tg!mL of kanamy-
cine and 400 units/mL of nystatine. In addition, 0- 1 mm 
hypoxanthine, 0-016 mm thymidine and 02 mm 2-mer-
captoethanol were added (BALTZ et al., 1985). Parasites 
were adapted to culture conditions for one month before 
the study but during this period 10% foetal calf serum 
and lO%  horse serum were used. During the first week 
of adaptation the trypanosomes were grown in the 
presence of Microtus montanus fibroblast feeder layer cells 
BRUN et al., 1981). Each well contained I mL of me-
dium. The cultures were incubated at 37°C in 4% CO2 in 
air. 
Drug 
200 mg of pentamidine isethionate powder (Pentacari-
nar, May & Baker, Dagenham, UK) were dissolved in 5 
mL of distilled water. This stock solution was further 
diluted with medium to the required concentrations, the 
dilution factor being calculated on the assumption that 
all the pentamidine remained in solution. All concentra-
tions were calculated in terms of pentamidine isethion-
ate. 
Study design 
5x 104 parasites were exposed to 0, 0-1, 1-0, 20, 10, 
Address for correspondence: Dr Ulf Bronner, Division of Infec-
tious Diseases, Huddinge University Hospital, S-141 86 Hud-
dinge, Sweden. 
100, 1000 or 10 000 tg/L of pentamidine for up to 10 d. 
The viability of the parasites was determined each day by 
microscopy and the number of live parasites in each well 
was calculated using a haemacytometer (Neubauer). 
Dividing parasites were counted as one individual. 
Whenever the number of live parasites exceeded lx 10 5 , 
the corresponding well was diluted with medium con-
taining the same concentration of pentamidine in order 
to reduce the number to 5 x 10 parasites. Each drug con-
centration was tested in triplicate. 
Results 
The response of live trypanosomes to prolonged expo-
sure to different concentrations of pentamidine is illus-
trated in the Figure. When no drug was added to the me-
dium, the trypanosomes continued to multiply and the 
population increased approximately 9-fold over each 
period of 24 h, indicating at least 3 divisions per day. 
Pentamidine at 01 tg/L had no effect during the 
study period. When parasites were exposed to 10 tg/L, 
multiplication was retarded after a few days but conti-
nued for 8 d. These parasites were examined for 20 d and 
remained viable even if no multiplication was occurring, 
as determined both by visual inspection and calculation 
of parasite numbers. 
During exposure to 2-0 ug/L, multiplication was re-
tarded and after 4 d no further multiplication took place, 
although parasites remained alive for another 3 d. When 
higher concentrations were used, killing was more rapid 
and no live parasite was seen after 4 d at 10 sg/L or 3 d at 
100 tg/L. Even at the latter concentration, parasites con-
tinued to multiply to some extent during the first 24 h. 
At 1000 sg!L, 74% were viable on the next day, but at 10 
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Figure. Activity in vitro of pentamidine on T. b. gambiense. Parasite num-
bers are means of 3 experiments. Whenever multiplication occurred, 
parasites were diluted to 5 x 104 each day. 
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MVR-PCR Analysis of Hypervariable 
DNA Sequence Variation 
D.E. Amot, C. Roper and A.A. Sultan 
Techniques for accurate marking of infec-
tious microbial agents circulating in popu-
lations would be very useful to epidemi-
ologists. In this article, David Amot, Cally 
Roper and Ali Sultan review recent pro-
gress in transferring MVR-PCR DNA finger-
printing techniques from human forensic 
medicine to parasitology. 
A common feature among eukaryotic 
genomes is the occurrence of mini-sat-
ellite repeats comprising short, tandemly 
reiterated DNA sequences, sometimes 
referred to as VNTR (variable number 
of tandem repeats) loci. High levels of 
inter- and intra-specific variation in the 
number of tandem repeats can occur at 
such loci. Where DNA probes exist that 
hybridize to many dispersed mini-satellite 
sequences simultaneously, a genome 
'fingerprint' can be obtained for use as 
a taxonomic characteristic. Such tech-
niques have been widely used in para-
sitology, especially in species where 
morphological differentiation is difficult 
(eg. in Leishmania'). 
The Development of MVR-PCR 
Despite the usefulness of genomic 
fingerprinting, the method depends on 
the length variation of target sequences 
and such variation can be limited. Length 
variation is also quasi-continuous, making 
definitive allele identification difficult. 
This can limit population genetic analysis, 
since real (but unquantifiable) differences 
in allelic size usually have to be handled 
by effectively degrading the information 
content of the data ('binning') 2 . Mini-
satellite variant repeat analysis using a 
specialized polymerase chain reaction  
(MVR-PCR, also known as the Jeffreys' 
method) is a recently developed tech-
nique that solves these problems by de-
tecting allelic sequence polymorphism 
without the effort required by DNA 
sequencing3 . The original version of the 
method exploits the hypervariable mini-
satellite tandem repeats at a human 
interstitial locus on chromosome I (the 
Dl S8 locus). There are two types of 
29 bp repeat at this locus that differ by 
a single G—A transition mutation, these 
are referred to as a-type repeats and 
t-type repeats. The a-type and t-type re-
peats show highly diverse interspersion 
patterns within different alleles. Oligo-
nucleotide primers can be designed that 
specifically hybridize to each of the 
variants. Combining such variant repeat 
specific primers and a primer located at 
a monomorphic site in the DNA flank-
ing the repeats, it is possible to gener-
ate PCR products extending from the 
flanking primer to each a-type or t-type 
repeat. Interspersion patterns can then 
be 'read' from autoradiographs of the 
separation gel (which have a certain 
resemblance to supermarket product 
bartodes) and converted into allele-
specific digital codes. 
Advantages and Flexibility 
Digitized codes derived from the se-
quences of individual mini-satellite loci 
reveal more polymorphism than is de-
tectable by allelic size comparisons and, 
therefore, more precise identification of 
individual alleles is achieved. This allows 
accurate allele-frequency estimation and 
simplifies standard population-genetic 
analysis. The technique is relatively  
simple, rapid and internally well con-
trolled, in that the PCR fragment sizes 
are predictably spaced in the gel and are 
thus themselves accurate size markers. 
This permits accurate comparison of 
the migration of different lanes, and 
makes intergel comparisons more re-
liable. Digital codes are also easier to 
compile and compare using computers. 
The main obstacle to the adoption of a 
MVR-PCR system is that of finding suit-
able MVR-PCR loci. Repeated DNA se-
quences flanked by conserved regions 
exist in most eukaryotes but few have 
been conveniently characterized. An ex-
ception is Plasmodium falciparum, which 
has many genes containing tandemly 
repeated DNA encoding conserved, re-
petitive amino acid sequences. We have 
used these features of the P. falciparum 
circumsporozoite (CS) gene to develop 
an MVR-PCR assay that can reveal very 
high levels of DNA sequence polymor-
phism at this locus 4. Box I illustrates the 
principles of the technique as applied to 
an ideal target locus in a haploid organ-
ism such as P. falciparum. MVR-PCR 
methodology must be adapted accord-
ing to the ploidy of the organism, the 
size of the tandemly repeated unit and 
the extent of conservation of the flank-
ing sequences. The P. folciparum system 
is adapted to the CS gene tandem-
repeat unit of 12 bp and, since pnmers 
have to be around 20 bp. our CS gene 
variant-specific primers overlap two 
units. In CS genes inter-repeat variation 
creates 'null' positions that do not cross-
hybridize with either primer and these 
positions are interspersed in the repeat 
array and contribute to allelic poly-
morphism. The results of MVR-PCR re-
actions on DNA extracted from blood 
© 1994, Elsevier Science Ltd 0169 -47581941$07,00 
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Box I. The Principle of Single-allele MVR-PCR 
The target locus is shown as the 5'-3' bar with two alternating variants of a 30 bp repeat A conserved sequence is situated 100 bp 
upstream and is the binding site for a 20 bp flanking primer (vertical hatch). Variant specific primers (VSPs) corresponding to the Type 
I (dark grey) and the Type 2 (light grey) repeats are 30 bp oligonucleotides, extended by a further 20 bp TAG. (The tagging strategy is 
necessary because high concentrations of primers complementary to the repeats will themselves result in a progressive shortening of 
fragment size at each PCR cycle through internal priming within the PCR products.) Addition of a sequence TAG onto the VSP and 
amplifying with low concentrations of TAGGED VSP and high concentrations of flanking primer and an oligonucleotide identical to the 
TAG sequence (the TAG primer) effectively uncouples the initial annealing reaction from the subsequent cycles of amplification. 
Thermostable DNA polymerase then catalyses the following reactions (see Fig. below): 
Reaction 1 
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V%V Variant specific primers 
LMW 
] with TAG sequence AAW 
TAG Primer 
(I) The low concentration of TAGGED Type I VSP anneals to approximately one Type 
I repeat per target locus and extends in a 5'–*3' direction into the flanking DNA 
(Reaction I). 
The flanking primer primes from the conserved upstream sequence until ending in 
a sequence complementary to the TAG addition. 
Fragments terminating at the flanking sequence and the TAG complement will 
now be amplified preferentially (because of the high concentrations of the flanking and 
TAG primers) to create bands whose size corresponds to the distance between the 
flanking sequence and the position of each Type I repeat unit. A separate reaction 
tube containing Type 2 VSP will generate a complementary set of fragments termin-
ating at the position of Type 2 repeat units (Reaction 2). Infrequent internal priming 
events using the VSP primers will generate authentic products but with a bias towards 
shorter fragments. 
Electrophoretic separation of the products of Reaction I and Reaction 2 is shown 
in diagrammatic form. Either agarose or acrylamide gels could be used, depending on 
the size of products (which largely depends on the size of the unit repeat). We use 6% 
acrylamide gels to separate fragments radioactively labelled by including a 32P-labelled 
dNTP during the polymerization reaction. The first PCR product will be 170 bp long, 
that is, the distance from the 5' end of the flanking primer to the 3' end of the frag-
ment created by annealing of the VSP to the closest variant repeat unit. Thereafter, 
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samples obtained from eight individuals 
infected with P. folciparum are illustrated 
in Fig. I. Extensive allelic variation in the 
interspersion pattern of vanant DNA 
repeats encoding the well-conserved re-
petitive amino acids (the famous NANP 
sequence) is displayed. Individual alleles 
are readily identified and encoded ac-
cording to the position of PCR bands. 
For example. sample 7 with Type I and 
2 variants in Lanes a and b, respectively, 
is numerically encoded 
100000 10122222222000 
for the first 20 repeats in the array. As 
with all genetic typing of clinical iso-
lates, parasite mixtures can cause prob-
lems of interpretation, giving rise to 
occasional bands in both lanes of the 
MVR-PCR reaction when two or more 
genotypes are present in roughly equi-
molar concentrations. However, not all 
isolates are multiclonal and information 
can be extracted from mixed isolates, 
particularly where one clone clearly 
predominates. 
Hypervariable sequences are the re-
sult of elevated mutation rates in tandem 
repeats and mutation rates as high as 
15% per gamete occur at some human 
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Plasmodium 
I. ciparum 	circum- - 	t sporozoite (CS) gene — as 	target 	locus. 
I • Genomic 	P. 	fl- 
- .. 
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pies collected from _ 
patients 	in 	the 
village of Dora wish 
am • 188 in 	the 	Eastern - dip 	' Province 	of Sudan 
144 
40 
during October 1992. 
Each pair of lanes 
shows 	a 	reaction 
with 	Type 	I 	and 
2 	variant 	specific 
129 40 primers 	(tracks 	a 
and b, respectively). 
Radiolabelled 	frag- 
ments 	were 	sep- 
arated 	on 	a 	6% 
acrylomide gel and 
96 fragment sizes are 
given in base pairs 
(Sample 8). 
• W Will • • 84 
minisatellite loci 5 although pedigree 
analysis of VNTR segregation 3 generally 
shows somewhat lower rates (0.8-
1.0%). The mutation rate in sperm DNA 
appears to be around 20 times higher 
than in blood DNA samples, which may 
suggest that most mutation is germ-line 
specific, perhaps meiotic (Aj. Jeffreys, 
pers. commun.). The CS repeats are 
evolving faster than the rest of the 
gene 6 .7 and, although we do not know 
the mutation rate, the MVR-PCR code 
of clone 3D7 has not perceptibly 
changed over a four-year period of 
mitotic division in continuous culture, 
nor has the 1­1133 code been affected by 
meiosis and mosquito passage. 
Microepidemiological Studies 
Epidemiology and forensic scientific 
detection have a lot in common. Each 
seeks the identity and mode of oper-
ation of some undesirable agent with a 
view to halting its activities. MVR-PCR 
was developed as a means of exploiting 
hypervariable DNA sequences to ident-
ify humans unambiguously from small 
(and often poorly preserved) samples of 
cellular tissue such as blood found at the 
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Fig. 2. (left) Global variation in the MVR-PCR codes from Plasmodium fatci-
parum CS gene tandem repeats. The numerical coding of interspersion patterns 
has been converted into symbolic codes for ease of visual comparison. The first 
ten isolates are derived by encoding published sequences and the complete 
repeat array is shown, the remaining six are experimentally derived and are, 
therefore, incomplete. NF54. 3D7 and CVD I are related; 3D 7 and CVD I being 
clones derived from NF54, an uncloned isolate whose country of origin is 
unknown. Wei is known to be West African, LES Liberian, 811 Ugandan and 
7G8 Brazilian. T4, T9/98, T91 Of and K I are all Thai, MAD120 is from Papua 
New Guinea, Dd2 is from Vietnam, H83 is from Honduras, PA 17 is Ugandan 
and the origin of R is uncertain, possibly Brazilian. Type I repeat, closed box; 
Type 2 repeat; hatched box; neither Type I nor Type 2, open box. 
Fig. 3. (right) Local variation in the MVR-PCR codes of the Plasmodium falciparum CS gene in isolates from the Gedaref region in the Eastern 
Province of Sudan. The SUD clones are all from Asar village (population 4000) isolates of the 1989 transmission season, whereas the Dara iso-
lates were from patients who became ill in the smaller village of Darawish (population 385, 1.5 km from Asar) during October 1992. Type I 
repeat, closed box; Type 2 repeat, hatched box; neither Type I nor Type 2, open box. 
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scene of a crime. Malariological MVR-
PCR is intended to identify P. falciparum 
isolates unambiguously in patient blood 
samples in order to investigate the popu-
lation structure and transmission of 
individual parasite genotypes. 
The potential of MVR-PCR polymor-
phism in the CS gene for the differen-
tiation of parasites at a local level is 
illustrated in Fig. 2 and Fig. 3. The extent 
of variation in a sample of P. falciparum 
isolates collected worldwide is shown 
in Fig. 2. Of 16 isolates, 14 have differ-
ent MVR-PCR codes (it should be noted 
that 3D7 and CVD I are both clones 
derived from the NF54 isolate). The 
variation present in two neighbouring 
Sudanese villages is shown in Fig. 2. In 
23 patient isolates, 21 MVR-PCR codes 
are detectable. Dara I has two bands at 
the same position, indicating that this iso-
late contains more than one genotype. 
There is apparently as much variation 
present at the local level as there is in 
the global sample. Given that both vil-
lage data sets were collected over short 
periods within the brief Eastern Sudanese 
transmission season (late August - mid-
October), there is no indication that ex-
panded clones dominate the population. 
This is in agreement with other pub- 
lished studies from The Gambia 8 and 
Sudan9 '° 
Two of the 1992 Darawish isolates 
(Dara 5 and Dara 7) were derived from 
sisters, living in the same hut, who be-
came ill on the same day, and these iso-
lates were identical. Our interpretation 
(confirmed with additional polymorphic 
markers) is that they were infected by 
the same parasite, perhaps acquired 
from the same mosquito during inter -
rupted feeding. We are currently ex-
tending these trial studies to monitor 
the temporal and geographic spread of 
MVR-PCR marked parasite genotypes 
through each malaria patient within 
Darawish village during the 1993 trans-
mission season. It may thus become 
possible to estimate the basic repro-
ductive rate of infection (Ro), the num-
ber of secondary cases generated by a 
primary case, for each parasite lineage 
being transmitted in the village''. 
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Abstract 
On the basis of conserved sequences characteristic of the Ran/TC4 subfamily of the GTPase superfamily, a fragment of 
the gene encoding a Plasmodiutnfalciparum Ran/TC4 homologue was amplified in the polymerase chain reaction. The 
fragment was used to screen a cDNA library to obtain clones which allowed determination of the complete gene 
sequence. The gene, designated pfran (Plasmodium falciparum ras-like nuclear protein), has around 70% amino acid 
identity with previously characterised Ran/TC4 proteins. Like other malarial mRNAs, the pfran mRNA contains a long 
(at least 679 bp) 5' untranslated region. Southern blotting experiments show that pfran  is a single copy gene located on 
chromosome 11. RNA hybridisation experiments indicate that pfran mRNA is abundant in late trophozoite and 
schizont stages, but present at very low levels in gametocytes and early asexual stages. 
Key words: Plasmodium falciparum; pJ'ran; GTPase; Cell cycle 
1. Introduction 
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Invasion of red blood cells by Plasmodium fal-
ciparum merozoites leads to entry into one of 2 
developmental pathways. Either the invading mer-
ozoite enters the asexual cycle during which sev-
eral mitotic divisions result in production of 8-32 
merozoites followed by haemolysis, or sexual dif-
ferentiation into gametocytes occurs [1]. Gameto-
cytogenesis requires the arrest of cell cycle pro-
gression, suggesting that sexual differentiation 
and cell cycle regulatory circuits may share some 
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common features. Neither the signals triggering 
sexual development nor the pathways of signal 
transduction during regulation of the cell cycle 
are understood in the malaria parasite. 
The molecular processes underlying these as-
pects of the Plasmodium life cycle are likely to in-
clude some forms of the signal transduction and 
regulatory pathways essential to all living cells. 
For example, in mammalian systems, small cyto-
solic enzymes of the Ras subgroup of the GTPase 
superfamily [2], are known to play a key role in 
growth factor receptor-mediated signal transduc-
tion [3], and are also implicated in the control of 
normal cell differentiation and mitotic regulation 
[4]. Mutant forms of the ras gene can also function 
as oncogenes capable of transforming normal cells 
[5,6]. Ran/TC4, a small ras-related GTPase origin-
ally identified in a human teratocarcinoma cDNA 
library [7], appears to function in signal transduc-
tion in the context of cell cycle regulation. Homo-
logues have been reported from Diclyostelium [ 8], 
fission and budding yeast [9,10] and filarial worms 
[Ii]. 
Ran/TC4 protein is abundant (0.36% of total 
HeLa cell protein [121), and forms a complex with 
another abundant nuclear protein called RCCI 
(regulator of chromosomal condensation-I), 
which binds to chromatin and catalyses the ex-
change of guanine nucleotides on Ran/TC4 [13]. 
Functional heterodimers of the Ran/TC4 and 
RCCI proteins are required for several major cel-
lular processes, including protein import into the 
nucleus [12], regulation of mitosis [14], RNA tran-
scription, processing and export [15], regulation of 
DNA synthesis [16] and regulation of the Sacchar-
omyces cerevisiae mating pathway [17]. 
We report the identification of a putative Ran! 
TC4 homologue in P. falciparum, pfran. The gene 
encodes a 214 amino acids protein containing the 
five conserved GTP-binding sites characteristic of 
the GTPase superfamily, and is interrupted by a 
single intron. In common with several other P. 
falciparum messenger species [18], the coding se-
quence is preceded by a long 5' untranslated re-
gion. Northern blotting experiments indicate that 
mRNA levels vary significantly during the ery-
throcytic development of the parasite.  
2. Materials and methods 
Parasite culture, DNA isolation and characterisa-
tion. Parasites of cloned P. falciparum lines 
3D7A, CIO and 1776 were grown under standard 
culture conditions. Gametocyte cultures were har -
vested at stages 2/3 (young) and 4/5 (mature) [19]. 
Genomic DNA extraction and endonuclease di-
gestion were performed following standard proto-
cols. Filters were prehybridised for I h at 65°C in 
5 x SSC (I x SSC = 0.15 M NaCl/ 0.015 M Na3 
citrate 2H 20, pH 7.0/ 5 x Denhardt's solution/ 
0.1% SDS/ 50 mM sodium phosphate buffer pH 
7/ 100 jg m1' denatured salmon sperm DNA. 
Hybridisation was carried out in the same buffer 
with 10% dextran sulphate added, at 65°C over-
night. Filters were extensively washed in 2 x SSC 
at room temperature and then washed in 0.5 x 
SSC/ 0.1% SDS at 65°C for 1 h. 
PCR amplification of genomic DNA. Two 
stretches of amino acids that are highly conserved 
among members of the Ran/TC4 family (residues 
32-38 [GEFEKKY] and residues 154-160 [YN-
FEKPE] [91) were used to design degenerate oligo-
nucleotides biased towards P. falciparum codon 
usage [20]. The oligonucleotides were then used to 
prime the polymerase chain reaction (PCR) with 
P.falciparum genomic DNA (clone 3137A) as tem-
plate. The oligonucleotide sequences were: the for-
ward primer, 5'GG(A/T)GAATT(A/C)GAAAA-
(A/G)AA(A/G)TA 3' and the reverse primer, 
5'GG(C/T)TT(T/C)TC(T/G) AA(A/G)TT(A/G)-
TA(A/G)TT 3'. 
PCR amplification was carried out in 100 uI 
PCR reaction mixtures containing 0.5 zg of P. 
falciparum genomic DNA/1.0 pM each primer/ 
200 MM each dNTP/10 mM Tris-HC1, pH 8.8/50 
mM KCl/2.5 mM MgC1 2/0.02% (w/v) gelatin/0.5 
units of Taq DNA polymerase. PCR amplification 
was carried out in a Hybaid TM thermal reactor as 
follows: 30 s at 94°C, 60 s at 55°C and 120 s at 
72°C for 30 cycles. 
Library screening and sequencing. The PCR frag-
ment was radiolabelled by random priming and 
used as a hybridisation probe to screen a P. falci-
parum asexual stage cDNA library constructed in 
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the plasmid vector pJFEI4 (a gift from A. Craig). 
50 000 colonies were screened, and both strands of 
the positive cDNA inserts were sequenced by the 
dideoxynucleotide chain termination method. 
Pulsed field gel electrophoresis. P. falciparum 
chromosomal DNA blocks were prepared as pre-
viously described [21]. Pulsed field gradient gel 
electrophoresis (PFGE) was performed using a 
Bio RadTM CHEF DRII gel apparatus and 1% 
Fastlane agarose gels. The chamber buffer was 10 
mM Tris HCI, 20 mM acetic acid and 2 mM 
EDTA circulated at 14°C. Gels were ramped 
from 360-800 s pulse times at a constant 100 V 
for 96 h. 
Northern blot analysis. Cultures were synchro-
nised by the method of Lambros and Vanderberg 
[22]. Total RNA from synchronous cultures of 
rings, trophozoites, schizonts and gametocytes 
was prepared as described [23]. For Northern blot-
ting, 2.5 jig of total RNA were separated by elec-
trophoresis in a 1.2% agarose gel containing 
0.74% formaldehyde in MOPS buffer, and trans-
ferred to Hybond-N ± membranes (Amersham) by 
alkaline transfer. Prehybndisation, hybridisation 
and washing of the membranes were performed 
according to the conditions described above for 
Southern blotting. 
3. Results and discussion 
Isolation and sequencing of the pfran gene. A 552 
bp DNA fragment was obtained by amplifying P. 
falciparum genomic DNA using 2 degenerate pri-
mers based on conserved regions of the Ran/TC4 
protein. Sequencing of the PCR product con-
firmed that the amplified fragment represented 
part of a gene encoding an open reading frame 
(ORF) with homology to the published Ran/TC4 
sequences. The ORF was interrupted by a 165 bp 
intron (see below). This fragment was used as a 
hybridisation probe to screen a P. falciparum 
cDNA library made with RNA extracted from 
asexual parasites. Screening of 50 000 clones 
yielded 3 strongly hybridising clones. One clone 
with a 1.4 kb insert, C4.1, was selected for se-
quence analysis. 
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Fig. I. (A) The complete sequence of cDNA clone 4.1 containing the large 5 UTR and complete coding sequence of pfran gene of P. 
falciparum. The predicted amino acid sequence for the coding region is shown below the nucleotide sequence in the single letter code 
and the amino acid sequences used to design the oligonucleotide primers are underlined. The site of the intron is indicated by an 
arrow. (B) Nucleotide sequence of the intron in the P. falciparum pfran gene obtained from genomic DNA. Intron sequence is in lower 
case typescript. Numbering as in (A). 
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in Fig. 1A. The insert contained a single ORF ex-
tending from nucleotide 677 to a stop codon 77 
bases upstream from the 3' terminus. The de-
duced amino acid sequence had a methionine co-
don at nucleotide 680 which permitted a homolo-
gous alignment of the sequence with available se-
quences of Ran/TC4 proteins. The C4.1 cDNA 
contained a long (679 bp) 5' untranslated region 
(UTR), and 77 bp of non-coding sequences at the 
3' end. Sequences of genomic DNA adjacent to the 
original 552 bp PCR product were obtained by 
utilising the inverse PCR procedure [24]. The cod-
ing sequence, the intron-exon boundaries, and 300 
bp of 5' UTR sequence proximal to the start co-
don were confirmed as identical in both the geno-
mic DNA and the cDNA clone. 
The ORF is interrupted by an intron between 
nucleotides 796 and 797 (Fig. 113). The intron is 
165 nucleotides long and is 90% A + I which com-
pares with 67% A + T for the coding sequence and 
85% A + T for the 5' and 3' UTRs. The sequences  
at the ends of the intron have the universally con-
served GT and AG dinucleotides marking the in-
tron-exon boundaries, and the 3' AG splice accep-
tor site is preceded by a stretch of 17 thymidine 
residues, an exaggeration of the pyrimidine nu-
cleotide motif generally found at the 3' intron 
boundary of eukaryotic genes [25]. The sequence 
at the 5' intron boundary (GTAAGTGAA) is 
also well conserved among Plasmodium introns 
and similar to the consensus eukaryotic intron 
boundary sequence. 
pfran is a single copy gene located on chromosome 
11. Genomic P. falciparum DNA was digested 
with restriction enzymes and analysed by South-
ern blotting, using the C4.1 insert as a probe (Fig. 
2A). All lanes containing DNA digested with re-
striction enzymes that do not cleave within the 
probe (AccI, BglII, Hind!, Hind!!!, MspII, NdeI, 
XbaI or XhoI) show hybridisation to a single frag-
ment. DNA digested with AM, Dral, Hinfl and 
Fig. 	A Southern blot analysis oF the p/ran gene Genomic DNA from P. talciparuni was digested with various enzymes, resolved, 
blotted and hybridised with pfran probes. The enzymes used were: (lanes 1-12): Act1. BgllI, Sau3A, Mspll, XhoL, Dral. HincIl, 
Hindu!, Alul, Hinfl. XbaI and Well. (B) Chromosome assignment of the pfran gene. (I): Ethidium bromide-stained pulsed field 
gradient gel of clones CIO and 1776, with chromosomes Il. 12, 13 and 14 marked; (11): autoradiograph of the blot from the gel in 
panel (1) probed with the radiolabelled pfran eDNA. 
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Sau3A, enzymes which cleave within the probe, 
yields more than one hybridising fragment, whose 
sizes correspond to the sizes predicted from the 
sequence. No further hybridising bands appeared 
after longer exposures with less stringently washed 
filters (final washing in 2 x SSC/ 0.1% SDS at 
55°C), indicating that a single copy of pfran exists 
in the genome of P. falciparuni. Using standard 
calculations for the melting temperatures of mis-
matched DNA hybrids at these salt concentra-
tions and temperatures it can be estimated that it 
is unlikely that a gene with nucleotide sequence 
homology to pfran of more than 80% exists with-
in the P. falciparum genome. 
P. falciparum chromosomes were resolved on 
the CHEF gel system and the blots were hybri-
dised to the C4.1 cDNA fragment. The pfran gene 
was found to be located on chromosome II (Fig. 
2B), according to the definition of chromosome 
numbers proposed by Kemp et al. [211. This was 
confirmed by probing the same filters with chro-
mosome 5 and 9 specific probes (pfmdr-1 and msp-
I) respectively (data not shown). 
Sequence homologies between pfran and other mem-
bers of the Ran/TC4 GTPase subfam-
ily. Comparison of the amino acid sequence 
deduced from clone C4.1 with the sequences con-
tained in the GenBank database showed that 
pfRan was clearly related to proteins of the small 
GTPase superfamily (Fig. 3). The highest similar-
ity scores were with the members of the Ran/TC4 
subgroup of this family; 72% and 70% with S. 
cerevisae Gspl and Gsp2 respectively [101, 69% 
with Schizosaccharomyces pombe Spil [9], 68% 
with the filarial worm Ran/TC4 proteins [11], 
67% with the human Ran/TC4 [7], and 66% with 
Dictyostelium Dd.TC4 [8]. 
The argument that the pfran gene is a P. falci-
parum homologue of the Ran/TC4 subfamily of 
small GTPases rests on sequence homology data 
and not as yet on functional data. Predicted mole-
cular weight and possession of the 5 conserved 
guanine nucleotide binding regions clearly indi-
cate that pfran is a member of the small GTPase 
superfamily. However, outside these conserved re-
gions, there are no obvious homologies between 
the pfRan sequence and those of the other three 
0-1 	 0-2 
rC4 	MAAQPQVQ TELVLVG0_T'rTFVXRSLT7EIKYV_ATLGVEVBPL 50 
Man 	MDSQ.YIP. V. .2 ...... V 
......... 
.......... I 	.......... 
od.0C4 MARE. I ......... V ...... Q.. ...... PR.I P .... S.... 
Spil 	$. .PQNVPT .......... .......... ......... I .......... 
0-3 
TC4 	V7WVNRGPIE Mr-42TAgM EYGmBOGYY IQAQCAIIJ4Y DVVSRV!KN 100 
PfR., 	E.Q. .F.KTQ .......... .......... .ESD ...... ..S. .1.... 
Dd.rC4 	I.Y..F.X.B .................................. IS... 
Spil 	B... F.E.0 ...................... 0. .0......... I.... 
0-4 	 G-S 
1C4 	VPNWBBDLVR VcENZPIVLC GNMIXOSK VEA1SIV1BR E1NL0YY5 150 
Man 	. . . .5. .15. . . .5. .fl. .V .....V..RQ . .SRQ.Q ..... ...... L. 
Dd.5C4 	..... S. .5 ................V..R. . .PSQ ..... BY. .S. . .V. 
Spil. .R.W ....................V.0 .. .... A.T ... .......... 
5C4 	MSWYNFUP YLWLBRXLIO DPNL!FVAI4P ALAPPEVV)4D PA1.AAQYEBO 200 
pfR.n 	.5 .............. 5.5$ Q ... V. .B .5. -.700. L.NIVREAS 
od.5C4 	.......... .....PS..L. NJIAVVL.QQ. V.r.L..r.L. SN.MSL. .50 
Spil 	.......... ........ V. N ....... S ........ QV. QQ.L. ... QQE 
TC4 	LEVAQ$PALP DODD-DO. 216 
PfRn 	. .Q.AAV.I- 	0.10$ 
Dd.5C4 VAD.AALP.. EDN.-DL 
Spil 	MNE.AAJIP ...... ADO. 
Fig. 3. Comparison of protein sequences from 3 members of the 
Ran/TC4 subfamily with the Pfran amino acid sequence. Se-
quences are aligned relative to the human Ran/TC4 protein, 
the first member of the subfamily to be described [ 7]. Dd.TC4 
is the D. discoikum sequence [8] and Spil is the S. pombe se-
quence [9]. Dots indicate identical residues, dashes indicate 
gaps introduced to maximise similarity within the alignment. 
The five regions involved in guanine nucleotide binding (GI to 
G5), which are highly conserved between all members of the 
small GTPase superfamily, are underlined. 
main subfamilies of this group, the ras-like proto-
oncogenes, the ypt/rab genes and the rho type 
genes [2]. pfRan does not have the carboxyterm-
inal cysteine motif that mediates isoprenylation 
and membrane association in Ras family mem-
bers, and like the Ran/TC4 proteins, has a stretch 
of acidic amino acid residues at this position [14]. 
pfRan shares 66-72% amino acid identity with all 
members the fourth small GTPase subfamily so 
far characterised, the Ran/TC4 type proteins. 
Although the homology between mammalian re-
presentatives of this subfamily is at least 95%, 
this drops to around 80% amino acid identity be-
tween human and yeast homologues and 68% 
identity between human and Dictyostelium Ran! 
TC4 proteins. The sequence homology argument 
for provisionally accepting pfRan as the P. falci-
parum representative of the Ran/TC4 small 
GTPases is therefore strong. 
mRNA size and expression during parasite develop-
ment. To obtain some information on how pfran 
mRNA levels are regulated during intraerythrocy-
tic development, we performed a Northern blot 
analysis of RNA isolated from synchronised asex- 
kb. 
2.8— 
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ual and gametocyte cultures. Total RNA from 
ring, trophozoite, schizont and gametocyte stages 
was probed with cDNA clone C4.1 (Fig. 4). The 
probe hybridised to a diffuse band of approxi-
mately 1.3-1.5 kb. T. and it is likely that clone 
C4.1 represents a full-length (or nearly full-
length) cDNA. Transcripts produced from sexual 
and asexual stage parasites appear to be similar in 
size. Signals were strongest on the schizont and 
trophozoite lanes (Fig. 4B, lanes I and 2), indicat-
ing progressively accumulating mRNA as the 
parasite prepares for and then undergoes nuclear 
division. Very low levels were observed in early 
asexual stages and in gametocytes (Fig. 413, lanes 
3, 4 and 5). It cannot be excluded that these low 
signals may result from contamination of rings or 
gametocytes preparations with small amounts of 
trophozoites or schizonts. Similar amounts of 
RNA were present in all lanes, as indicated by 
ethidium bromide staining of the gel prior to 
transfer (Fig. 4A). As an internal control for hy-
bridisation to gametocyte mRNA, the same filter 
was hybridised to sequences from the gametocyte-
specific Pfg25/27 gene [26]. As expected, we ob-
served an intense signal only in lanes containing 
RNA from gametocytes (Fig. 4C). 
The size of the pfran mRNA supports the evi-
dence obtained from cDNA and genomic DNA 
sequences that a much larger transcript is pro-
duced than would be required to encode the pro-
tein. It is becoming clear that many Plasmodium 
transcripts are considerably longer than required 
for coding purposes alone, and that this appears 
to be mainly a consequence of having exception-
ally long 5' untranslated regions [18]. The function 
of these long 5'UTR remains to be determined. 
In both higher and lower eukaryotic cells it is 
known that GTPase activity of the Ran/TC4 pro-
tein requires the association of both a Ran specific 
GTPase activating protein [27] and an abundant 
DNA binding nuclear protein known as RCC1 in 
human [15] and Pimi (premature initiation of mi-
tosis) in S. pombe. These three molecules have 











Fig. 4. Northern blot analysis. Total P. falciparum RNA obtained from different developmental stages of clone 3D7A was fractio-
nated in a denaturing formaldehyde gel, blotted and hybridised to the pfran gene probe and Pfg27125 gametocyte specific gene. A: 
Ethidium bromide stained gel. B and C; autoradiographs of the above gel probed with pfran and pJg27125 genes respectively. Lane I: 
schizonts. lane 2: trophozoites, lane 3: rings, lane 4: mature gametocytes and lane 5: young gametocytes. 
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as yet poorly understood, role in the regulation of 
the eukaryotic cell cycle. Various possibilities have 
been suggested including a Ran mediated signal 
transduction inhibiting mitosis when chromosome 
replication is incomplete [13] and involvement of 
the Ran/RCC1 complex in the maintainance of 
interphase chromosome structure [15]. DNA 
synthesis in erythrocytic P. falciparum starts dur-
ing the latter part of trophozoite development [28]. 
Our results indicate that the steady-state pfran 
mRNA levels are developmentally regulated, in 
that mRNA levels are high during schizogony 
and low in the ring and gametocyte stages. Low 
levels of pfranmRNA in these developmental 
stages may reflect the fact that little or no DNA 
synthesis is occurring in these cells [29]. Increased 
synthesis of pfranmRNA may be required from 
mid-trophozoite stage onwards to produce a pro-
tein involved in the regulation of subsequent nu-
clear division and it is known that Ran/TC4 mu-
tants interfere with DNA synthesis and therefore 
disrupt cell cycle progression [16]. An anti-pfRan 
antiserum would permit temporal and spatial loca-
lisation of the protein within the parasite and fa-
cilitate a search for associated proteins such as 
homologues of the RCC1 protein [13] and the 
Ran-specific GTPase activating protein [27]. 
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